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ABSTRACT
The experiments documented in this thesis investigate the use of aqueous two-phase 
systems (ATPS) as a viable method for the processing of influenza virus particles in a 
feedstock derived from embryonated hen's eggs. The virus particles are currently 
purified in an industrial process using stages of sucrose density gradient 
ultracentrifugation that produce a subunit vaccine Fluvirin  which consists of the 
immunoprotective antigens haemagglutinin (HA) and neuraminidase (NA). The current 
purification scheme suffers process bottlenecks in particular, limitations of scale hence 
volumetric throughput and time taken to produce a batch that could be circumvented by 
ATPS.
Manipulations of polyethylene glycol (PEG) molecular weight, tie-line length (TLL) 
and volume ratio were exploited for the design of aqueous two-phase systems. A simple 
two-stage process was designed in which, (i) 60 % (by mass) of contaminating proteins 
were eliminated in an ATPS comprising PEG 300 22.2 % w/w/ phosphate 17.9 % w/w at 
pH 7.5 and (ii) HA antigen was released from intact influenza particles in the presence of 
1 % w/w Triton X100 in an optimised secondary ATPS comprising PEG 300 13.9 % 
w/w/ phosphate 24.3 % w/w, pH 7.5. The first purification stage using ATPS performed 
as well as the ultracentrifugation method. The material was produced with purification 
factor of 4.2 and intact virus recovery of 72 % within one hour, (as compared to a 
purification factor 4.0 and recovery of 109 % within 18 hours, using ultracentrifugation). 
Thus ATPS has demonstrated potential in fractionating particulate feedstocks in 
relatively short times, thus facilitating the circumvention of bottlnecks in the current 
commercial process.
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Chapter One
CHAPTER ONE.
1. INTRODUCTION TO VACCINES AND THEIR COMMERCIAL
MANUFACTURE.
1.1 Vaccine development: A historical perspective.
Vaccination is an efficient, cost-effective means to protect human and animal populations 
against a variety of diseases such as cholera, polio, diphtheria, measles and influenza (Cryz 
Jr., 1991; Liljeqvist and Stahl, 1999). More recently with the advent of recombinant DNA 
technology, the range of diseases that can be safely treated has been extended. The concept 
of vaccination is not a new one, dating back to 1000 BC in China and India. At the end of 
18l century the first "rational" approaches to vaccination were made by Jenner, (using 
naturally attenuated cowpox to immunise against smallpox), followed by vaccines produced 
by Pasteur (Cryz Jr., 1991). The development, large-scale production of vaccines (which has 
perhaps surprisingly, changed very little) and the establishment of immunisation 
programmes began at the turn of the 20th century. These vaccines permitted the management 
of many diseases including the eradication of smallpox (Breman and Arita, 1980; WHO, 
1980).
1.2. Definition and function of a vaccine.
A vaccine is defined as heterogeneous class of anti-infective medicinal product 
containing antigenic substances capable of inducing specific and active immunity against 
the infecting agent or the toxin or other important antigenic substances produced by this 
agent (definition in the Ph. Eur. 1998: 0153). The primary aim of a vaccine is that it 
stimulates an appropriate immune response when administered; that it should provide
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immunoprophylaxis upon subsequent exposure to the disease for a period of time and that it 
should protect populations from that disease. These vaccines act as immunogens by 
stimulating (to varying degrees) the cellular and humoral arms of the immune system. 
Different factors influence the arm that is preferentially stimulated (as discussed by Shearer 
and Clerici, 1997), which could impact upon the vaccine design. Vaccine development has 
progressed significantly over the decades from "first generation" highly purified vaccines 
consisting of whole organisms, killed- inactivated or live- attenuated (Plotkin, 1993) through 
to specific organism-derived components such as detoxified toxins- purified subunit 
vaccines (Liljeqvist and Stahl, 1999). In addition "second generation" recombinant subunit 
vaccines utilised plasmid DNA that encoded the protective subunit proteins and were 
expressed in hosts such as yeast cells. The first such vaccine licensed in the US in 1986, 
consisted of the surface antigen (S antigen) of Hepatitis B and was produced in 
Saccharomyces cerevisiae (for example Energix B , GlaxoSmithKline) whilst Hepagene  
(Medeva Pharma, now Powderject Pharmaceuticals pic) contained the S antigen in addition 
to other protective antigens which were derived from a mammalian cell line. These vaccines 
are useful in minimising both risk of pyrogenicity caused by other viral proteins (Salk, 
1948) and the reversion back to wild type, virulent genotypes. More recently "third 
generation" vaccines consisting of naked DNA (containing the information required to 
encode the protective antigens) are delivered directly to the nucleus (Ulmer et al, 1993; 
Ulmer et al, 1996c and Donnelly et al, 1997). It was shown that both arms of the immune 
response were stimulated in animal models for bacterial, parasitic and viral diseases.
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1.3. Purification of traditional vaccines.
"First generation" vaccines are usually the type of vaccine that comes to mind- the type 
that is given paraenterally (or in some cases such as polio, orally). In the context of this 
discussion they are referred to as traditional vaccines. Such vaccines originate from a range 
of organisms: bacteria (pertussis from Bordetella pertussis, Madsen, 1933; typhoid from 
Salmonella typhi, Germanier and Purer, 1975), parasites (as described in an overview by 
Cryz Jr., 1991) and viruses (polio, Sabin, 1985 and influenza A, Burnet, 1941). Safety and 
obtaining the appropriate responses (specific, at required therapeutic levels, for defined 
periods) are the biggest issues surrounding the production of vaccines. Thus the 
fractionation and elimination of impurities (undesirable components internal to the system 
such as cell debris and proteins) and contaminants (undesirable substances added to the 
system such as detergents) away from the target organism is necessary to prevent 
inappropriate (potentially fatal) responses or to ensure that the true response is not masked. 
As discussed in the previous section, some "first generation" vaccines have an excellent 
safety record hence the reluctance by manufacturers to change their production methods.
1.3.1. An introduction to'down-stream processing (DSP).
The degree of purification required for therapeutic proteins including protein-based 
vaccines is very high >99.9998 % since their end-use are as therapeutics (Wheelwright, 
1989). Their recovery depends upon bioprocesses that incorporate a range of technological 
activities including the design of a sequence of purification steps, (leading to the generation 
of purified target molecules from an initially crude feedstock) to facilitation of the process 
operation at larger scales. The purification process is called a down-stream process, DSP,
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(Wheelwright, 1989). Information regarding mass transfer and reaction kinetics which in 
turn depend upon the different phase separations required, (solid-liquid, liquid-liquid or gas- 
liquid), and thermodynamics of the system all contribute to the development and design of a 
process and the process equipment. Each individual step is known as a unit operation. By 
rational selection of these operations, one may obtain the optimal process conditions with 
respect to safety and efficacy and also requirements such as high purity and yield, cost- 
effective economics or speed to market.
1.3.1.1. Large scale purification of organisms and components comprising traditional 
vaccines.
Traditional vaccine manufacture has remained relatively consistent with respect to the 
purification schemes employed. Bacterial and some parasitic traditional vaccines (for 
example vaccines for diphtheria and malaria) are produced by a combination of fermentation 
(upstream processing), primary and secondary (downstream) processing. Primary processing 
involves microfiltration to remove cells (if a toxin is the vaccine, for example, diphtheria) 
and a detoxification step (chemically or using heat treatment). Secondary processing 
involves a combination of diafiltration or ultracentrifugation and precipitation (with 
ammonium sulphate or ethanol). Polishing is often achieved using adsorption 
chromatography including size exclusion media (Cryz Jr., 1991). This thesis focuses on the 
manufacture of a traditional viral vaccine (influenza). Viral vaccines are often sourced from 
viral seed stocks, which are inoculated and propagated into hosts in vivo (embryonated 
fertile hens egg or suckling mice) or in vitro using cell cultures, (O'Neil and Balkovic, 
1993). These vaccines are often attenuated, that is their virulence is naturally tempered to
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the disease whilst still retaining the ability to stimulate an appropriate immune response. 
Alternatively the vaccines are killed (inactivated) chemically or with the use of heat 
treatment. They are usually harvested as intact particles thus the type of impurities observed 
in these preparations are likely to be similar between viral feedstocks (cell membrane 
fragments, proteins, endotoxins and adventitious agents) and hence their primary 
purification strategies are likely to be comparable. However further downstream, depending 
on the vaccine requirements (such as a subunit vaccine) and the physico-chemical properties 
of the virus particles, the purification strategies are expected to diverge as different 
characteristics are exploited. Most of the unit operations used in the commercial production 
of bacterial and parasite vaccines are commonly applied to the purification of components 
comprising traditional viral vaccines and include: filtration, centrifugation and 
chromatography (see Figure 1.1). Precipitation is often used in the recovery of viruses on 
laboratory scale but not so frequently on larger scales because of poor selectivity and the 
high precipitant concentrations can affect their infectivity in cases where this is required 
(O'Neil and Balkovic, 1993).
1.3.1.2 Unit operations used in viral vaccine manufacture.
Utilisation of conventional unit operations such as filtration, centrifugation and 
adsorption chromatography exploit physico-chemical differences between biomolecules. For 
example filtration separates on the basis of particle size, density centrifugation, on the basis 
of particle size and density, adsorption chromatography on the basis of size, charge, 
hydrophobicity or affinity. Microfiltration (a primary processing step) and ultrafiltration 
(used in secondary processing) are solid-liquid separation techniques that isolate particles
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across a membrane according to size (Zydney and Kuriyel, 2000). Micro filtration can be 
used to fractionate particles with a diameter of 5.0 x 102 to 2.0 x 104 nm (Schmidt-Kastner 
and Golker, 1987). Ultrafiltration handles a smaller particle size range- 5.0 x 10° to 2.0 x 103 
nm (Schmidt-Kastner and Golker, 1987). The feed flow is pumped parallel (under pressure) 
to a synthetic polymer membrane with pore sizes that have been pre-selected to permit or to 
prevent the passage of target molecules. A fraction of the feed is driven through the 
membrane due to a pressure drop (the transmembrane pressure, TMP). At large scale these 
processes are operated in cross-flow (tangential flow) mode, whereby flow at a tangent to 
the feed flow continually "sweeps" the membrane surface to minimise protein and debris 
binding to the membrane, leading to the phenomena of concentration polarisation (Porter, 
1972) and fouling. Membrane performance often depends upon the characteristics and 
concentration of the feedstock (which allows selection of the most suitable membrane).
Density gradient ultracentrifugation is a processing technique that fractionates molecules 
on the basis of both density and size differences between solids and liquids. The use of a 
density gradient makes this a highly resolving fractionation technique (van Holde, 1986). 
The density gradient is magnified by the application of large centrifugal forces (in the order 
of 2.5 x 104 xg) that cause the particles to rotate at high speeds and is suitable for handling 
particles of diameter 2.0 x 10 1 to 2.0 x 103 nm (Schmidt-Kastner and Golker, 1987). Two 
types of density gradient ultracentrifugation are often employed. The first is rate zonal 
ultracentrifugation, which often uses a sucrose density gradient. In this technique, 
sedimentation transport of molecules occurs through the gradient causing a mixture of 
molecules to be fractionated according to their density and size (see Equation 1.1). The 
second is equilibrium density gradient ultracentrifugation, which (commonly) uses caesium
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Upstream processing: Fermentation 
(bacterial or parasitic organisms). In vivo 
or in vitro cell culture (see text).
Primary processing: Removal of cells 
and cell-related debris. (Stabilisation).
Detoxification/in activation: Chemically 
(using formalin, formaldehyde or - 
propiolactone). Alternatively use heat 
treatment (60°C).
Secondary processing: Concentration 
removal of water (High yield at expense 
of low purity).
Secondary (intermediate) processing:
Removal of protein and lipid, impurities 
as well as endotoxins, nucleic acids and 
adventitious agents.
Secondary processing (polishing): To
achieve desired purity (by further 
removal of the above impurities) and 
safety. (Lower yield at expense of higher 
purity).
Formulation: Final form of vaccine (for 
example purified particles suspended in 
sterile buffer).
Tangential flow microflltration:
Using 0.45 and 22 jam filters. 
Low speed centrifugation:
Approx. 8.0 x 103 to 1.0 x 104 x g.
Ultrafiltration, (diafiltration) : 
Achieved with a variety of membrane 
systems (e.g. Pellicon ). 
Ultracentrifugation: Continuous 
flow density gradient centrifugation 
using zonal rotors with speeds in the 
order of 2.5 x 104 xg. 
Precipitation: Using ammonium 
sulphate or ethanol (not often used 
for viral purification).
Adsorption chromatography:
Using ion exchange, 
hydrophobic, affinity or size 
exclusion adsorbents. 
Ultrafiltration, (diafiltration).
FIGURE 1.1. Flow chart depicting typical stages in a down-stream process scheme 
commercial scale traditional vaccine manufacture.
A general process outlining the steps in the large scale purification of organisms (to be used 
as vaccines) using conventional unit operations. These operations are shown on the right 
hand side. A more specific scheme for processing influenza virus nanoparticles is presented 
in Chapter Two Sections 2.1.5 and 2.16.
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chloride as the gradient former. This type of centrifugation is run until equilibrium is 
attained and no transport of the molecules occurs. At this point the buoyant density and 
ultimately the molecular weight of the molecules can be determined (van Holde, 1986). 
Sucrose gradients are often preferred because they are better at maintaining viral integrity 
(Faff et al, 1993). Zonal rotors are often used in fractionation because both types of 
centrifugation can be used. Also continuous flow centrifuges are often employed on 
commercial scales in order to process large feedstock volumes, whereby fresh feedstock is 
continually pumped across the centripetal surface of the density gradient (Cline and Ryel, 
1971).
Sedimentation follows Stokes Law:
t = 18r|/ d2 to2 Ap * L+Zi/L+z2 Equation 1.1.
t = time taken for single sphere of particle diameter (d) to settle a distance z\ to z? in a radial 
direction;. t| = liquid viscosity; (0 = angular velocity; Ap = difference in density between 
particle and liquid; L = radius of inner liquid surface.
From this equation it is observed that if the particle diameter, the angular velocity or the 
density difference (between particle and liquid) are small, then the longer it takes for the 
particles to sediment (hence the reason for inducing precipitation using flocculants to 
increase the density difference).
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Adsorption chromatography (once optimised) can permit highly selective and specific 
interactions between molecules and adsorbent based on size, charge, and affinity differences 
between the target molecules and impurities (Hammond and Scawen, 1989). The most 
frequently used mode of operation involves binding of the target molecules to the adsorbent 
(allowing the impurities to pass through), followed by elution of the target molecules by 
manipulating conditions (such as salt concentration or pH).
Examples in literature detailing the use of these techniques for traditional viral vaccine 
production at commercial scale are scarce. In addition since many of these commercial 
processes have been in place for some decades, improved materials (filtration membranes, 
ultracentrifugation density media and chromatographic adsorbents) were probably not 
available at the time of establishment of the purification protocols. Thus if the bioprocess 
scientists had a commercial process that worked, then there was no real impetus to evaluate 
alternatives (also contributing to the lack of information in the public domain). However 
there are recent examples in literature whereby viruses have been purified using anion 
exchange chromatography on a relatively smaller (milligram to decigram) scale (Walin et a/, 
1994). Inactivated HIV-1 particles purified by anion exchange chromatography followed by 
diafiltration produced enough virus particles for Phase III clinical trial, (Richieri et al, 
1998). O'Keefe et al, (1999) showed that DISC-HSV-1 Type 2 viruses cultured from Vero 
cells could be isolated in relatively high titre from impurities whilst maintaining their 
infectivity. The chromatographic matrix used (heparin sulphate) was also proposed for use 
with other similarly charged enveloped viruses: human cytomegalovirus (CMV) and human 
immunodeficiency virus (HIV-1). Cation exchange chromatography for the purification of 
herpesviruses was also reported by (Karger et al 1998). However the following discussion
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1.3.1.3. Highlighting problems associated with the use of conventional unit operations for 
commercial scale virus purification.
The unit operations previously discussed depend upon the size, density or surface 
properties of the target particles. Most viruses have a particle diameter of between 2.0 x 10 1 
to 2.0 x 102 nm thus they can be classed as nanoparticulates. These unit operations are 
designed for the recovery of proteins (particle diameter of 1.0 x 10° to 1.0 x 10 1 nm). 
Microfiltration (operating range 5.0 x 102 to 2.0 x 104 nm) is often used as a gross 
clarification step (retaining debris and cells, whilst permitting proteins to pass through) 
ultrafiltration (operating range 5.0 x 10° to 2.0 x 103 nm) is used further downstream (refer 
to Figure 1.1). These techniques are fine when there is a relatively large difference in size 
between the proteins and debris or cells, hi fact ultrafiltration (and nanofiltration) are often 
used as process scale methods of removing viruses from feedstocks (Hoffer et al, 1995; Graf 
et al, 1999 and Azari et al, 2000). However when the target molecule is in the 
nanoparticulate range, the size difference between the nanoparticles and debris is less thus 
decreasing the resolution of the technique, hi addition during the filtration process, the flux 
of liquid per unit membrane decreases due to fouling. This contributes significantly to the 
operational cost. Scale up increases the volumetric capacity but also the cost.
In the case of ultracentrifugation, proteins can be efficiently fractionated from debris and 
viruses (when these are a contaminant) since there is a large difference in density between 
the surrounding liquid and the proteins and the debris; in addition there is a large difference 
in size between the proteins (particle diameters of between 1.0 x 10° to 1.0 x 10 1 nm) and 
debris and cells (particle diameters in excess of 1.0 x 102 nm). However when 
nanoparticulates such as viruses (particle diameters of between 2.0 x 10 1 to 2.0 x 102 nm)
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are fractionated, one observes that the size differences between the molecules and densities 
differences between the debris and liquid are much smaller, leading to a decrease in 
resolution. Thus long process times are required in order to fractionate the nanoparticles 
from the debris, (refer to Equation 1.1 and O'Neil and Balkovic, 1993) rendering this unit 
operation energy-intensive. Another disadvantage lies in the limited volumetric capacity of 
the rotors. Even if a continuous flow rotor was used, there is only a finite volume of 
feedstock that can be processed at any one time. In practice this is circumvented by using 
multiple rotors (which adds to the cost of the process). The preparation and set up of 
gradients on large scale is labour-intensive (Braas et al, 1996) and gradient forming 
chemicals such as caesium chloride (CsCl) are relatively expensive and high concentrations 
can place the virion (of enveloped viruses) under osmotic stress leading to viral disruption 
that can affect viral infectivity; although this is circumvented to some degree by the 
introduction of synthetic gradient media (Karger et al, 1998). This is not a problem for 
traditional viral vaccines (that are not required to maintain their infectivity for their end 
purpose) but it could be a problem with viruses required for other purposes such as gene 
therapy vectors that require infectivity to gain access to target cells.
Conventional packed bed adsorption chromatography can be specific but requires that the 
feedstock be clarified prior to loading onto a column (this was the case in all the examples 
described at the end of Section 1.3.1.2), which adds to the process time and costs. 
Conventional gel adsorbents contain pores in the 3.0 x 10 1 to 4.0 x 102 nm range (O'Keefe 
et al, 1999). This is fine for penetration of proteins (1.0 x 10° to 1.0 x 10 1 nm range) but the 
pores tend to exclude viruses (in the 1.0 x 102 nm range) leading to diminished capacity 
(Walin et al, 1994) Although a promising report concerning the capacity of heparin-HP
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media and HSV-2 virus, documented a capacity in excess of 5.0 x 109 pfu ml" 1 gel (O'Keefe 
et al, 1999). This would just about be adequate for the production of traditional viral 
vaccines but with future ambitions of meeting the commercial demand for viral gene therapy 
vectors, this capacity needs to be improved by at least three orders of magnitude, which 
could be realised with improved matrix design (Braas et al, 1996). The scale-up of unit 
operations using adsorption chromatography can be problematic; the large amount of 
adsorbent and requirements for rigorous sanitation also add to the process cost. Thus each 
conventional unit operation suffers from specific problems that prevent their maximal 
utilisation when applied to the processing of nanoparticles. This provides the stimulus to 
look at alternative techniques to handle such particles.
1.3.1.4. A commercial example of viral vaccine production using conventional unit 
operations.
The discussion has so far centred on the commercial manufacture of traditional vaccines 
with emphasis on those of a viral nature. The theme of this thesis concerns the commercial 
production of an influenza virus vaccine. Influenza disease is still a potential killer (Reid et 
al, 1999). Medeva Pharma (now Powderject Pharmaceuticals pic) the UK's premier vaccine 
manufacturing company produces an attenuated, inactivated influenza subunit vaccine. 
Medeva Pharma identified problems with one of their processes- using influenza particles 
(approximately 1.0 x 102 nm particle diameter). The vaccine is currently produced by stages 
of sucrose density ultracentrifugation (further details are given in Section 2.1.5 of this 
thesis), which as previously discussed is an energy-intensive, scale-limited unit operation. 
Multiple rotors are employed to increase throughput (which again adds to the energy
12
Chapter One
consumption). This creates a bottleneck (or rate-limiting step), which (i) compromises the 
throughput (due to the long processing times required), (ii) possibly affects the potency of 
the vaccine (prolonged residency) and (iii) definitely impacts upon the profitability of the 
process. This is a prime example of a successful bench-scale process (Brady, PhD Thesis, 
1974), which has been directly scaled up without investigation of alternative (and possibly 
better) purification commercial-scale strategies. Density gradient ultracentrifugation is 
frequently used in harvesting viruses and thus is employed in the experimental work herein 
as a benchmark by which to judge the performance of alternative techniques.
The pressure to find and test out alternative techniques is even more urgent in the light 
that companies continue to use sub-optimised processes consisting of conventional DSP unit 
operations in order to qualify their products through regulatory bodies. This is governed by a 
number of reasons: a reluctance to change the existing dogmas; speed to market (particularly 
if a new product); constraints of costs; accountability to shareholders and the existing wealth 
of validation data at both small and large scale that perpetuates the use of the conventional 
techniques in regulatory submissions, hi practice the techniques, which meet the required 
purification criteria first, tend to set the regulatory ground rules and the precedent for 
subsequent techniques. Therefore the only way that alternative techniques could be 
considered would be if a company decides that their process (using conventional techniques) 
was not cost effective, hi the interim, field researchers must continue to build up a body of 
evidence for alternatives in order to convince the companies. Hopefully a "domino effect" 
would ensue in that other companies begin to adopt alternative techniques and so change 
existing regulatory frameworks.
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1.4. A brief survey of alternative bioseparation technologies useful for processing 
nanoparticulates.
A selection of alternative techniques is briefly discussed in order to give an insight into 
exciting developments in the field of bioseparation. All are being currently investigated to 
handle proteins but it may be possible that some will successfully be used to handle 
nanoparticles such as the influenza virus.
1.4.1. Fluidised bed adsorption chromatography.
Fluidised bed adsorption chromatography has been used as a purification technique since 
the 1950's. This technique consisted of the adsorbent being placed in a stirred tank to allow 
binding of target biomolecules such as the recovery of antibiotics from broths (Bartels et al, 
1958). These fluidised beds were inefficient (providing a single equilibrium stage) with 
extensive channelling and turbulence and poor recoveries. It was in the late 1980's and early 
1990's that stable fluidised (so-called, expanded) beds were created with similar 
characteristics (plug flow, low back-mixing) to a packed bed. Not long after that that these 
beds were being used to recover proteins from particulate feedstocks (Wells and Lyddiatt, 
1987) such as whole cell fermentation broths and cell disruptates. This technique was 
proposed as a means of circumventing some of the solid-liquid separation problems 
(outlined in Section 1.3.1.3) such as removal of particulate material from proteins (without 
the requirement for clarification), decreasing the number of unit operations and process 
integration. This unit operation employs porous adsorbents (like those used in packed bed 
adsorbent chromatography) but in order to acquire different settling velocities between the 
feedstock molecules and the adsorbent particles during fluidisation, it was necessary to
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integration. This unit operation employs porous adsorbents (like those used in packed bed 
adsorbent chromatography) but in order to acquire different settling velocities between the 
feedstock molecules and the adsorbent particles during fluidisation, it was necessary to 
increase the density of the latter. This was achieved by creating an inert core of increased 
density, 1.15- 1.3 g ml" 1 , (Hjorth, 1997; Zhang et al, 1999) and then derivatising these with 
the required ligands. The frequently used STREAMLINE  range of adsorbents 
(manufactured by Amersham Pharmacia Biotech., Uppsala, Sweden) employ a crystalline 
quartz inert core. The feedstock is loaded onto the column in an upward flow which 
separates the particles allowing passage of the feedstock molecules, permitting the proteins 
to bind to the chromatography matrix and the paniculate material to be washed away. 
Protein elution occurs in packed bed mode (Hjorth, 1997; Pharmacia Handbook, Edition 
AA). Much research has been undertaken on the performance of proteins. The current focus 
is on designing new matrices including novel ligands and engineered proteins to enhance 
recovery on chromatographic matrices (Asplund et al, 2000; Hober, et al, 2000), processing 
strategies such as process integration (Bierau et al, 1999) were designed to improve 
recovery and minimise residence times of labile proteins. In addition the hydrodynamic 
performances of these matrices was also investigated (Thommes et al, 1995). This technique 
is thought not to generate shear and has been used for separations involving mammalian cell 
culture (Batt et al, 1995). In addition it has been demonstrated on large scale to showing 
significant improvement over packed bed with respect to decreased time and process 
volumes and increased throughput (Johansson et al, 1996). However this technique has been 
primarily demonstrated for protein recovery. Its potential for handling nanoparticles has 
only so far been undertaken using plasmids (Varley et al, 1999; Ferreira et al, 2000).
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chromatography could be applied to other nanoparticulate feedstocks such as those 
containing viruses.
1.4.2. Selective precipitation.
Chemicals such as alcohol, PEG 6000 ammonium sulphate have been used as 
precipitants. (Ingham, 1990 and 1984), which involves the removal of water from the 
surface of the proteins leading to a decrease in solubility. This technique is not utilised 
frequently due to poor understanding of the mechanisms involved that make it possible to 
precipitate selectively. The commercial use of precipitation for the preparation of bacterial 
and parasitic vaccines was briefly discussed in Section 1.3.1.1. However this method tended 
to be used when the vaccine component was secreted into the fermentation medium (for 
example, diphtheria toxin) and the cells removed prior to adding the precipitant. Utilisation 
of this technique for the purification of nanoparticulates such as viruses would probably 
affect their infectivity (important for gene therapy vectors) and require time-consuming 
desalting techniques (Braas et al, 1996).
1.4.3. Aqueous two-phase systems (ATPS).
Albertsson (1958) first looked at aqueous two-phase systems (ATPS) as a potential 
purification technique for partition of proteins in polymer-polymer solutions. This technique 
is highly versatile being able to selectively fractionate secondary metabolites, proteins, 
nanoparticles and macromolecules (Albertsson, 1986). Each phase contains in excess of 
70% water. Thus ATPS has been used in partitioning biomolecules due to the mild 
environment provided. The conventional bioseparation techniques discussed in Section
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1.3.1.2 were effective within certain particle size ranges. ATPS has demonstrated 
fractionation procedures over a much wider range of particle sizes, which points to its utility 
as a versatile purification technique that will be discussed in detail further in the text.
1.4.4. Selection of a potential alternative bioseparation technology to process influenza 
particles.
Separation using ATPS was initially considered because it could offer a solution to the 
problems faced in the Medeva Fluvirin  Process. Ideally, time-consuming (rate-limiting) 
unit operations could be circumvented with the elimination of process bottlenecks (Hustedt 
1985; Huddleston et al, 1991b). In addition this process could provide a suitable 
environment for the influenza particles and is relatively easy to scale up.
1.5. A Description of ATPS.
Aqueous two-phase extraction using aqueous two-phase systems (ATPS) is a liquid- 
liquid separation technique that was initially used to partition proteins (enzymes), 
nanoparticles (viruses) and macromolecules- cells and organelles, (Albertsson, 1986). An 
ATPS consists of a polymer pair (for example polyethylene glycol-PEG and dextran) or a 
polymer salt pair (for example- PEG and phosphate). When these are mixed in common 
solvent- water above critical concentrations, their incompatibility leads to the formation of 
two phases that coexist and are in equilibrium with each other. Each phase is enriched with 
one of the polymers (or salts). For example in a polymer-salt ATPS, the top phase is 
enriched in polymer and the bottom in salt.
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1.5.1. Mechanism of phase separation in ATPS.
Explanations regarding the mechanism of phase separation in polymer-polymer ATPS 
have been attempted using thermodynamics. As the polymers mix, the enthalpy of mixing is 
great; there is a concomitant decrease in entropy to compensate as the polymers separate to 
their respective phases. This forms the basis of several models reviewed by (Abbott et al, 
1990). There are many combinations of polymer-polymer or polymer salt systems that can 
form ATPS (for example polyvinyl alcohol-Dextran; methylcellulose-PEG). The most 
studied use polyethylene glycol (PEG) and Dextran and PEG-phosphate (or sulphate). 
Polyethylene glycol is a homopolymer consisting of repeating ethylene units linked by an 
ether bond. It possesses some unique features that are responsible for its solubility such as 
the ability to efficiently order a hydration layer because some molecules with similar 
structures exist that are less soluble (Huddleston et al, 1991b). Dextran is derived from 
Leuconostoc mesenteroides. Dextran possibly orders a layer of water leading to H-bonding 
between water and hydroxyl groups on the polymer. It is thought that water surrounding 
these polymers are orientated differently and therefore when mixed (above critical 
concentrations) repel each other leading to phase separation. Phase separation in PEG-salt 
(for example phosphate) ATPS is thought to be brought about by a balance between 
enthalpic and entropic interactions (Huddleston et al, 1991b). Phase separation in a PEG-salt 
ATPS depends on the type of salt used. The ions form a lyotropic series based on ability to 
salt out (Ananthapadmanabhan and Goddard, 1987). In this series, the anion is more 
important than the cation in phase separation and multivalent ions more important than 
monovalent ions. This is because the larger, more-charged ions cannot interact with PEG 
and are thus repelled leading to phase separation. If the interactions were closer (such as
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between PEG of longer chain length) this would occur more readily. Thus an ATPS 
comprising PEG of high molecular weight and potassium (K+) and phosphate (HPO42~) ions 
would be very effective at phase separation.
1.5.2. Factors affecting phase separation in ATPS.
When a two-phase system is mixed, droplets from one of the phase formants coalesce 
and as the ordered water molecules surrounding the phase formant are disrupted, there are 
interactions with the other phase formant. Mass transfer of the molecules occurs across the 
interface. As the water molecules regain order, the interactions between phase formants 
becomes unfavourable and phase separation occurs. The rate of droplets coalescing depends 
on the interfacial tension (Bamberger et al, 1984), which provides the driving force for 
adsorption of particles at the interface. Adsorption of particles at the interface can lead to 
their denaturation (presumably due to changes in conformation as a result of osmotic effects 
and high shear forces). The relatively low interfacial tension in ATPS provides the reason 
why aqueous-aqueous systems are preferred for processing biological molecules instead of 
aqueous-organic systems. The former exhibit interfacial tensions in the order of 0.1-2 mN" 1 
for PEG-salt ATPS and 0.0001-0.1 mN" 1 for PEG-dextran ATPS, whilst the latter possess 
interfacial tensions of at least an order of magnitude greater (Hustedt et al, 1985). Lowering 
of the interfacial tension is thermodynamically favourable since energy is used to decrease 
the interfacial area and thus decrease the number of particles adsorbing at the interface 
(Sadana, 1993). This is important in context of the work presented in this thesis since it has 
been observed and reported that systems loaded with nanoparticles partition to the interface 
(Braas, PhD Thesis, 2000). Thus it is probable that the influenza virus particles will exhibit
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similar partition behaviour. In addition, such a strategy of lowering the interfacial tension 
has been employed in the experimental work documented in this thesis. In this case, the 
target particles require harvesting from the interphase. This is not conventional since this 
phase is often overlooked. However this presents the advantage of harvesting a de-watered, 
relatively concentrated product (which can reduce process costs of removing excess water 
further downstream) and also the challenges of how to harvest such a phase at process scale 
and how to characterise ATPS consisting of both solid and liquid phases. The interfacial 
tension is also affected by temperature (increased temperature decreases the interfacial 
tension), differences in polymer concentration and salt concentration (increases in these 
variables increases the interfacial tension). Physico-chemical properties of the phases such 
as density and viscosity of the phases affect phase separation. The densities of the phase 
formants determine which predominantly occupies the top and bottom phases. The viscosity 
of the phases determines the scale up feasibility of a separation. Denser more viscous phases 
are slower to phase separate than less dense and less viscous phases, which could have an 
impact upon the stability of labile proteins or particles. Temperature affects both of these 
parameters therefore affects the phase separation. The type of phase formant and their 
relative concentration in the ATPS determines the type and strength of interaction during 
mixing.
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FIGURE 1.2. A schematic illustration of a binodal curve showing a PEG-phosphate 
aqueous two-phase system.
All systems above the curve are biphasic and those below are monophasic. The line AC 
denotes a tie line. All systems on this tie line will have the same tie line length (ILL). 
Thus the tie line provides a positional co-ordinate on the binodal. These systems have 
different overall compositions but the same final phase compositions thus the top phases 
are all of equal composition and the bottom phases are all of equal composition. Thus 
the only difference is in the ratio of the volumes. This parameter provides a locational 
coordinate on the binodal curve. The point X marks the critical point, which is the point 
where the phase transition from monophasic to biphasic just occurs. Theoretically it is 
the point where the volume ratio is equal to unity and the TLL is equal to zero. The 
shaded areas on the test tubes represent PEG-rich phases and the clear areas represent 
phosphate-rich phases.
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1.5.3. Characterisation ofATPS.
Aqueous two-phase systems (ATPS) are characterised by a phase diagram or binodal 
(Figure 1 .2). The phase diagram is ternary in nature but simplified in the binodal by showing 
only two axes (the remaining solute is water by inference). On the binodal depicted in 
Figure 1.2, systems with compositions above the binodal are biphasic and those below 
monophasic. Systems on the binodal curve with different overall composition but same final 
phase composition can be connected by a tie line. The length of a tie line is referred to as the 
tie-line length (TLL) and is one of the characteristics used to describe an ATPS. The TLL 
can be easily estimated from a Pythagorean procedure using Equation 1 .2 (Huddleston et al, 
1991b);
TLL = (ACt0p2 + ACbottom2 ) 1/2 Equation 1.2.
Where ACtop and ACbottom are differences in concentration (determined from the binodal) of 
the top and bottom phases respectively. Any selected co-ordinates along the tie-line gives a 
volume ratio (Vr), Equation 1.3.
Vr = Vtop /Vbottom Equation 1.3.
This can be estimated from the binodal as the ratio of tie-line segments bisected by the 
overall system composition (for example in the case of system D2, Equation 1.4).
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Vtop /Vbottom = CD2/AD2 Equation 1 . 4.
The volume ratio is an approximation assuming that the density (p) of each phase is unity. 
Therefore a more accurate estimation is to use the mass ratio, Equation 1.5.
Mr = Vtop* Ptop /Vbottom * ptop Equation 1.5.
Thus the TLL gives positional co-ordinates and volume ratio gives locational co-ordinates. 
The binodal also possesses a unique point (X) in Figure 1 .2 This is known as the critical 
point; theoretically it is the point where the TLL is zero and the volume ratio is equal to 
unity. At this region, ideal partition is obeyed. This gives rise to systems that are highly 
sensitive to changes such as those of composition, temperature, and pH. These systems will 
be referred to herein as "sensitive" systems, while those systems distant from the critical 
point will be referred to as "robust" since they are robust with respect to such changes. 
However there is evidence to suggest that even robust systems can behave in a sensitive 
manner, using plasmids (personal communication, F. Luechau, 2001).
1.5.4. Factors controlling molecular partition.
Partitioned material distributes unequally between the two phases and can be estimated 
from the partition coefficient (K) a useful parameter as shown in Equation 1.6 (Hariri et al, 
1989).
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K= Ct/Cb Equation 1.6.
Where Ct is the concentration of target solute in the top phase and Cb is the concentration of 
target solute in the bottom phase. K is a function of many parameters: K = K electrostatic + 
Khydrophobic+ Kconformation+ Ksjze + Kaffmjty +Ktemp+ Kother (Albertsson, 1986). In addition K 
electrostatic is influenced by system pH and the addition of neutral salts; Khydrophobic influenced 
by type and molecular weight of the phase-forming chemicals such as PEG; the 
concentration difference between the phases; Kconformation and KS ize are influenced by the 
shape and surface area of the particles. These factors can be manipulated to direct impurities 
away from the target particle(s) or to control partition characteristics. For example BSA in 
PEG 1000-salt ATPS partitions to the top phase (at high TLL) whilst in a PEG 3350-salt 
ATPS this protein partitions to the bottom phase, (Huddleston et al, 199la). The 
determination of K is so important because of its thermodynamic origins and the fact that it 
can be used to assess the performance of a bioseparation procedure. The ATPS have been 
described so far with respect to containing only the phase forming chemicals (and a low 
concentration- < 0.1 % of protein, which has little effect on the binodal, Baskir et al, 1988); 
these systems will be defined as "blank" systems; when the protein concentration is higher 
than this, and/or contains biomass, they will be defined as "loaded" systems.
1.5.5. Loaded ATPS.
hi practical working systems (that is, loaded ATPS), the binodal curve is shifted towards 
lower concentrations of phase formants (Figure 1.3), suggesting that the biomass contributes 
to the overall composition of the system. Different feedstocks impact upon the binodal in
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FIGURE 1,3. Schematic binodal curve showing the effect of biomass.
The presence of biomass (forming a loaded ATPS) has shifted the binodal towards the 
origin (towards lower concentrations of phase-forming chemicals). The dashed line 
curve indicates the new position of the binodal curve. The solid line curve indicates the 
original position of the binodal (that is with a blank ATPS). Note that the shift depicted 
is stylised since different feedstocks impact on the binodal in different ways (and also 
depends on the loading). Also note that the tie line length (TLL) has increased. These 
effects are observed when pH or temperature is increased. The bold arrow indicates the 
general direction of the shift of the binodal. There is often multiple phase formation in 
the presence of biomass. The shaded areas of the two tubes in the insert represent the 
types of multiple phases observed; refer to main text for details.
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different ways and this is manifested in the presence of multiple phases (see insert of Figure 
1.3). Some researchers disregard the solid phases accepting that some loss of product is 
inevitable (Boland, 1991); others treat them as belonging to one of the bulk phases (Rito- 
Palomares and Cueto, 2000; Lebreton, PhD Thesis, 1998) or some assume that it belongs 
equally to either phase, (as discussed by Walker, PhD Thesis, 1998). In this thesis, multiple 
phases (including interphases and sediments) are treated as discrete phases wherever 
possible and the description proposed by (Walker, PhD Thesis, 1998) was used to interpret 
the results (refer to Section 2.18). Kim, (PhD Thesis, 1986) first modelled the formation of 
interphases in PEG-salt ATPS. These effects (which are used to explain partitioning 
phenomena in these systems) involve a combination of salting out (Melander and Horvath, 
1977) from the bottom phase and excluded volume from the PEG-rich phase. The latter 
effect is simply envisaged as increased entanglement of PEG chains as their length (or 
average molecular weight increases) that leads to an exclusion of molecules from their 
surfaces. Ideally one wishes the target molecules to partition to one of the bulk phases. The 
bottom phase is preferred because in a PEG-salt ATPS, salt can be more easily removed 
than PEG allowing for interfacing with other unit operations such as hydrophobic interaction 
chromatography (Huddleston et al, 1996) or ultrafiltration (Guan et al, 1992). There are 
many examples whereby a protein favouring the top phase has been deliberately back- 
extracted to achieve this (Boland, 1991; Rito-Palomares, PhD Thesis, 1995; 1996a). In 
addition this permits PEG recycling to save on process costs (Rito-Palomares, 1996a). 
However in a recent publication Walker and Lyddiatt, (1999) suggest the potential for 
recovering target particles as a sediment.
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1.5.6. The diversity of purification problems handled by ATPS.
It is exciting to note that ATPS is playing a role in the harvesting of commercially 
relevant enzymes that affect many areas of our lives: medical, chemical, textiles and paper 
production, (refer to Figure 1.4). A strategy that has been employed in using ATPS on large 
scale has been to look at current industrial processes with problems, identify them, and 
attempt to propose where ATPS may be used to overcome these problems. Since the 
exploitation of ATPS as a separation technique began (Albertsson, 1958), it has been mainly 
used in the isolation of intracellular enzymes from debris (Kroner et al, 1978; Veide et al 
1983.) Although the potential of ATPS for fractionating particles such as blood cells, 
chloroplasts and viruses has been demonstrated (Albertsson, 1986). This technique has 
demonstrated versatility in isolating proteins from different sources: bacteria, yeasts, plants 
(Hustedt et al, 1978; Kulkarni et al, 1999; Guan et al, 1992; Flanagan et al 1991; 
Huddleston et al, 199la; Cole, 1993; Miranda and Cascone, 1997) and also with 
biomolecules of different size ranges from secondary metabolites (antibiotics; Paquet et al, 
1994 and organic acids; Planas et al, 1997), through to proteins and finally to nanoparticles 
larger organelles. The many diverse areas of current research in this field are outlined in 
Figure 1.4. Successful commercial processes (incidentally originating from the US) offer 
significant advantages such as high partition coefficient (K) values, the ability to interface 
with other unit operations or procedures (for example, Genencor, patented a process for the 
production of chymosin from a fermentation broth with K in excess of 80. The high K 
occurs at low pH (2.0- 2.5). The ATPS is interfaced further downstream with ion exchange 
chromatography to remove the PEG. Also Genentech, San Francisco, CA,
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FIGURE 1.4. A summary of the current research areas in the field ofATPS. On the basis 
of the data obtained from the two major areas, a case could be presented for the 
consideration of ATPS as a serious candidate for the large scale processing of 
nanoparticles (including viruses).
Persson et al, 2000; 19991'2; Skuse et al, 19923; Hughes and Lowe, 19884; Veide et al, 1984s; Kroner and Kula, 
19826; Hustedt et al, 1978 7; Kroner et al, 1978s; Kroner et al, 19849; Rito-Palomares,1996a'°; Lebreton and 
Lyddiatt 2000";1998r~~'3;Huddleston et al, 1991"' b 14~1S; Forciniti and Hall, 1992!6;Eitman and Gainer, 
199017;Abbott etal, 1990IS;Albertsson, 1986I9;Cabezas et al, 199020;Braas et al, 200021 ;Walker and Lyddiatt, 
1998"; Sebastiao et al, 199723; Zhou et al, 199724; Sivars and Tjerneld, 200025; Terstappen et al, 199326:; 
Johansson' 198527;Su and Feng, 199928;Huddleston, 199629; Joshi et al, 199030
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USA obtained human insulin-like growth factor I inclusion bodies using PEG 8000-salt 
ATPS. They were able to use process conditions to directly resolubilise the protein and to 
simultaneously remove cells from the fermentation broth (Hart et al, 1994). Examples of 
ATPS used in the processing of nanoparticulates include: surrogate mimics (Braas and 
Lyddiatt, 2000), vaccines on small scale, (Hammar et al, 1990; 1989a and 1989b); small 
inclusion bodies of alpha glucosidase (Walker and Lyddiatt, 1998; 1999), and surrogate 
mimics (Braas and Lyddiatt, 2000); virus-like particles (Andrews, 1995); and prion protein 
aggregates (transmissible spongiform encephalopathy) required in large amount for research 
and diagnostic assays, (Walker et al, 1996).
1.6. Aims of investigation.
The aim (and emphasis) of this thesis was to investigate the laboratory scale fractionation 
of influenza virus nanoparticles that form the basis of a commercial subunit vaccine 
(Fluvirin ) using ATPS. The decision to use PEG-salt ATPS was made on the basis of 
favourable process economics (salt being relatively inexpensive compared to Dextran; the 
ability to work at a wider range of volume ratios for similar cost); faster de-mixing kinetics 
due to lower phase viscosities (Sikdar, 1991) and also due to literature reporting the 
potential of these systems in the handling of nanoparticulates (Walker and Lyddiatt, 1998; 
1999). The next objective was to design a downstream process whose end product was 
similar to that produced by the Medeva Fluvirin  Process. Once it was demonstrated that 
ATPS was useful in the processing of the influenza virus, the next goal was to evaluate its 
performance (with respect to purity and yield) against a benchmark method: sucrose density 
ultracentrifugation (and more importantly in this case, the method currently employed by
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Medeva Pharma). A critical analysis of these techniques would enable one to weigh up their 
relative advantages and disadvantages and also help decide where in the DSP scheme, ATPS 
could be employed. This would provide conclusions regarding the technique that was most 
suitable for handling influenza virus particles. Successful meeting of all or most of these 
objectives would further demonstrate the processing of nanoparticles by ATPS and also 
permit the description of systems containing real feedstocks and multiple phase formation 
which could point to generic partition mechanisms thus aiding process design.
1.7. Structure of thesis.
The requirement for a bioseparation process that can selectively fractionate the target 
molecules away from impurities is the central theme of this project, hi this context the target 
molecules were influenza virus nanoparticles and the impurities consisted of (for the most 
part) proteins and cell membrane debris. This feedstock originated from a commercial 
process (Medeva Fluvirin  Process), which suffered from various bottlenecks. It was 
proposed to use ATPS as a candidate bioseparation technique that could overcome these 
bottlenecks (for reasons discussed previously). Initially, potential ATPS were evaluated 
using purified influenza viral particles (refer to Appendix I). This allowed characterisation 
(using Medeva-sourced assays) of the virus particles with respect to their surface antigens 
(haemagglutinin and neuraminidase) and also permitted tracking of virus partition within the 
ATPS. The PEG molecular weight, tie-line length (TLL) and volume ratio were 
manipulated. The purified virus particles spiked with a major protein contaminant 
(ovalbumin) was also investigated to allow selection of ATPS capable of fractionating the 
virus particles away from the ovalbumin. Chapter Two describes the method scouting
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experiments undertaken to define potentially useful systems for the partitioning of the 
conditioned crude feedstock from the Medeva Fluvirin  Process, inactivated bulk fluid 
(IBF). This material contained the influenza virus particles in allantoic fluid (derived from 
fertile hen's eggs). The IBF feedstock was characterised with respect to the viral proteins 
and the protein impurities using an in-house method developed using SDS PAGE and one- 
dimensional densitometry. In addition to manipulation of the PEG molecular weight and 
TLL, the volume ratios of selected ATPS were varied and from this the most promising 
ATPS was taken forward for further process development. Chapter Three describes the 
employment of the candidate ATPS (defined in the previous chapter) in a DSP scheme. The 
use of detergent in ATPS was evaluated and then employed to solubilise the surface 
antigens. This was followed by further purification using tangential flow ultrafiltration. The 
material generated by ATPS at the end the DSP scheme was compared with material 
generated at the end of the Medeva Fluvirin  Process (using sucrose density 
ultracentrifugation). The comparison was made on the basis of purity, yield and time to 
produce an equivalent batch. Preliminary conclusions and discussions regarding 
experimental work undertaken were presented at the end of each chapter and final 
conclusions were given in Chapter Four. Further work and was discussed along with how it 
contributes to work undertaken by other field researchers. Finally, future directions and 
trends were indicated for the processing of other nanoparticles using ATPS.
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CHAPTER TWO.
2. SCREENING FOR SUITABLE AQUEOUS TWO PHASE SYSTEMS FOR 
PARTITIONING A CRUDE FEEDSTOCK CONTAINING INFLUENZA VIRUS
PARTICLES.
2.1. INTRODUCTION.
2.1.1. Aims of Chapter Two.
The technique of ATPS is suited to fractionation of nanoparticles (Walker and 
Lyddiatt, 1998; 1999). Influenza virus is considered a nanoparticle and will be described 
in the following section. This chapter focuses on the utilisation of ATPS in the screening 
for suitable ATPSs capable of fractionating influenza virus particles in a crude feedstock 
originating from the commercial Medeva Fluvirin  Process. Structural information 
regarding the components of this feedstock is given along with details of the current 
Medeva Fluvirin  Process.
2.1.2. The structure of Influenza virus.
Influenza virus is an enveloped, RNA orthomxyovirus approximately 80 to 120 nm in 
diameter (Kilbourne, 1975) that is of extreme biological importance from an 
epidemiological viewpoint in humans and other species. The advent of electron 
microscopy, negative staining techniques and other biochemical techniques have 
contributed in providing detailed description of this virus (Choppin et al, 1961 and Hoyle 
et al, 1961). Influenza is a heterogeneous virus and is composed of 70 to 75 % protein, 
20 to 24 % lipid, 5 to 8 % carbohydrate and 0.8 to 1.1 % RNA. It has a molecular mass 
of between 270 x 103 to 290 x 103 kDa as determined by electron microscopy and 
sedimentation analysis, (Kilbourne, 1975). Key characteristics of the virus are illustrated
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in Figure 2.1. Influenza virus consists of strains of type A, B and C. Only A and B 
strains cause significant human disease (Murray et al, 1994). Influenza virions possess 
two important antigenic proteins: haemagglutinin (HA) and neuraminidase (NA). 
Haemagglutinin is a 224 kDa "triangular-shaped" (when viewed end-on), homotrimer, 
which is approximately 14 nm long and 4 nm across (Laver and Valentine, 1969; 
Kilboume, 1975). HA is composed of monomers of approximately 80 kDa (Kilboume, 
1975), which are held together by disulphide bonds to form the homotrimer. Cleavage 
(enzymatic or reductive) of the monomers generates two polypeptides of approximately 
50 kDa, (HAi) and 25 kDa (HA2). These are referred to as heavy and light chain 
polypeptides respectively. They are both glycosylated, but the majority of the 
oligosaccharides are attached to the HAi sub unit. This sub unit carries the molecular 
domains exposed to the environment and thus carries the majority of antigenic sites 
(suggesting that these oligoscaacharides are at least partly implicated in antigenic 
recognition). The HA2 subunit possesses some antigenic sites, but is primarily 
responsible for the hydrophobic properties which include anchorage of the HA to the 
lipid bilayer (see Figure 2.2). When viewed end-on, the NA molecule is observed as a 
"mushroom-shaped" tetramer (see Figure 2.2), which has a molecular mass of 240 kDa 
(Laver and Valentine, 1969; Varghese et al, 1983). In most strains, each subunit is 
approximately 60 kDa in size. The antigenic and enzymatic activities of NA are located 
in separate domains of the NA (Ada et al, 1963; Kobasa et al, 1997). The major 
structural protein of the viral envelope is the matrix (M) protein, subdivided into Ml and 
M2 proteins. Other proteins present in an influenza virion are nucleoprotein- NP 
(associated with RNA in the nucleus), the polymerase, P proteins that are also located in 
the nucleus and are associated with the nucleocapsid (possibly involved in RNA
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HA
FIGURE 2.2. Model of the influenza virus.
Haemagglutinin (HA) spikes consist of trimers of HA polypeptides. The HAi sub unit 
represents the more exposed part of the spike and the HA2 sub unit represents the region 
embedded into the lipid bilayer. The neuraminidase (NA) spikes consist oftetramers of 
NA polypeptides. Non-glycosylated matrix, (M) protein lines the inner surface of the 
lipid bilayer. Within the envelope, are the nucleocapsids that contain single-stranded 
RNA. The protein sub unit of the nucleocapsid is the nucleoprotein, (NP) polypeptide. 
(Reproduced from Compans and Choppin, 1968).
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transcriptase activity of the virion) and the non-structural (NS) proteins. The occurrence 
of these proteins are summarised in Table 2.1. An unusual feature of the virus is its 
segmented genome. There are eight strands of RNA (seven in C strains) and it is this 
arrangement that is implicated in the virus's ability to create antigenic variability so 
successfully (Kilbourne, 1975).
2.1.2.1. Functions of antigenic influenza virus components.
The HA and NA are implicated in influenza disease therefore any influenza virus 
vaccine, would include these components. The HA attaches to sialic acid on cell 
membrane receptors thus promoting fusion and subsequent infection (Murray et al, 
1994). It is the causative agent in antigenic drift and shift (which involves a continual 
generation of new influenza viral A strains, Laver and Webster, 1968). The NA (also 
known as sialidase or receptor-destroying enzyme) is an acyl neuraminyl hydrolase, EC 
3.2.1.18. It is attached to the viral membrane via the N terminus (see Figure 2.2); it binds 
to a-ketosidic linkages in NANA (N-acetyl neuraminic acid) and cleaves this sialic acid 
post infection, thereby preventing self-aggregation of the progeny resulting in virus 
release. In so doing, the host cell receptor is destroyed (Webster and Laver, 1967).
Protein identity.
Haemagglutinin (HA)
Neuraminidase (NA)
Matrix Protein (M)
Nucleoprotein (NP)
Polymerase proteins (P)
Non-structural protein
(NS).
Molecular Weight (kDa).
75 to 80
55 to 70
21 to 27
55 to 65
81 to 94
Not given.
Abundance
(%).
Approx. 30
Up to 5
Up to 35
Up to 25
Up to 3
Up to 3
TABLE 2.1. The main proteins of the Influenza virion.
The Table gives ranges of molecular weights and abundance relative to the total 
protein of a typical virion. These ranges indicate the variation between strains. 
(Taken from Kilbourne, 1987).
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FIGURE 2.2. Diagrammatic representation of influenza virus HA and NA 
structure.
The HA trimer and NA tetramer are inserted into the viral lipid membrane. A carbon 
chain representation of the polypeptide (from x-ray crystallography studies by Wilson 
et al, 1981; Colman et al, 1983) is shown for a single HA and NA subunit. The HAi 
polypeptide is designated in thicker line whilst HA\ is shown in thinner line. The host 
cell receptor-binding site is indicated along with four antigenic sites (A-D). The N 
terminus ofHA2 has fusion activity whilst the C terminus penetrates through the lipid 
layer to contact the M monolayer. The epitopes on NA are more widely distributed 
around the enzyme active site. 
(Reproducedfrom Kilbourne, 1987).
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Neuraminidase, like HA is also characterised by antigenic changes associated with 
evolutionary drift and shifts (Kilboume, 1975). Research has shown that the ratio of HA: 
NA is 5:1 and whilst HA is uniformly distributed over the viral surface, NA has been 
found in localised patches, (Lamb, 1983). This distribution was confirmed by 
immunoelectron microscopy using indirect immunogold staining. It was thought that this 
distribution prevented premature cleavage by NA (thus preventing infection) and 
prohibited blockage by NA of the fusion peptide (Murti and Webster, 1986).
2.1.3. Influenza strain designation.
The World Health Organisation (WHO), established in 1971, the current naming 
system for the antigenic subtypes of HA and NA produced by the virus. The subtypes are 
named by type: A, B or C followed by the place of original isolation (for example, 
Sydney), the date of original isolation (month/year) and finally the antigen subtype: HA 
followed by NA. The B strain is named in the same way but without mention of H or N 
antigens. The strains are chosen approximately 9 months prior to commencement of the 
influenza season (to allow time for subtle antigenic variations to be detected).
2.1.4. Current manufacture ofFluvirin  vaccine (upstream processing).
Although influenza disease can be treated with drugs (such as rimantidine and 
oseltamivir), they are not always effective against certain viral strains. As a result, 
vaccination is still regarded as the best method of protection. Influenza vaccination 
campaigns occur annually to ensure at risk persons are treated to minimise illness 
(MMWR, 1997). Hence the requirement for high-yielding, generic purification strategies 
that meet demands for the production of efficacious, non-allergenic influenza vaccines.
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Exploitation of the fact that HA and NA are the key immunoprotective antigens in 
influenza illness (Hobson et al, 1972), and that these antigens could be released from the 
viral lipid membrane leaving an intact sub viral particle (Skehel 1971), lead to 
production methodologies for subunit vaccines. These types of vaccines are less 
pyrogenic (better for immunocompromised vaccinees) as compared to whole virus-based 
vaccines (Webster and Laver, 1966). Pyrogenicity was thought to be caused by other 
viral proteins and co-purifying bacterial components (Salk, 1948). In addition, subunit 
vaccines are advantageous because the pathological organism is eliminated and there is 
no possibility of reversion to wild type in attenuated vaccines (Liljeqvist and Stahl, 
1999). However the drawback in using such vaccines lay in their low antigenicity, 
(which could be improved by the use of an adjuvant, Brady and Furminger, 1976 b).
Fluvirin  is an attenuated, inactivated sub unit influenza vaccine that derives from 
X31 recombinant virus (which has the HA and NA of A3/Aichi/2/68 and the growth 
characteristics of AO/PR8/34). Non-infective, high growth virions are produced in large 
titre by a process of adaptation, which attenuates the virus, making it less virulent and 
produces a predominance of spherical progeny. Adaptation occurs after a total of 10 
passage cycles- a process that begins at NIBSC, (National Institute of Biological 
Standards) and is then completed at Medeva Pharma whereby a seed of the attenuated 
virus is inoculated into the allantoic cavity of an embryonated hens egg (Figure 2.3). 
Following an 11 -day incubation period, the virus infects the chorio-allantoic membrane 
(CAM) and the allantoic fluid is harvested to collect the released virus particles, which 
contains the H3N2 antigens that have originated from the A/Hong Kong 1968 virus. The 
WHO reviews the world epidemiological situation annually. If it is necessary, it will
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FIGURE 2.3. Diagram illustrating the compartments within an embryonated hen's
egg- 
Chick embryos were first used for influenza virus propagation by (Smith, 1935). The 
virus can be inoculated via two routes: the allantoic and the amniotic the latter is more 
sensitive. The virions used to make Fluvirin  were produced by the allantoic route (see 
Section 2.1.4). Reproduced from (Barren and Inglis, 1985).
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recommend new strains to be used in vaccine manufacture on the basis of 
epidemiological evidence.
2.1.5. Manufacture of Fluvirin™ vaccine (downstream processing).
Earlier attempts to purify the viral proteins, before and after splitting (disruption) 
failed because of the co-purification of bacteria and egg proteins from the egg cultivation 
procedures. These were pyrogenic and allergenic- (Salk, 1948; Peck, 1968 and Walsh et 
al, 1988). The arrival of the KII continuous flow zonal ultracentrifuge (Electro- 
Nucleonics Incorporated) superseded conventional centrifuges (such as the Sharpies 
tubular bowl centrifuge). Using rate zonal centrifugation followed by isopycnic banding 
(with sucrose), permitted both clarification (kilogramme quantities of impurities were 
removed from gram quantities of virus) and concentration of the virus (Reimer, 1967; 
Guerin and Anderson, 1969). In addition, Triton N101 was used to release the surface 
antigens leaving the core intact (Corbel et al. 1970; Corbel and Rondle, 1970).
The major steps in the processing of Fluvirin  as used commercially by Medeva 
Pharma are illustrated in Figure 2.4. The Fluvirin  process uses low-speed 
centrifugation (Westfalia) to remove gross contaminants such as chick erythrocytes 
followed by zonal centrifugation (using the KII rotor) to remove further contaminants. 
Starting with inactivated bulk fluid, DBF, (pre-concentrated allantoic fluid containing 
inactivated influenza virus particles) the initial sucrose density ultracentrifugation 
procedure, (Stage 5, Figure 2.4), eliminates contaminating proteins and debris producing 
purified whole virus as a purified zonal concentrate (PZC). Addition of Triton N101, 
(Stage 6) selectively releases surface antigen from the viral lipid envelope leaving an 
intact core particle. The resulting size and mass differences permitted separation of these
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1. Virus-infected allantoic fluid (2000 litres).
2. Clarification. 
Using low speed Westfalia centrifugation. Concentration.
3. Ultrafiltration. Inactivated Bulk Fluid.
4. Inactivation with fi-Propiolactone (360 litres).
5. Zonal centrifugation (40 litres). 
KII Rotor (ENI).
6. Selective release of HA antigen.
7. Ultrafiltration (40 litres).
8. Pooling ofmonovalent antigen.
Sucrose density 
ultracentrifugation 
(produces Purified Zonal 
Concentrate).
Sucrose density 
ultracentrifugation. 
Addition of detergent 
(releases HA antigen 
leaving intact viral 
cores).
Diafiltration (polishing).
9. Formulation.
FIGURE 2.4. An outline of the down-stream processing stages in the 
current Medeva Fluvirin ™Process.
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components. The detergent is removed by adding phosphate (salting out) and a 
diafiltration step (Stage 7) eliminates traces of salt, detergent and exchanges the buffer to 
yield a monovalent blend antigen pool (MBP). The final vaccine (Fluvirin ) is a 
formulation of two A strains and one B strain and conforms to the definition of an 
inactivated influenza vaccine (as stated in the British Pharmacoepia, BP, 1997 and the 
European Pharmacoepia, EP, 1997). The total time taken to produce one batch from IBF 
to MPB is between 36 to 48 hours.
2.7.6. Re-evaluation of the current Medeva Fluvirin'™ Process process and the potential 
for utilising ATPS.
In the face of commercial pressures and regulatory demands, the Fluvirin  
manufacturing process has not significantly altered since the investigations undertaken 
by Brady PhD Thesis, (1974). As is often the case, these demands meant that there was 
insufficient time/funds to further optimise a process, although it is important to stress 
that an optimised process may not necessarily be the most economically feasible one. 
However in the case of Fluvirin  manufacture, stages of sub-optimal performance (so- 
called bottlenecks) have been identified (in particular: the capacity of the rotors used at 
Stages 5 and 6, Figure 2.4). The use of zonal centrifugation results in long processing 
times to eliminate impurities from the virus particles (to standards stated in BP and EP 
guidelines). This makes the process energy-intensive. However, it would be desirable to 
circumvent these bottlenecks and reduce the processing times in order to increase 
process productivity and throughput. Alternative purification techniques therefore 
deserve examination from both processing and economic viewpoints.
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Partitioning using aqueous two-phase systems (ATPS) has been recognised as a 
candidate technology whose potential has been discussed previously (see Section 1.4.4). 
For application in the Medeva Fluvirin  Process, it would be necessary to demonstrate 
significant advantages over the existing technique, of sucrose density gradient 
ultracentrifugation. Previous researchers demonstrated a role for ATPS in the processing 
of nanoparticulates (Walker et al, 1996; Walker and Lyddiatt, 1998; 1999 and Braas et 
al, 2000). The current study aims to extend this role by demonstrating the application of 
ATPS in the processing of influenza virus nanoparticles that are currently used in a 
commercial vaccine manufacture process. This provides the unique opportunity to 
compare the performance of ATPS with a commercially used purification process for 
virus particles and to highlight the challenges faced when applying this technique on 
large scale.
2.1.7. Strategy for the utilisation of ATPS as a technique for the processing of Fluvirin™. 
In order to evaluate the success of ATPS as a potential technique in the processing of 
Fluvirin , it was necessary to decide from the outset what criteria the process should 
meet. It was envisaged that ATPS would serve as a primary down-stream processing step 
for the selective removal of bulk impurities from intact viral particles in allantoic fluid. 
During the early stages, it was desirable to maintain the integrity of the virus (in spite of 
the final product being of subunit form) in order to simplify and to monitor the 
purification.
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2.1.7.1. Establishing the analytical methods.
The first essential activity to undertake in such a development study was the 
establishment of analytical methods. This would permit the characterisation of 
components in the feedstock and underpin aspects of process design. In addition, the 
analytical techniques used could decide the success of the process, since they enable the 
detection and quantitation of the feedstock components and monitoring of the purity and 
recovery throughout the process. An important thermodynamic and bioprocess parameter 
in ATPS is the partition coefficient (K), which enables quantitative monitoring of 
partition between phases (see Section 1.5.4). One of the main methods developed in this 
study was the use of sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS 
PAGE) and quantitative one-dimensional densitometry to estimate K of individual 
proteins in loaded ATPSs.
2.1.7.2. Characterisation of egg white proteins.
During harvest of the allantoic fluid, the albumen sac is ruptured (due to its close 
proximity to the allantoic cavity, Figure 2.3), and released contents contaminate the 
allantoic fluid. These contents comprise egg white proteins, which make up roughly 50 
% of the egg components (Romanoff and Romanoff, 1949). The key components are 
listed in Table 2.2. Ovalbumin is the major egg white protein and provides the chick with 
a nutrient source. The proteins ovotransferrin (a haem protein), ovoglobin and lysosoyme 
prevent bacterial growth. Ovomucoid has protease inhibiting activity (mainly trypsin). 
Ovalbumin is also one of the most allergenic proteins in egg white, followed by 
ovotransferrin, lysosyme and ovomucoid. Thus it is desirable to remove these proteins in 
the purification process from the virus.
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Egg white proteins.
Ovalbumin
Ovotransferrin 
(conalbumin)
Ovomucoid
Ovoglobin
Lysosyme
Ovomucin
Percentage (%) of egg 
white proteins.
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12 to 13
11
8
3.4 to 3.5
1.5 to 3.5
Molecular weight (kDa).
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75
28
25
14
0.22-270 xlO6
TABLE 2.2. Egg white proteins.
Egg white is a well-characterised feedstock (see main text). Thus Table 2.2 was used to 
confirm the identities of key egg white proteins that were partitioned using ATPS and 
fractionated using SDS PAGE gels (see Appendix I). The data was taken from Awade and 
Efstathiou, (1999).
2.1.7.3. Characterisation of egg yolk.
In addition to rupture of the albumen sac, during allantoic fluid harvest, the yolk sac 
is often ruptured too, leading to release of its contents. Therefore not only is the allantoic 
fluid contaminated with egg white proteins but also egg yolk components also. Egg yolk 
is composed of approximately 48 % water and 33 % (wet weight) lipid- in the form of 
triglycerides (Evans et al, 1973), 17 % protein and the remaining 2 % as, carbohydrates 
and minerals. Egg yolk is divided up into approximately three compartments: the 
granular compartment (consisting of phosvitins and lipovitellins), the very low-density 
lipoprotein (VLDL) compartment and the water-soluble compartment (Figure 2.5). Some
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VT >500 kDa (granular compartment)
I
r
C 33kDa"
 F 13kDa"
II
t
PB 40kDa fl
III
t
PEi 15kDa fl
orPE2 18kDa fl
IV Lipovitellins
t t
PX? fl
and
Membrane protein
(VLDL compartment)
Apoprotein B
AI
t
All
t
" 20kDac/
AIII AIV AV
65kDae/ 75kDae/ 90kDae/
AVI 
t
170kDae/
Livetins (water soluble compartment)
a p 8 y 
70kDaA 42kDa/! ISOkDa* 200kDagA '
Key: A Apovitellenin; L Lipovitellin; P Phosvitin; VT Vitellogenin
Figure 2.5. Showing origins and interrelationships of the proteins in egg yolk.
a: Wallace and Morgan, 1986a' b. b: Wang and Williams, 1980. c: Burley, 1975. 
d: Burley and Davies, 1976. e: Burley and Sleigh, 1980. f: Evans and Burley, 
1987. g: Joubert and Cook, 1958. h: Burley and Vadehra, 1979 and i: Burley, 
1978.
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of these proteins have been difficult to study due to their strong binding preference for 
lipids (Burley, 1975). The main constituents are apovitellenins, phosvitins and livetins. 
The apovitellenins (I and VI) and phosvitins have also been implicated in allergic 
responses (Walsh et al, 1988).
2.1.8. Rational investigation of suitable ATPSs to process IBF material.
This chapter documents and discusses the strategies employed in the selection of 
ATPSs suitable for the processing of influenza virus particles. Key variables, which are 
known to influence the partition of proteins and particles in ATPSs, were investigated 
including the molecular weight of PEG, the TLL and volume ratio, (Albertsson, 1986; 
Hustedt, 1986). Polyethylene glycol (PEG)-phosphate ATPSs were examined because 
the cost of salt were known to be less than for that of Dextran (Sigma Chemical 
Company). The wealth of information regarding PEG-salt systems provided the 
incentive for their further investigation with respect to the influenza particles, 
(Huddleston, PhD thesis, 1996; Rito-Palomares, PhD thesis, 1996; Walker, PhD thesis, 
1998; Lebreton, PhD thesis, 1998 and Braas et al, 2000).
To broadly appreciate the partition behaviour of the influenza virions in an ATPS, it 
was decided to undertake initial experiments using PZC alone. Information from this 
study was then used in the deployment of selected ATPS suitable for handling the crude 
process feedstock, IBF as the start-point. Aqueous two-phase systems consisting of PEG 
of nominal molecular weight 300 to 8000 were used (since most useful separations had 
been obtained using PEG in this range). Systems with varying tie-lines lengths (TLLs) 
were selected to investigate how system composition affected the partition of virus and 
contaminants (refer to Appendix II). An arbitary designation of short (1-20 % w/w),
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intermediate (21-34 % w/w) and long (>35 % w/w) TLLs was employed. The volume 
ratio was initially fixed at unity so that the observed partition behaviour would be a 
function of ILL and PEG molecular weight alone. Walker, (1998), argued that 
measurement of volume ratios for loaded systems were ambiguous where the presence of 
multiple solid phases such as an interphase, (Boland, 1989) compromised conventional 
estimates. Thus the term "Vrd" was coined (which will be used herein), defined as the 
volume ratio of a "dirty" or loaded ATPS (Walker PhD Thesis, 1998). This parameter 
takes account of the relative contribution each phase makes, whilst still calculating the 
phase ratio (where T is the top phase, I is the Interphase and B is the Bottom phase):
T(%)= T x 100 Equation 2.1.
(T + I + B)
B (%)= B x 100 Equation 2.2. 
(T +I + B)
Vrd = T Equation 2.3.
B
The Vrd can also be conveniently represented as T: I: B which indicates the proportion 
that each phase occupies. The benefit of the viral particles partitioning into an interphase 
or sediment include the concentration of product into a small volume making it easier to 
handle further downstream. Potentially useful ATPSs were studied in the optimisation 
and ultimately the design of a bench-scale process that could be compared with end-
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stage material generated from the current, conventional ultracentrifugation process. 
Information from this study would also contribute to an evaluation of the generic 
application of ATPSs in the processing of nanoparticulates from a "real" process.
2.1,9. System nomenclature.
Each ATPS used in the study is assigned a number, which is used herein. Strictly 
speaking ATPSs in the presence of biomass are not the same (with respect to their 
compositions) as their parent blank system. For convenience the same system number 
was used. For example, SI, (PEG 300 20.0 % w/w/ phosphate 22.0 % w/w, pH 7.5), used 
in this study (see Appendix II) is also referred to as SI in the presence of biomass.
2.2. MATERIALS and METHODS.
All reagents from Sigma unless stated otherwise.
2.2.1. Construction of blank ATPSs.
The systems were selected from a binodal constructed by the cloud point method 
(Bamberger et al, 1985). The ATPSs were constructed using a top-pan balance (Oertling 
RB153). Polyethylene glycol (PEG) of average molecular weights: 300, 600, 1000, 3350 
and 8000 were used. Polyethylene glycol of average molecular weight 6000 was 
obtained from BDH. Dibasic and monobasic potassium orthophosphate was combined in 
the ratio of 18:7 to provide a system of pH 7.5. The appropriate masses of phase-forming 
chemicals, 2g inactivated fluid bulk (IBF) material and water were added to clean 15ml 
centrifuge tubes (Sarstedt) to a total of lOg w/w. The IBF loading represented 20 % of 
this total. The samples were mixed for one hour at 20-22 °C using a rotary mixer (SB1, 
Stuart Scientific) and centrifuged for 5 minutes at 2000 xg (Jouan, C422 bench top
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centrifuge). After noting the volume ratios, (Vrd's- the volumes of the top 
phase:interphase:bottom phase) the top phase was harvested into a clean bijou tube. The 
interphase was carefully harvested using a clean pipette tip and resuspended into 1ml of 
0.01M PBS pH 7.4. Finally, piercing the bottom of the tube allowed the bottom phase to 
be collected into a clean bijou. For a complete summary of the ATPSs studied, refer to 
Appendix II.
2.2.2. Construction of loaded ATPSs.
The loaded ATPSs were constructed as in Section 2.2.1 but with the addition of 
biomass. The biomass used was IBF reserve material (A/Sydney batch 753134) provided 
by Medeva Pharma, Liverpool, UK.
2.2.3. SDSPAGE.
Homogeneous gels consisting of 12 % monomer concentration were made with 30 % 
Acrylamide/Bis: acrylamide in the ratio of 37.5:1 and containing a crosslinker (N N 
N'N1 tetramethyl ethylenediamine, TEMED), of concentration, 2.6 % (BioRad), were 
used along with stacking gels consisting of 4 % monomer concentration. The resolving 
gel contained 1.5M Tris-HCl, pH 8.8, SDS at a concentration of 1 % w/v and ammonium 
persulphate at a final concentration of 0.5 % v/v. The stacking gel contained 0.5M Tris- 
HCl, pH 6.8, as described by Laemmli, 1970). The gels were made and electrophoresed 
using 16x 20 cm glass plates giving a gel thickness of 1.5 mm The clamp system and gel 
tank were part of the PROTEAN® II xi cell from BioRad.
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2.2.3.1. Sample preparation.
Partitioned samples from top, interphase or bottom phase were added to an equal 
volume of 10 % w/v TCA into 1.5 ml microfuge tubes and vortexed briefly. The samples 
were then placed in a -20 °C freezer for one hour, subsequently thawed out and 
centrifuged at 11,600 xg for 10 minutes (MSB bench centrifuge). The supernatant was 
discarded and washed with 1ml of 1:1 mixture of ethanol and ether in capped 
microcentrifuge tubes (that had been pierced to release the build-up of pressure). The 
centrifugation step was repeated twice more using this wash step. After the last wash, the 
supernatant was removed and the resulting pellet allowed to air dry. The sample was 
resolubilised in a 70 \JL\ of reduced sample buffer (0.625M Tris-HCl pH 6.8, 4 % w/v 
SDS, 10 % v/v p-mercaptoethanol, 2 % w/v sucrose and trace bromophenol blue). 
Samples involved in the volume ratio (Vrd) study (Section 2.3.4), were prepared as 
described by Bensadoun and Weinstein, (1976). This was because the TCA was 
insufficient on its own to precipitate the proteins. The Bensadoun and Weinstein method 
appeared to work better due to the added deoxycholate, which acted as a carrier and 
possibly increased the availability of TCA to act as a precipitant.
2.2.3.2. Marker preparation.
The markers (low molecular weight kit from Pharmacia), were simply reconstituted in 
100 ^1 reduced sample buffer and gently mixed. For IBF analysis (see Section 2.3.1) this 
stock mixture was directly applied to the gels. For all other analysis, the stock was 
diluted ten-fold in reduced sample buffer before gel application. This was due to the 
large format gels of greater thickness used in the analysis of IBF (which required a
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higher protein concentration to visualise the bands after Coomassie staining). For 
economic reasons, the smaller mini gels utilised a more dilute mixture of the markers. 
The low molecular markers consisted of the following protein subunits: phosphorylase a 
(97 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (31 
kDa), trypsin inhibitor, (21 kDa) and lysosyme (14 kDa).
2.2.3.3. Electrophoresis Conditions.
The samples and marker were placed in a boiling water bath for 5 minutes at 100 °C, 
allowed to cool and then a known volume applied to a lane on the gel. The samples were 
electrophoresed at 80 volts for approximately 18 hours. The electrophoresis stock buffer 
was made as a concentrate containing 1 % w/v SDS, 3M Tris-HCl and 1.92 M glycine. 
This was diluted 10-fold in Milli-Q water to provide the electrophoresis running buffer.
2.2.3.4. Staining/Destainingprocedure.
The gels were removed from the electrophoresis tank and stained for a minimum of 
three hours in Coomassie Brilliant Blue stain (2 g Coomassie Blue R250 per litre in 5 
parts methanol, 5 parts Milli-Q water and 2 parts glacial acetic acid (Fisher Scientific). 
The gels were rocked to promote the staining reaction. Coomassie Brilliant Blue could 
detect a lower limit of sensitivity 1 ug total protein ml" 1 . The gels were destained with a 
solution of the stain solvent. The gels were dried using a gel drying kit (Promega) and 
then scanned using Ultroscan XL densitometer (LKB Pharmacia).
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2.2.4. One- dimensional densitometry.
The densitometer consists of a helium-neon (He-Ne) laser source, which provides an 
intense coherent beam of monochromatic light at 633 nm. The laser beam light is split 
into two: 90 % goes to the sample bands and the remaining 10 % goes to the reference 
detector. The detector measures the portion of light absorbed by a sample band, which 
manifests as a photocurrent and is converted to a voltage. The voltage is proportional to 
the amount of light detected and is compared to the light from the reference detector. The 
resulting signal is proportional to the absorbance of sample. The detector signal is 
integrated by computer software to compute the absorbance area (in absorbance units or 
AU) x thickness of gel for each major band (in mm). These are represented as peaks on 
the computer printout.
2.2.4.1.Estimation of mass of proteins on gel using SDS PAGE and one-dimensional 
densitometry.
The mass of protein present in each band on the gel was estimated as follows. Firstly, 
the major protein bands in the IBF feedstock were identified. The concentration of the 
EBF feedstock was estimated by using the method of Lowry et al, (1951). The mass of 
IBF on the gel and the relative proportion of each major protein band were deduced. The 
IBF material was then serially diluted (to obtain a calibration curve), loaded onto a 
reduced SDS PAGE gel and electrophoresed (as described in Section 2.2.3). A typical 
calibration gel is shown in Figure 2.6. The insert shows a typical Rf plot used to deduce 
the molecular weight of the individual proteins (Weber and Osborn, 1969). Table 2.3 
summarises the main proteins observed in the FBF material and their molecular weights. 
The relative proportion of each major protein is depicted in Figure 2.7. From this, it was 
possible to construct calibration curves of the individual proteins contained within the
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IBF material (an example using ovalbumin is shown in Figure 2.8). Thus the amount of 
major proteins present in each experimental ATPS could be deduced. By knowing the 
amount of a certain protein (for example ovalbumin) in each phase, weight ratios could 
be deduced in a manner analogous to that of K. This will be further discussed in the 
following section. The SDS PAGE/densitometry method was evaluated for precision a 
total of six times. The error in recovery of proteins was estimated to be ± 20 %. This 
was primarily due to variability in TCA precipitation. It was decided to use this method 
since the major proteins (the viral proteins, ovalbumin and apovitellenins accounting for 
at least 80 % of the proteins) were quantitatively precipitated.
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10
94.0 kDa
67.0 kDa
43.0 kDa
30.0 kDa
y=-1.0985*+ 2.0143 
R l = 0.9795
0.5 
Rf
20.1 kDa
14.4 kDa
FIGURE 2.6. Typical calibration gel used to quantify the amounts of individual 
proteins within IBF feedstock.
One-dimensional densitometry was used to estimate the absorbance of each individual 
protein band. By knowing the amount of IBF protein loaded in each lane and the 
proportion each band represents out of the total, (see Figure 2.7), calibration curves of 
the individual proteins were constructed (see Figure 2.8). Thus the amount of each 
protein could be estimated in samples partitioned in ATPSs and Partition Mass Ratios 
could be deduced. The viral proteins are indicated on the gel as B and D.
Lanes 1 to 4 inclusive: IBF material diluted in the range 112.5 to 14.1 jug of protein. 
Lane 5: Low molecular weight marker (10 ul load).
Lanes 6 to 9 inclusive: IBF material diluted in the range 7.0 to 0.9 ug of protein. 
Lane 10: PZC material 45 ugprotein.
Key: A: Apo III-V; B: HA,/NP/NA; C: OA; D: HA2/M; E and F: PB and PE,; G: Apol 
(refer to Table 2.3).
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Identification.
Apovitellenin VI (Apo VI)
Apovitellenin V (Apo V) plus reduced 
multimers of Apo VI
Apovitellenin IV (Apo IV) plus reduced 
multimers of Apo VI
Apovitellenin III (Apo III)
Haemagglutinin i (HAi) 
Neuraminidase (NA) 
Nucleoprotein (NP)
Ovalbumin (OA)
Haemagglutinin 2 (HA2) 
Matrix protein (M)
Phosvitin B (PB)*
Apovitellenin II (Apo II)
Phosvitin EI (PEi)
Apovitellenin I (Apo I)
Mean Mwt. 
(kDa).
>97kDa
83.5
76.5
70.5
60.9
49.9
29.9
24.5
17.6
14.6
11.2
Coefficient of 
Variation
(CV) %.
3.7
2.6
1.8
1.7
3.3
2.3
2.7
2.7
2.4
2.6
3.8
TABLE 2.3. A summary of the proteins observed in IBF material as deduced by 
SDS PA GE and Rfplots.
The molecular weights were estimated as the mean of six individual runs. The 
error in the determination are shown as coefficient of variances. *The molecular 
weight determination of phosvitin B was flawed since it is known to behave 
anomalously on straight percentage gels (Wallace and Morgan, 1986b). The 
actual value should be nearer to 40 kDa. The identities of the proteins were 
confirmed from a literature review (see Figure 2.5). The viral proteins are 
highlighted in bold font. Abbreviated forms of the protein names are shown in 
bracket (refer to SDS PAGE gel presented in Figure 2.6). The relative proportions 
of the key proteins in IBF are presented in Figure 2.7.
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T D Proportion of protein 
in IBF
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kDa VI III-V
FIGURE 2. 7. Histogram illustrating the proportion of key proteins within IBF.
The bars represent standard errors from six determinations. The proteins are 
presented in Table 2.3.
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FIGURE 2.8. A typical calibration curve obtained from SDS PAGE and densitometric 
analysis ofovalbumin contained within IBF material.
Ovalbumin (a key protein in IBF) was selected an example. Serially diluted IBF 
material was electrophoresed and individual proteins were quantified on a gel. This 
permitted calibration curves of main proteins within IBF to be produced. The data 
shown was calculated as a mean of six such typical calibration curves generated from 
gels typified by Figure 2.6. The mean absorbance units x thickness of area scanned 
(AU*mm) was obtained from densitometric analysis. The bars represent standard 
errors.
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2.2.4.2. Definition of Fractional Mass Ratio (FMR).
The partition behaviour of virus-derived proteins and protein contaminants were 
characterised using fractional mass ratios (FMRs), the authors own nomenclature. This 
provided a means of monitoring protein partition between the phases as well as 
permitting a quantitative description of the system in the presence of solid phases (since 
the conventional partition coefficient (K) has no relevance in such situations). Therefore 
the FMR for target molecules is defined in Equations 2.5d, 2.6c and 2.7c:
Top phase = mass target proteintop phase/ total mass protein x 100 Equation 2.5a 
Interphase = mass target proteinjnterphase/total mass protein x 100 Equation 2.5b 
Bottom phase = mass target protein bottom phase/ total mass protein x 100
Equation 2.5c
Thus the FMR = Top phase: Interphase: Bottom phase Equation 2.5d
The FMR is redefined for purpose of the volume ratio study (Section 2.3.4) as follows: 
For PEG 300-based ATPSs.
Top phase = mass target proteintop phase / total mass protein x 100 Equation 2.6a
Interphase/bottom phase = mass target proteininterphase/bottomphase/ total mass protein x 100
Equation 2.6b
Thus the FMR = Top phase: Interphase/ bottom phase Equation 2.6c
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For PEG 8000-based ATPSs.
Top phase/interphase = mass target proteintop phase/interphase / total mass protein x 100
Equation 2.7a 
Bottom phase = mass target proteinbottom phase / total mass protein x 100
Equation 2.7b
Thus the FMR = Top phase/interphase: Bottom phase Equation 2.7c
Cone, of target 
particle top
Cone, of target 
particlebottom
Blank ATPS (contains only 
phase-forming chemicals).
K = CtoP/Cbottom, (see Equation 
1.6).
* * **
Mass of target 
particletop
Mass of target
particle jnterphase
Mass of target 
particlebottom
Loaded ATPS (containing 
biomass).
FMR= Fractional mass top phase/
Fractional maSS jnterphase /
Fractional mass bottom phase 
(see Equations 2.5a to2.5d).
FIGURE 2.9. Schematic interpreting the partition coefficient in 
blank and loaded A TPSs.
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2.2.5. Total protein concentration determined by Lovory assay (Lowry et al, 1951).
Five reagents were prepared:
Reagent A: 20 g Na2CO3 , 4 g NaOH made up to 1000 ml in Milli-Q water.
Reagent B-l: 1 g CuSO4 .5 H20 in 100 ml Milli-Q water.
Reagent B-2: 2 g sodium potassium tartrate in 100 ml Milli-Q water.
Reagent C: A mixture of Reagents B-l and B-2 in a 1:1 volumetric ratio. Used on day of
preparation.
Reagent D: 2N Folin Ciocalteau Reagent diluted in an equal volume of 10 % w/v TCA in
Milli-Q water.
The samples were mixed with an equal volume of Reagent A post TCA precipitation (as
in Section 2.2.3.1). A volume of 0.5 ml of this mixture was added to 2.5 ml Reagent C,
vortexed and incubated for ten minutes at 23 °C. A volume of 0.5 ml Reagent D was
added followed by immediate mixing. The solution was read at a transmission of 550 nm
after an incubation period of 30 minutes at 23 °C.
2.2.6. The murexide test.
One drop of concentrated nitric acid was added to the test sample on a clean 
microscope slide (this lead to the production of alloxantin from uric acid present). The 
sample was heated then cooled. A drop of ammonia (26 % v/v) was added which lead to 
the formation of murexide from the alloxantin. Formation of a red-purple colour 
indicated a positive test for uric acid.
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2.3. RESULTS AND DISCUSSIONS.
2.3.1. Partition of Inactivated Bulk Fluid (IBF).
In order to detect and quantitate the viral proteins in the ATPSs, it was decided to use 
validated assays that were already in place at Medeva Pharma and to modify them as 
necessary. Therefore the assays used initially to investigate the PZC were the HA test, 
the Neuraminidase enzyme-linked assay in microplates (NELLAM) and the Micro BCA 
assay for total protein (see Appendix I). With the exception of the NELLAM, these 
assays were relatively quick to perform. The assays used for the detection and 
quantitation of PZC partitioned in ATPS could not be used in the analysis of Inactivated 
Bulk Fluid (IBF). The NELLAM could not detect the NA perhaps due to masking of the 
response due to the presence of lipoproteins in the allantoic fluid (NA is less abundant 
than HA and could be more susceptible to this effect). Dilution of sample did not appear 
to overcome this effect. Alternatively, the result could be due to aggregation, (Cassidy, 
1965). The Micro BCA assay was affected by the presence of uric acid at levels known 
to interfere with this assay, (Pierce Technical Bulletin) and confirmed upon undertaking 
the murexide test. The Lowry method was used (Lowry et al, 1951) and produced 
anomalous results in the presence of PEG 8000 thought to be due to the presence of 
lipoproteins such as the apovitellenins (Kashyap et al, 1980). The Coomassie binding 
protein assay (Bradford, 1976) was also attempted. An alternative was to use SDS PAGE 
with TCA precipitation followed by Coomassie Brilliant Blue staining and one- 
dimensional densitometry to quantitate the total protein within the bands (see Sections 
2.2.3 and 2.2.4). Trichloroacetic acid (TCA) precipitation was the preferred method of 
preparing the samples for SDS PAGE to concentrate proteins of relatively low initial 
concentration and to remove salts derived from the phase formant. It was decided to use
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this method since the major proteins (the viral proteins, ovalbumin and apovitellenins) 
were quantitatively precipitated.
Electrophoresis of IBF material on a reduced gel (Figure 2.6) showed it to be more 
complex than the simple gel pattern shown by the egg white proteins (Figure A4). In fact 
the gel pattern of EBF looked more like the proteins present in egg yolk. Possible 
explanations for this were that there were differences between a fertile and non-fertile 
hens egg; or the yolk sac had ruptured during harvesting of allantoic fluid causing it to be 
contaminated with the egg yolk proteins. The ovalbumin was present presumably 
because it served as a nutrient source for the chick. Thus the egg white spiking data 
(Appendix I) was only useful from a method development point of view. However, the 
data from partition of PZC could be used to support the data from the partition of the 
IBF. The main differences between reduced and non-reduced IBF samples included the 
loss of Apovitellenin I multimers upon reduction (and gain in the Apovitellenin 
monomer). In addition, bands in the 60 to 90 kDa region appeared on the reduced gels 
with a concurrent diminished staining intensity of the high molecular weight bands- > 97 
kDa (data not shown). These were thought to be oxidation products from Apovitellenin 
VI. Therefore to simplify quantitation, the bands were identified as Apovitellenins III-V. 
This is correct to some extent (Apovitellenins IV and V are present in small amounts), 
but also present were the oxidation product of Apovitellenin VI.
2.3.2. Effect of PEG molecular weight and ILL upon Fractional Mass Ratios (FMRs) of 
the viral components.
Partition of the viral components in IBF material in ATPSs were monitored using 
SDS PAGE gels and Fractional Mass Ratios (FMRs) were used to characterise partition
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in these systems. The viral components include haemagglutinin subunits 1 and 2, 
nucleoprotein, neuraminidase and matrix protein (HAi and HA.2, NP, NA and M 
respectively). In ATPSs comprising PEG 300, Systems S2 and S3 (refer to Appendix II) 
the FMRs for HAi/NP/NA, indicate that the HAi/NP/NA proteins are predominantly 
located at the interphase and that no proteins were detected in the bottom phase (Table 
2.4). The increase in TLL has little effect on these partition characteristics. In ATPSs 
comprising PEG 1000, (Systems S7, S8 and S9), the viral proteins partition 
predominantly between the interface and the bottom phase, hi ATPSs comprising PEG 
3350, (Systems S10, Sll and SI2), the HAi/NP/NA proteins partition exclusively to the 
interphase at short to intermediate TLLs, but in S10 (at long TLL), approximately a third 
of these proteins partition to the top phase (refer to Table 2.4). This anomalous behaviour 
can be explained by an increase in precipitation (observed in PZC/ egg white analysis, 
Appendix AI) with increasing TLL, leading to saturation of the interphase. No 
HAi/NP/NA proteins were detected in the bottom phase. This was attributed to large 
salting out effects (which was also observed in the PEG 300 ATPSs). These effects will 
be discussed later. Saturation of the interphase meant that the proteins partitioned to the 
top phase. The PEG 6000 ATPS (S13, S14 and S15) demonstrated that the viral proteins 
partitioned predominantly to the interphase in systems of short to intermediate TLL. At 
longer TLL, the proteins partition to the bulk phases. As the interphase becomes 
saturated and because the proteins cannot partition to the top phase (due to increased 
excluded volume effects, to be discussed later), these proteins partition increasingly to 
the bottom phase. This observation is replicated in PEG 8000 ATPSs, S22, S23 and S24 
except that in S24, the both the interphases and bottom phases become saturated (with 
protein and debris) and these proteins partition to the top phase (overcoming any
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TLL (%w/w)
PEG Mwt. 300
PEG Mwt 1000
PEG Mwt 3350
PEG Mwt 6000
PEG Mwt 8000
Short
N/A
(S9) 6: 77: 17
(S12) 0: 100: 0
(S15) 0:71:29
(S24) 0: 88: 12
Intermediate
(S3) 13:87:0
(S8) 26: 40: 34
(Sll) 0: 100:0
(S14) 0:61:39
(S23) 0:67:33
Long
(S2) 27:73:0
(S7) 3: 80: 17
(S10) 37:63:0
(S13) 35:65:0
(S22) 3:97: 0
TABLE 2.4. The effect of PEG molecular weight and TLL upon FMR of the viral 
components HAj/NP.
The systems used were shown in brackets (refer to Appendix II), followed by the 
fractional mass ratios of protein in the top: interphase: bottom phase (see Section 
2.2.4.2 for a fuller explanation). Definitions of short, intermediate and long TLL are 
given in Section 2.1.8.
TLL (%w/w)
PEG Mwt. 300
PEG Mwt 1000
PEG Mwt 3350
PEG Mwt 6000
PEG Mwt 8000
Short.
N/A
(S9) 27:62:11
(S12) 0: 100: 0
(S15) 0: 56: 46
(S24) 0: 76: 23
Intermediate.
(S3) 23: 77: 0
(S8) 19:36:45
(Sll) 0: 100:0
(S14) 10: 79: 10
(S23) 39:51: 10
Long.
(S2) 27: 73: 0
(S7) 8: 87: 5
(S10) 55:45:0
(S13) 6:38:56
(S22) 21:75:47
TABLE 2.5. The effect of PEG molecular weight and TLL upon FMR of the viral 
components HA-/M.
The systems used were shown in brackets (refer to Appendix II), followed by the 
fractional mass ratios of protein in the top: interphase: bottom phase (see Section 
2.2.4.2 for a fuller explanation). Definitions of short, intermediate and long TLL are 
given in Section 2.1.8.
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excluded volume effects). The trends in partition of HA2/M proteins are generally similar 
to those described for HAi/NP/NA proteins except with systems comprising high 
molecular weight and long TLL PEG (Table 2.5). This suggests that in these relatively 
extreme conditions, the salting out effects are large so the proteins are "forced" to 
partition to the top phase.
In order to assess the usefulness of a system for processing IBF material, it is also 
essential to deduce the partition characteristics of the contaminant proteins. The FMR 
analysis described in the previous section was applied to examine the partition behaviour 
of the key protein contaminants, ovalbumin, apovitellenin I, apovitellenins III to VI and 
the phosvitins. Ideally useful systems would be those, which direct the contaminating 
proteins away from the interphase. Thus far it can be concluded that ATPSs of long TLL 
would be suitable for partitioning the virus.
2.3.2.1. Effect of PEG molecular weight and TLL upon Fractional Mass Ratios (FMRs) 
of ovalbumin.
In ATPSs comprising low molecular weight, PEG 300 the FMRs for ovalbumin 
indicate that as the TLL length increases, a greater proportion of this protein partitions to 
the top phase (approximately 7 times more in S2 compared to S3, refer to Table 2.6). In 
ATPSs comprising PEG 1000, the FMRs for ovalbumin indicate that as the TLL length 
increases, more ovalbumin partitions to the interphase. The same proportion of 
ovalbumin partitions to the bottom phase, therefore changes must be due to a in protein 
from the top phase. In ATPSs comprising PEG 3350, increasing TLL results in an 
increasing top phase preference and decreasing bottom phase preference. In ATPSs 
comprising PEG 6000, increasing TLL results in increased partition of ovalbumin to the
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top and interphase and less to the bottom phase. In ATPSs comprising PEG 8000, the 
ovalbumin shows a bottom phase preference with all TLLs investigated.
TLL (%w/w)
PEG Mwt. 300
PEG Mwt 1000
PEG Mwt 3350
PEG Mwt 6000
PEG Mwt 8000
Short.
N/A
(S9) 51:31:18
(S12) 16:24:60
(S15) 0: 16: 84
(S24) 0:7: 93
Intermediate.
(S3) 51:49: 0
(S8) 47: 13: 40
(Sll) 26:66: 8
(S14) 4: 12: 84
(S23) 0:8: 92
Long.
(S2) 87: 13: 0
(S7) 35:59:6
(S10) 62: 38: 0
(S13) 20:32:48
(S22) 17: 1: 82
TABLE 2.6. The effect of PEG molecular weight and TLL upon FMR of ovalbumin 
(OA).
The systems used -were shown in brackets (refer to Appendix II), followed by the 
fractional mass ratios of protein in the top: interphase: bottom phase (see Section 
2.2.4.2 for a fuller explanation). Definitions of short, intermediate and long TLL are 
given in Section 2.1.8.
2.3.2.2. Effect of PEG molecular weight and TLL upon Fractional Mass Ratios of 
(FMRs) of apovitellenins III to V.
In ATPSs comprising low molecular weight, PEG 300 the FMRs for apovitellenins III 
to V, increasing TLL increases the proportion of these proteins partitioning to the top 
phase (refer to Table 2.7). In ATPSs comprising PEG 1000, increasing the TLL leads to 
an increase in apovitellenin II to V partition to the interphase (and a concurrent decrease 
in these proteins to the top phase). In ATPSs comprising PEG 3350, the apovitellenins 
III to V partition preferentially to the interphase at lower TLLs. (similar to PEG 300). At 
increased TLL, these proteins partition to the top phase as the interphase becomes
67
Chapter Two
saturated (with protein and debris). In ATPSs comprising PEG 6000 and 8000, the 
intermediate TLLs. However as these phases became saturated (with protein and debris), 
the apovitellenins partition to the top phase.
TLL (%w/w)
PEG Mwt. 300
PEG Mwt 1000
PEG Mwt 3350
PEG Mwt 6000
PEG Mwt 8000
Short
N/A
(S9) 73: 0: 27
(S12) 0: 86: 14
(S15) 7:43:50
(S24) 0: 55: 45
Intermediate
(S3) 29:71: 0
(S8) 50: 12: 38
(Sll) 0: 100: 0
(S14) 0: 53: 47
(S23) 0: 59: 41
Long
(S2) 60:40: 0
(S7) 6: 72:22
(S10) 41:59:0
(S13) 18:54:28
(S22) 11:50:39
TABLE 2.7. The effect of PEG molecular weight and TLL upon FMR of 
apovitellinins III to V.
The systems used were shown in brackets (refer to Appendix II), followed by the 
fractional mass ratios of protein in the top: interphase: bottom phase (see Section 
2.2.4.2 for a fuller explanation). Definitions of short, intermediate and long TLL are 
given in Section 2.1.8.
2.3.2.3. Effect of PEG molecular weight and TLL upon Fractional Mass Ratios of 
(FMRs) of apovitellenin I.
In ATPSs comprising molecular weights PEG 300 to 8000, > 60 % apovitellenin I 
partitioned to the interphase regardless of TLL (refer to Table 2.8). It is unclear why 
apovitellenin I should display different partitioning behaviour from the other 
apovitellenins in these systems.
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TLL (%w/w)
PEG Mwt. 300
PEG Mwt 1000
PEG Mwt 3350
PEG Mwt 6000
PEG Mwt 8000
Short
N/A
(S9) 0: 76: 24
(S12) 0: 100: 0
(S15) 0: 100: 0
(S24) 0: 92: 8
Intermediate
(S3) 31:69: 0
(S8) 0: 62: 38
(Sll) 0: 100: 0
(S14) 8: 70: 22
(S23) 17:65:18
Long
(S2) 10:90: 0
(S7) 0: 100: 0
(S10) 0: 100: 0
(S13) 4: 96 0
(S22) 25: 75: 0
TABLE 2.8. The effect of PEG molecular weight and TLL upon FMR of apovitellinin 
I.
The systems used were shown in brackets (refer to Appendix II), followed by the 
fractional mass ratios of protein in the top: interphase: bottom phase (see Section 
2.2.4.2 for a fuller explanation). Definitions of short, intermediate and long TLL are 
given in Section 2.1.8.
2.3.2.4. Effect of PEG molecular weight and TLL upon Fractional Mass Ratios of 
(FMRs) of remaining contaminant proteins.
Although ovalbumin and apovitellenins III to V comprised the majority contaminants 
(> 70 % by mass) in IBF feedstock, other contaminating proteins included the phosvitins. 
Phosvitin B (the main phosvitin) partitioned exclusively to the top phase regardless of 
PEG molecular weight or TLL used (data not shown, but refer to Figure 2.6, Band E to 
observe the solitary protein band between 20 and 30 kDa). Minor phosvitins such as EI 
partitioned in a manner similar to apovitellenin I.
2.3.3. Selection of ATPSs to fractionate protein contaminants from influenza virus
particles.
The results using SDS PAGE gels and FMR data demonstrate that the virus favours 
the interphase at all TLLs and PEG molecular weight used in this study. This occurs 
because adsorption to the interface lowers the free energy of the system by lowering the
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interfacial area (Walter et al, 1991). Systems that were especially useful in partitioning 
virus particles to the interphase were those comprising PEG 300 (and long TLL), 3350 
(and short to intermediate TLL) and PEG 8000 (any TLL used in the study). The ATPSs 
comprising PEG 3350 were discontinued for use because of co-purification of 
contaminant proteins (particularly the apovitellenins). Also such systems were subject to 
impaired recovery of proteins (especially in systems of long TLL, for example S10). 
This result was in agreement with the findings regarding partitioned PZC and egg white 
(Appendix AI). Employing systems comprising PEG 300 and long TLL facilitated the 
partition of ovalbumin away from the interphase (see Table 2.6). Such PEG molecules 
are relatively hydrophilic and ovalbumin is a hydrophilic protein (Liu et al, 1995), thus 
this protein partitions to the phase that it is most compatible with. However, ovalbumin 
displayed a bottom phase preference in PEG 8000-based ATPSs (see Table 2.6). Thus it 
must be more compatible with the salt-rich phase in such systems. At least 50 % (by 
mass) of the apovitellenins III to V partitioned preferentially to the interphase regardless 
of the PEG molecular weight or TLL used (refer to Table 2.7). These proteins are 
lipoproteins, which possibly interact with membranous debris (or co-habit with the 
debris) at the interphase. Only S2 (comprising PEG 300 and long TLL) displayed a 
degree to elimination of these proteins to the top phase. This could be due to exclusion of 
these proteins to the top phase (as membraneous debris increases at the interphase upon 
increasing the TLL). The partition behaviour of the apovitellenins III-V proteins was 
similar because they were related, (Burley and Sleigh, 1980). Also included was the 
partition behaviour of apovitellenin VI, whose oxidation products have molecular 
weights in the same range as apovitellenin III-V. The behaviour of apovitellenin I could 
be explained by its ability to bind to lipids (possibly on the viral membrane) and to form
70
Chapter Two
aggregates (Burley, 1975). This implies that it would be difficult to remove from the 
virus. The reason for the behaviour of phosvitin B was because it is highly 
phosphorylated (Joubert and Cook, 1958; Wallace and Morgan, 1986a). Interactions with 
phosphate anions cause repulsion from the bottom phase into the top phase. Although 
PEG molecules possess a lone pair of electrons on the ether oxygen, and there is a low 
concentration of phosphate present in the top phase, any possible repulsion effects 
between phosvitin B and PEG are expected to be minimal as compared to those between 
phosvitin B and the phosphate-rich phase. From point of view of elimination of 
contaminant proteins from the virus, the partition behaviour of phosvitin B is 
advantageous. The minor Phosvitins EI showed similar partition trends to the 
apovitellenin I (suggesting that these proteins are less phosphorylated than phosvitin B). 
These phosvitins are derived from different vitellogenin subunits than phosvitin B (refer 
to Figure 2.5) so maybe this is not surprising. The fact that these phosvitins could be 
observed at all suggested powerful resolution of ATPS as a technique since Wallace and 
Morgan, (1986a) had to undertake a lengthy centrifugation step to obtain these proteins. 
Livetins were not identified since they would have been associated with apovitellenin 
III-V at high salt concentration (Burley, 1978).
To conclude, on the basis of the FMR data presented here, ATPSs comprising low 
PEG molecular weight (and long TLL) or high PEG molecular weight (and low to 
intermediate TLL) would be useful for removing key protein contaminants ovalbumin 
and apovitellenins III to V. The fact that apovitellenin I and the minor phosvitins were 
not removed from the virus particles at the interphase was not critical at this stage since 
they could be separated further downstream using a unit operation (such as 
ultrafiltration) which could separate these low molecular weight contaminants from the
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larger proteins. In addition, these proteins constitute approximately 20 % (by mass) of 
the protein contaminants (refer to Figure 2.7), so these proteins should not ultimately 
pose a problem for their removal from the process stream. Thus ATPSs that met the 
criteria discussed were ATPS S2 (PEG 300 20.0 % w/w/ phosphate 20.0 % w/w, pH 7.5, 
TLL, 43.4 % w/w) and ATPS S23 (PEG 8000 15.0 % w/w/ phosphate 11.1 % w/w, pH 
7.5, TLL, 22.4 % w/w) and are investigated later. The required manipulations of PEG 
molecular weight and TLL to direct contaminating proteins away from virus particles at 
the interphase are summarised in Table 2.9.
The SDS PAGE/densitometry method was useful to monitor the distribution of the 
viral and contaminating proteins both qualitatively and quantitatively, allowing 
deduction of Fractional Mass Ratios (FMRs). The main source of error was introduced 
by the precipitation of proteins using TCA. An estimation of this error was determined 
by measuring the IBF concentration. This concentration, deduced by the method based 
on Lowry et al, (1951) was 1.4 mgml" 1 (± 18 %). This is similar to the value deduced 
using SDS PAGE/densitometry of 1.5 ingm!" 1 . The samples analysed using the Lowry 
Method were TCA precipitated which gives an indication of the error in the densitometry 
technique. It was previously noted that Coomassie Brilliant Blue stain produced 
differential staining effects of proteins (lysosyme and phosvitin B). The fact that the 
latter protein is highly phosphorylated and the dye is anionic in character meant that 
there would be repulsion between them and less binding. Use of a cationic dye such as 
Stains-all would have circumvented this (Wallace and Morgan, 1986a).
The behaviour of viral and contaminating proteins in IBF feedstock can be explained 
in terms of excluded volume and salting out effects. A summary of these effects upon 
PEG molecular weight and TLL are depicted in Figure 2.10.
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Protein
OA
Apo III-V
Apo I
PB
Top
TLL
t
t
1
•«-»•
PEG Mwt.
1
1
4  >
++
Bottom
TLL
1
1
<«-*
N/A
PEG Mwt.
t
t
<*— >>
N/A
TABLE 2.9. A summary of manipulations of PEG molecular weight and TLL 
required to direct contaminating proteins away from influenza virus particles in IBF 
feedstock.
The virus particles partition preferentially to the interphase, therefore the contaminant 
proteins must be directed away from this phase. Proteins such as ovalbumin (OA) are 
responsive to their environment and their partition can be manipulated by changing the 
PEG molecular weight and TLL. Other contaminating proteins such as apovitellenin 1 
(Apo I) and phosvitin B (PB) are unresponsive to their environment so that 
manipulation of PEG molecular weight and TLL are not useful. This suggests that these 
proteins possess physico-chemical characteristics, which dominate their partition (see 
main text for details).
Key: N/A not applicable; 
Decrease the parameter; 
Increase the parameter; 
Parameter insensitive.
I 
t
The virus favoured partition to the interphase at all TLLs and PEG molecular weights 
used. Systems of short TLL were precluded from use due to their low salting out
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capacity. Systems of intermediate or long TLLs (and any PEG molecular weight in the 
range investigated) were suitable for use. Selection of optimal ATPSs depended upon 
how the contaminants partitioned in these systems. It can be concluded that ATPSs S2 
(PEG 300 20.0 % w/w/ phosphate 20.0 % w/w, pH 7.5, TLL, 43.4 % w/w) and ATPS 
S23 (PEG 8000 15.0 % w/w/ phosphate 11.1 % w/w, pH 7.5, TLL, 22.4 % w/w) both 
met the required criteria. The next stage of the ATPS screening process involved further 
investigation of the candidate systems (S2 and S23), examining the effect of volume 
ratio manipulation upon fractionation of EBF material.
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SHORT TLL LONG TLL
Excluded volume effects
Salting out effects
PEG 300: The high salting out effects 
mean that partition occurs between the 
top and interphase. The low excluded 
volume effects mean that major 
contaminants can partition to the top 
phase.
PEG 3350: Short TLL: The excluded volume 
and salting out effects have increased 
compared to PEG 300. Solutes can access both 
top and bottom phases. Long TLL: salting out 
effects are greater (excluded volume effects 
have increased slightly) hence precipitation 
and a lower HA antigen recovery. 
Major contaminants partition to the top and 
bottom phases then to the interphase at long 
TLL.
PEG 8000: The excluded volume effect and 
salting out are greatest at long TLL. A larger 
interfacial area is presented so more viral 
particles adsorb to the interphase hence a 
higher response in the ELISA. Major 
contaminants partition to the bottom phase.
Slight excluded volume 
increases and marked 
increases in salting out 
effects.
FIGURE 2.10. The effect of PEG molecular weight and TLL upon 
partition oflBF.
Schematic summarising the partitioning effects in PEG-phosphate ATPSs 
with Vrds of value unity. The partition behaviour is interpreted in terms oj 
excluded volume and salting out effects. The widths of tubes represent the 
interfacial area.
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2.3.4. Rationale for volume ratio manipulation.
Aqueous two-phase systems using extremes of PEG molecular weight appeared 
useful for selectively partitioning the IBF material. The virus partitioned preferentially to 
the interphase. The harvesting and preparation of the interphase on small scale could be 
quite time-consuming and difficult to undertake on larger scale. Therefore it was decided 
to ease this harvesting concern and take advantage of the observation that partition of 
proteins in these systems was between the interphase and a bulk phase, hi the case of 
PEG 300, the bulk phase was the top phase (therefore the bottom phase was virtually free 
of proteins as judged by the analytical techniques used). For PEG 8000, the opposite was 
true. Low starting volumes would also be advantageous from a processing point of view. 
One way of achieving this using ATPS would be to manipulate the volume ratio and 
concentrate the product into a smaller top or bottom phase volume. The ATPSs that 
showed potential in the processing of IBF were systems S2 (PEG 300 20.0 % w/w/ 
phosphate 20.0 % w/w, TLL 43.3 % w/w, pH 7.5) and S23 (PEG 8000 15.0 % w/w/ 
phosphate 11.1 % w/w, TLL 22.4 % w/w, pH 7.5). Proteins partitioned preferentially 
between the top phase and interphase in the former ATPS and between the interphase 
and the bottom phase in the latter. These ATPSs were used as starting points from which 
to manipulate the volume ratio (see the schematic phase diagrams showing the 
manipulation of the volume ratio along the tie-line, Figures 2.11 and 2.12). In the PEG 
300-based ATPSs, the top and interphase/bottom phases were harvested and in the PEG 
8000-based ATPSs the top/interphase and bottom phases were harvested. The data was 
analysed using SDS PAGE/densitometry (as Section 2.3.2).
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System 
identification 
number (PEG 300- 
based ATPS).
S2
S25
S26
S27
S28
S29
Volume ratio (Vrd)
1.33
1.50
1.92
6.00
7.80
Monophasic
System 
identification 
number (PEG 
8000-based 
ATPS).
S23
S30
S31
S32
S33
Volume ratio (Vrd)
1.06
0.69
0.50
0.29
0.20
TABLE 2.10. Table listing the volume ratios (Vrds) of ATPSs used in volume ratio 
manipulation study.
The ATPSs S2, (TIL, 43.4 % w/w) and S23, (TIL, 22.4 % w/w) were useful in directing 
contaminant proteins away from the virus particles contained in IBF feedstock (see 
Section 2.3.2). The volume ratios of these systems were manipulated to obtain further 
process advantages in the purification of IBF. Refer to the schematics depicted in Figures 
2.11 and 2.12 and to Appendix II for details of these systems.
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S28
I
o 1 
o
ro
O
w
S29
Increasing Vrd
[phosphate] %w/w
FIGURE 2.11. An illustration of the phase diagram and position of the PEG 300 
ATPSs used in the manipulation of volume ratio (Vrd).
Refer to Appendix II for a complete list of systems used. See also Table 2.11 for details 
of the Vrds of these systems.
o 
o 
o 
oo
oPQ
Decreasing 
Vrd
S33
[phosphate] %w/w
FIGURE 2.12. An illustration of the phase diagram and position of the PEG 8000 
ATPSs used in the manipulation of volume ratio (Vrd).
Refer to Appendix II for a complete list of systems used. See also Table 2.11 for 
details of the Vrds of these systems.
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2.3.4.1. Manipulation of volume ratio in ATPSs comprising PEG 300 and effect on FMR 
deduced by SDS PAGE and one-dimensional densitometry.
The data presented in Table 2.11 derives from the gels depicted in Figures 2.13 and 
2.14. Manipulation of the Vrd such that the move is towards higher concentrations of 
PEG 300 (see Figure 2.11), increased the volume ratio. This resulted in ATPSs with a 
progressively smaller interphase/bottom phase. The FMR was redefined since the 
partition was essentially being monitored between two phases: top phase: interphase/ 
bottom phase (see Equation 2.6c for definition).
ATPS
PROTEINS
>97kDa
ApoVI
Apo III-V
HAi/NP/NA
OA
HA2/M
PB
PEi/F
Apo I
S2
1.9
NS
7.2
IB
6.2
IB
VF
VF
1.3
S25
IB
NS
12.6
0.9
13.5
2.4
T
VF
1.5
S26
IB
IB
0.4
NR
NR
IB
NR
VF
1.5
S27
IB
IB
4.3
0.2
1.7
0.4
T
VF
IB
S28
ffi
IB
2.0
IB
1.8
IB
T
VF
IB
INCREASING Vrd
TABLE 2.11. Summary table indicating the effect of volume ratio upon partitioning individual 
proteins within IBF material in PEG 300 ATPS (TLL, 43.4 % w/w).
The > 97 kDa protein refers to higher molecular weight species believed to be derived from
higher molecular weight apovitellenins. The samples (from top phase and interphase/bottom
phase) originated from SDS PAGE gels (Figures 2.13 and 2.14 respectively) and analysed using
Quantiscan™ software, Biosoft. The viral proteins are highlighted in bold typeface. See Table
2.10 for details of system volume ratio.
Data for S29 was not shown since its corresponding blank ATPS was monophasic and therefore
had not originated from the same TLL as S2 and S25 to 28 inclusive.
Key: NR: No result; NS: Not seen; VF: Very faint; T: exclusive partition to the top phase; IB:
exclusive partition to the interphase/bottom phase.
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3456 7 8 9 10
20.1 kDa
14.4 kDa
FIGURE 2.13. Partition oflBF material in PEG 300 ATPS of increasing Vrd (top phase 
samples).
Systems S2, S25 to S29 (all with of TLL 43.4 % w/w) were loaded with 20 % w/w IBF 
material used in Fluvirin™ processing (refer to Section 2.1.6) and partitioned as described 
in (Section 2.2.2). The top phase samples were prepared for analysis on 12 % SDS PAGE 
gels (see Section 2.2.3). Samples of IBF (pre-partition) and PZC were also shown for 
comparison. A volume of 150 [ll sample was loaded into each lane. Refer to Table 2.11 for 
details of volume ratios of these ATPSs.
Lane 1: IBF 112.5 fJ,g protein.
Lane 2: PZC 45.0 tig protein.
Lane 3: Unused.
Lane 4: Top phase from S2 (PEG 300 20.0 % w/w/phosphate 20.0 % w/w).
Lane 5: Low molecular weight markers (5 yd load).
Lane 6: Top phase from S25 (PEG 300 22.2 % w/w/phosphate 17.9% w/w).
Lane 7: Top phase from S26 (PEG 300 25.5 % w/w/phosphate 15.0 % w/w).
Lane 8: Top phase from S27 (PEG 300 32.2 % w/w/phosphate 10.0 % w/w).
Lane 9: Top phase from S28 (PEG 300 32.5 % w/w/phosphate 8.4 % w/w).
Lane 10: Top phase from 529 (PEG 300 32.2 % w/w/phosphate 7.3 % w/w).
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10
HA,/NP/NA
67.0 kDa 
43.0 kDa
HA2/M 
30.0 kDa
20.1 kDa
14.4 kDa
FIGURE 2.14. Partition of IBF material in PEG 300 ATPS of increasing Vrd 
(interphase/ bottom phase samples).
Systems 52, 525 to 529 (all with of TLL 43.4 % w/w) were loaded with 20 % w/w IBF 
material used in Fluvirin™ processing (refer to Section 2.1.6) and partitioned as described 
in (Section 2.2.2). The interphase/bottom phase samples were prepared for analysis on 12 
% SDS PAGE gels (see Section 2.2.3). Samples of IBF (pre-partition) and PZC were also 
shown for comparison. A volume of 150 ^l sample was loaded into each lane. Refer to 
Table 2.11 for details of volume ratios of these ATPSs.
Lane 1: IBF 112.5 /ig protein.
Lane 2: IBF 56.3 fig protein
Lane 3: IBF 28.1 ^g protein.
Lane 4: IBF 14.1 ng protein
Lane 5: Low molecular weight markers (5 \il load).
Lane 6: Interphase/bottom phase from 52 (PEG 300 20.0 % w/w/phosphate 20.0 % w/w).
Lane 7: Interphase/bottom phase 525 (PEG 300 22.2 % w/w/phosphate 17.9 % w/w).
Lane 8: Interphase/bottom from S26 (PEG 300 25.5 % w/w/phosphate 15.0% w/w).
Lane 9: Interphase/ bottom from 527 (PEG 300 32.2 % w/w/phosphate 10.0% w/w).
Lane 10: Interphase/bottom from S28 (PEG 300 32.5 % w/w/ phosphate 8.4 % w/w).
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Thus the aim here was to concentrate this phase in order to ease its harvest. For 
information regarding the volume ratios used in this study, refer to Table 2.10. The FMR 
value was defined as the ratio of masses of target protein between the top phase and the 
interphase/bottom phase (Equation 2.6c). Since the virus preferentially partitions to the 
interphase, for successful fractionation of the contaminating proteins away from the 
virus, the contaminants should generate a relatively large FMR. The HAi/ NP/NA 
proteins were located almost exclusively in the interphase/bottom phase in most of the 
ATPSs used (refer to Table 2.11). The HA2/M followed a similar trend except with S25 
where there was partition of these proteins to the top phase. The FMRs of the major 
contaminants (apovitellenins III to V and ovalbumin) were greatest with S25 (which 
demonstrated a two-fold increase in FMR, giving values of 12.6 and 13.5 for 
apovitellenins III to V and ovalbumin, respectively). Thus S25 demonstrated the most 
efficient removal of these key contaminants from the interphase/bottom phase with little 
loss of the virus. The > 97 kDa and apovitellenin I proteins co-purified with the virus in 
the interphase/bottom phase at all volume ratios used (however, as discussed in Section 
2.3.3, this was not significant at this stage). Partition of phosvitin B partitioned 
independently of the volume ratio used (as it did with the TLL and PEG molecular 
weight used) and showed a top phase preference. The minor phosvitins also favoured this 
phase. The poor staining intensity of these bands was partly due to their relative low 
abundance, dilution effects in the ATPS and in the case of phosvitin B its highly 
phosphorylated state (as previously discussed).
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2.3.4.2. Manipulation of volume ratio in ATPSs comprising PEG 8000 and effect on 
FMR deduced by SDS PAGE and one-dimensional densitometry.
Manipulation of the Vrd such that the move is towards lower concentrations of PEG 
8000 (see Figure 2.12), decreased the volume ratio. This results in ATPSs with a 
progressively smaller top phase/interphase. The aim here was to concentrate this phase in 
order to ease its harvest. For information regarding the volume ratios, please refer to 
Table 2.10. The FMR was redefined since the partition was essentially being monitored 
between two phases: top phase/interphase: bottom phase (see Equation 2.7c for 
definition).
ATPS
PROTEINS
>97kDa
ApoVI
Apo III-V
HAi/NP/NA
OA
HA2/M
PB
PEi/F
Apo I
S23
0.8
TI
0.1
0.6
0.0
NR
VF (TI)
0.2
1.0
S30
TI
TI
0.6
2.2
0.4
1.3
VF (TI)
B
TI
S31
TI
TI
0.6
2.5
0.2
1.3
TI
NR
TI
S32
TI
TI
0.6
2.0
0.2
1.7
VF (TI)
NR
TI
S33
TI
TI
0.6
2.7
0.3
1.9
VF (TI)
TI
TI
DECREASING Vrd
TABLE 2.12. Summary table indicating the effect of volume ratio upon partitioning individual 
proteins within IBF material in PEG 8000 ATPS (TLL, 22.4 % w/w).
The > 97 kDa protein refers to higher molecular weight species believed to be derived from 
higher molecular weight apovitellenins. The samples (from top phase and interphase/bottom 
phase) originated from SDS PAGE gels (Figures 2.15 and 2.16 respectively) and analysed using 
Quantiscan™ software, Biosoft. The viral proteins are highlighted in bold typeface. See Table 
2.10 for details of system volume ratio.
Key: NR: No result; NS: Not seen; VF: Very faint; TI: exclusive partition to the top 
phase/interphase; B: exclusive partition to the bottom phase.
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8 10
94.0 kDa
67.0 kDa
HA,/NP/NA 
43.0 kDa
OA 
30.0 kDa
HA2/M
20.1 kDa 
14.4 kDa
FIGURE 2.15. Partition of IBF material in PEG 8000 ATPS of decreasing Vrd (top/ 
interphase samples).
Systems S23, S30 to S33 (all with of TLL 22.4 % w/w) were loaded with 20 % w/w IBF 
material used in Flavian™ processing (refer to Section 2.1.6) and partitioned as described 
in (Section 2.2.2). The top/interphase bottom phase samples were prepared for analysis on 
12 % SDS PAGE gels (see Section 2.2.3). Samples of IBF (pre-partition) and PZC were 
also shown for comparison. A volume of 150 /nl sample was loaded into each lane. Refer to 
Table 2.11 for details of volume ratios of these ATPSs.
Lane 1: IBF 112.5 /J,g protein.
Lane 2: IBF 56.3 ng protein
Lane 3: IBF 28.1 /ng protein.
Lane 4: IBF 14.1 fJLg protein
Lane 5: Low molecular weight markers (10 fj.1 load).
Lane 6: Top phase/Interphase from S23 (PEG 8000 15.0 % w/w/phosphate 11.1 % w/w).
Lane 7: Top phase/Interphase from S30 (PEG 8000 12.5 % w/w/phosphate 12.2 % w/w).
Lane 8: Top phase/Interphase from S31 (PEG 8000 10.0 % w/w/phosphate 13.5% w/w).
Lane 9: Top phase/Interphase from S32 (PEG 8000 7.2% w/w/ phosphate 15.3% w/w).
Lane 10:Top phase/Interphase from S3 3 (PEG 8000 5.3 % w/w/ phosphate 16.3 % w/w).
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5 6 8 10
HAi/NP/
NA
94.0 kDa 
67.0 kDa
43.0 kDa
OA
30.0 kDa
HA2/M
20.1 kDa 
14.4 kDa
FIGURE 2.16. Partition oflBF material in PEG 8000 ATPS of decreasing Vrd (bottom 
phase samples).
Systems S23, S30 to S33 (all with of TLL 22.4 % w/w) were loaded with 20 % w/w IBF 
material used in Fluvirin™ processing (refer to Section 2.1.6) and partitioned as described 
in (Section 2.2.2). The bottom phase samples were prepared for analysis on 12 % SDS 
PAGE gels (see Section 2.2.3). Samples of IBF (pre -partition) and PZC were also shown for 
comparison. A volume of 150 \il sample was loaded into each lane. Refer to Table 2.11 for 
details of volume ratios of these ATPSs.
Lane 1: IBF 112.5 ng protein.
Lane 2: PZC 45 ng protein.
Lane 3: Unused.
Lane 4: Bottom phase from S23 (PEG 8000 15.0 % w/w/phosphate 11.1 % w/w).
Lane 5: Low molecular weight markers (10 /ill load).
Lane 6: Bottom phase from S30 (PEG 8000 12.5 % w/w/ phosphate 12.2 % w/w).
Lane 7: Bottom phase from S31 (PEG 8000 10.0 % w/w/phosphate 13.5% w/w).
Lane 8: Bottom phase from S32 (PEG 8000 7.2% w/w/phosphate 15.3% w/w).
Lane 9: Unused.
Lane 10:Bottom phase from S33 (PEG 8000 5.3 % w/w/phosphate 16.3 % w/w).
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Use was made of the parameter FMR (as defined in Section 2.2.4.2). Again, in this case 
only one FMR value was defined as the ratio of masses between the top phase/interphase 
and the bottom phase (see Equation 2.7c). For successful fractionation of the 
contaminant proteins away from the virus, the contaminant proteins should generate a 
relatively small FMR. The data presented in Table 2.12 demonstrated that the virus was 
located in the top/interphase fraction. The FMR increased slightly along the TLL 
(decreasing Vrd) indicating a small degree of concentration. The FMR values of 
ovalbumin and apovitellenin III to V are low (which is desirable) but there was no 
concentrating effect (since the PMR value did not alter significantly). The phosvitins and 
apovitellenin I co-purified with the virus in the top phase/interphase. To conclude 
manipulation of the volume ratio to concentrate the virus and remove contaminating 
proteins was most beneficial for PEG 300 ATPSs and in particular, ATPS, S25 (PEG 
300 22.2 % w/w/17.9 % w/w phosphate, TLL 43.4 % w/w). Refer to Table 2.11.
2.4. Analytical Considerations.
2.4.1. PEG/salt vs PEG/Dextran ATPSs.
PEG-phosphate ATPSs were used in preference of PEG-Dextran systems because 
they were cheaper. The fact that the cost doesn't change significantly over a wide variety 
of volume ratio (Kroner et al, 1984) makes these systems attractive since this parameter 
can be manipulated with little regard for cost unlike PEG-Dextran systems. Data using 
PEG-Dextran was not shown primarily because it showed no benefit over PEG 6000 or 
8000. Such systems could be used satisfactorily only at low TLLs since the viscosity 
increased dramatically at intermediate and long TLLs (hampering the overall virus 
recovery). This coupled with knowledge regarding the physico-chemical nature of the
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feedstock components can enable one to manipulate partition variables accordingly (for 
example, the use of PEG 300-based ATPS S2, demonstrated its usefulness in directing 
key protein contaminants away from the virus). The influenza virus partitioned to the 
interphase, (more energetically favourable) in this study at all PEG molecular weights 
employed (in the range of 300 to 8000) and with Vrd of unity. The emphasis then was in 
directing protein contaminants away from the virus. Partition behaviour of these proteins 
was explained in terms of excluded volume and salting out effects. The partition was 
also monitored using an HA antigen ELISA. This method could be potentially adapted to 
confirm the identities and quantitate impurities using Western blot techniques, (Towbin 
et al, 1979), probing with antibodies specific for other proteins (such as neuraminidase, 
ovalbumin and M protein), or for nucleic acids.
The EBF material proved extremely sensitive to storage with the highest level of HA 
detected in the order of material stored at -70 °C, -20 °C and 4 °C. Samples of IBF 
analysed by SDS PAGE could detect no such difference in band pattern. An explanation 
for the instability of IBF could be the presence of proteases and other enzymes from the 
host cell membrane that were isolated along with the virus and are often not removed 
using sucrose density ultracentrifugation (Rosenbergova et al, 1981).
The neuraminidase (NA) antigens could not be monitored using the NELLAM. It was 
believed that the NA tetrameric structure was damaged in the presence of PEG, thus 
preventing its use. The release of NA was compared to a calibration curve generated by 
using V.cholerae from bacteria the NA source (Ada et al, 1961). This may not have been 
useful and ideally an NA source from the same influenza strain should be used (since 
variation occurs even between strains, Cabezas et al, 1980). Ultimately this would not 
have been detrimental since the data generated would contain a consistent systematic
87
Chapter Two
error. Another reason that detection of the virus could not rely on monitoring NA alone 
is that its activity could suddenly "nose-dive". One suggested explanation for this could 
be due to aggregation and reversible polymerisation (Cassidy et al, 1965).
2.4.2. System Characterisation.
To enable understanding of partition on the molecular level, the system must be fully 
characterised. This is not an easy task when the system contains biological biomass and 
debris. During this study the impact of PBS and thiomerosal (present in PZC) and uric 
acid in DBF upon the phase diagram was ignored. This would require further 
investigation. Walker, PhD Thesis, (1998) suggested that true partition equilibria are 
never reached because they are inhibited by material accumulation at the interphase. It 
was therefore suggested that one talks in terms of an effective equilibrium. Finally, an 
observation was that ATPS S24 (PEG 8000) spiked with egg white (total protein- 12.5 
mg) produced no visible interphase (see Appendix I). The same ATPS loaded with IBF 
(3 to 5 mg total protein) produced an interphase. This suggested that it is not necessarily 
the amount of protein loaded into a system that determines the formation of an 
interphase, but the composition of these components. For example, IBF contains a high 
proportion of lipoproteins (especially apovitellenin I known to aggregate at the pH used 
in this study).
Thus in conclusion, the study in this chapter has demonstrated the usefulness of SDS 
PAGE/ one-dimensional densitometry in monitoring the partition behaviour of influenza 
virus proteins and also of the contaminant proteins. Manipulation of volume ratio was 
useful in PEG 300 based ATPSs. The system that showed optimal and selective removal 
of contaminating proteins (mainly ovalbumin and apovitellenins) and concentration of
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virus was achieved using ATPS S25 PEG 300 22.2 % w/w/ phosphate 17.9 % w/w, pH 
7.5). This system will be investigated in detail in Chapter Three.
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CHAPTER THREE.
3. OPTIMISATION OF AQUEOUS TWO-PHASE SYSTEMS AND
COMPARISON WITH ULTRACENTRIFUGATION IN PROCESSING
INACTIVATED BULK FLUID GENERATED BY THE MEDEVA FLUVIRIN™
PROCESS.
3.1. INTRODUCTION.
3.1.1. Proposed purification strategy using ATPS.
The ATPS S25 (PEG 300 22.2 % w/w /17.9 % w/w phosphate, pH 7.5) was useful in 
partitioning virus and contaminating proteins to different phases. This system was 
incorporated in the strategy outlined in Figure 3.1. The virus particles and debris 
partitioned predominantly to the interface of the ATPS, forming an interphase, similar to 
that described (see Section 2.1.8). Removal of the top phase of this primary ATPS 
eliminated a significant proportion of the contaminant proteins (approximately 50 % by 
mass, as quantitated using densitometry). Options for harvesting nanoparticles, (such as 
influenza virus) from an interphase include (i) repartitioning into a second ATPS to 
maximise target particle yield and (ii) decreasing the interfacial tension of the primary 
ATPS to make particle adsorption to the interface less favourable, thereby facilitating 
true partition. The former option appeared to work with inclusion bodies, when some 
degree of phase selectivity existed already between polymer and salt-rich phases 
(Walker, PhD thesis, 1998). However, if (like the virus), partition was directed 
predominantly to one phase, then repartitioning the interphase would not be expected to 
do this. Therefore the latter option was taken. The interfacial tension (predominantly 
responsible for interphase formation) was reduced by use of a surface-active agent: (a 
detergent) and also by attempting to reduce the tie line length of the resulting secondary 
hybrid system. In such experiments, the interphase and bottom phase were harvested as
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though a single discrete phase. This was justified by previous data, which demonstrated 
that no detectable protein (viral or otherwise), partitioned to the bottom phase. It was 
envisaged that harvesting the interphase and bottom phase together would circumvent 
the practical problems associated with harvesting discrete interphases at enhanced scales. 
The laboratory scale scheme (illustrated in Figure 3.1) employed an intermediate (blank) 
ATPS, which was constructed and the top phase removed. This phase was combined 
with the interphase/bottom phase from the primary ATPS and added detergent (for 
example Triton XI00) to yield a hybrid system described as an aqueous-detergent two- 
phase system -ADTPS (Figure 3.1). The rationale behind using the ADTPS was to 
partition soluble antigens and detergent to the top phase whilst leaving contaminant 
proteins and core material in the interphase/bottom phase.
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Primary ATPS:
PEG 300 22.2 % w/w/ phosphate
17.9%w/w,pH7.5(S25).
Intermediate 
ATPS.
First extraction 
top phase.
First extraction
interphase/bottom
phase.
Top phase. Interphase/bottom phase.
Remove
contaminating
proteins.
Add detergent.
Secondary ADTPS 
"hybrid" system
Second extraction top 
phase (Contains 
solubilised HA antigen).
Second extraction 
interphase/bottom phase (Contains: 
intact core particles).
Tangential flow 
ultrafiltration.
Discard.
Permeate: removal of 
detergent, contaminants and 
phase-forming chemicals.
Retentate: purified, 
concentrated HA antigen.
FIGURE 3.1. Proposed lab-scale route to purified HA 
antigen production from IBF material.
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3.1.2. Solubilisation Study.
The production of Fluvirin™ subunit vaccine is possible because of selective release 
of surface antigens haemagglutinin (HA) and neuraminidase (NA) with detergent using 
sucrose density gradient ultracentrifugation (see Figure 2.4). Method development 
underpinning the Medeva Fluvirin™ Process relied upon screening a range of detergents 
for optimal detergent and operating concentration (Hjelmland and Chrambach, 1984; 
Hjelmland, 1990). The ability of ultracentrifugation to discriminate between the 
solubilised surface antigens and the denser intact core material permitted the separation 
of these components (Brady, PhD Thesis, 1974; Brady and Furminger, 1976a). The 
schematic depicted in Figure 3.2, illustrates typical situations encountered when 
monitoring detergent solubilisation of surface antigen from purified influenza virus in 
the ultracentrifuge. Analysis of resulting fractions collected from the ultracentrifuge 
during the run is undertaken using refractive indices to monitor sucrose concentration 
and absorbance at 280 nm, to monitor protein concentration. Such a scheme was 
employed in the detergent screening in the Medeva Fluvirin™ Process (Brady, PhD 
Thesis, 1974).
Profile "A" (Figure 3.2) is a typical profile obtained when the virus particles are 
completed disrupted. The viral components are located in sucrose of low concentration, 
approximately 20 % w/v (corresponding to a density of 1.081 g ml" 1 at 20 °C, Bates, 
1942). Profile "B" (Figure 3.2) is typical of selective solublisation of the surface antigens 
(as described by Bachmayer, 1975). The HA and NA antigens are located in sucrose of 
low concentration, approximately 20 % w/v, whilst the intact core material remains in 
sucrose of high concentration, approximately 40 % to 50 % w/v (corresponding to 
densities of 1.176 to 1.230 g ml" 1 at 20 °C, Bates, 1942). Profile "C" (Figure 3.2) is
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Profile "A".
Total protein 
cone, (g ml" 1 )
Fraction number
Surface antigen
Paniculate core 
material
Profile "B".
Total protein 
cone, (g ml' 1 )
Fraction number
Profile "C".
Total protein 
cone, (g ml' 1 )
Fraction number 
INCREASING DENSITY.
Surface antigens and 
disrupted viral components 
. 20 % w/v sucrose.
Sucrose cone, 
(g ml' 1 )
Sucrose cone, 
(g ml' 1 )
Sucrose cone. 
(gmr1 )
Intact viral particles. 
Approx. 40 % to 45 % 
w/v sucrose.
Key:
Total protein cone, (g ml' 1 ) 
Sucrose cone, (g ml" 1 )
FIGURE 3.2. Schematic illustrating the possible outcomes when detergent is incubated with
influenza virus and subjected to ultracentrifugation using a sucrose density gradient. Taken from
Brady, PhD Thesis, (1974).
Profile "A ". Depicts the virus in a fully disrupted state.
Profile "B". Depicts virus with solubilised HA and NA antigens leaving behind the dense core
material.
Profile"C". Depicts the profile obtained when the detergent has been unable to solubilise surface
antigen from the whole virus.
A detergent that produced a similar profile to Profile "B" (that is, maximum antigen release) would
be judged suitable for further utilisation in an aqueous two-phase system.
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"B". Maintaining intact core particles are important in simplifying the purification 
scheme, since the nucleoproteins, polymerase proteins and non-structural proteins 
(Figure 2.1 and Table 2.1) are contained inside.
In order to identify potential detergents that could selectively release surface antigens 
from influenza particles partitioned in an ATPS (as proposed in Figure 3.1), it was 
decided to use the same evaluation method as that used to develop the Medeva 
Fluvirin™ Process. Nonionic detergents were preferred to ionic ones since they would be 
less denaturing (Makino et al, 1973).
3.1.3. Considerations at the outset of the solubilisation study.
The use of detergents in an ATPS raises several concerns, which are summarised as 
follows. Modification of the established phase separation may occur such that new, more 
complex systems would require re-characterisation. Methods must be established to 
assess the efficiency of antigen release and to distinguish between solubilised and non- 
solubilised antigens. Consideration must also be given to removal of detergent from the 
partitioned product.
3.1.4. Description of detergents.
A detergent consists of soluble amphiphilic molecules with surface-active (or more 
generally interfacial-active) properties (Helenius and Simons, 1975). They migrate to 
surfaces or interfaces in solution and act by decreasing the surface (or interfacial) 
tension, thereby assuming the most energetically favourable location in a particular 
system (Tanford, 1980). Detergents are broadly classified as non-ionic, zwitterionic and 
ionic in character (Tanford and Reynolds, 1976; Helenius et al, 1979). Representative
95
Chapter Three
detergent structures are depicted in Figure 3.3 from each of these classes. Nonionic 
detergents in common use consist mainly of polyoxyethylenes (the Triton series) and the 
bile salts (for example, deoxycholate). The molecular structure of polyethylene glycol 
(PEG) (refer to Figure 3.3) is shown to share some commonality with the structure of the 
polyoxyethylene detergents.
3.1.5. Properties of a detergent.
A detergent can be characterised by the ability of its monomers to self-aggregate and 
form micelles. This change, (from monomer to micelle), occurs abruptly over a narrow 
concentration range, known as the critical micellar concentration (CMC). The CMC also 
refers to the maximum chemical potential of a monomer (Neugebauer, 1994). 
Micellization is illustrated in Figure 3.4. The structure of a monomer influences the 
structure and size of the micelle (Neugebauer, 1990). Micelle structure can also be 
influenced by other parameters such as temperature, pH, ionic strength, and residual 
impurities from detergent manufacture. Micelle structure and size are of consequence in 
the removal of detergent by final downstream purification techniques, which depend 
upon parameters such as size or charge discrimination. Another parameter used to 
characterise polyoxyethylene detergents is the hydrophile-lipophile balance (HLB) 
number (Griffin, 1949). This number expresses the hydrophilic character of a detergent. 
It can be either calculated or determined empirically. Thus, the larger the HLB number 
(usually between 12 to 20), the greater the hydrophilic nature of the detergent. The 
aggregation number refers to the number of monomers required to form a micelle. Table 
3.1 gives the properties of some commonly used detergents including those selected for 
use in this study.
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O
Sodium 
Deoxycholate
OH
tOH)
[CH2 -CH2 -0]X H 
Triton X100
O'Na+
-[OH-(CH2 -CH2-0)X Hi-
Polyethylene glycol 
(PEG)
[CH2 -CH2 -0]X H
Synperonic NP9
Zwittergent 3-14
Cetyltrimethlyammonium 
bromide (CTAB)
CH3
+ _ CHj Br
CH,
O
S — O'Na+
O
Sodium dodecylsulphate (SDS)
O
O — S — O" Na+
O
FIGURE 3.3. Structures of commonly-used detergents including those 
used in the solubilisation study.
The detergent structures illustrated are representative of the main 
detergent classes (see main text this Section). The structure of PEG is 
included in the insert for comparison with polyoxyethylene detergent 
structures. 97
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Trade Name.
Triton XI 00
Triton Nl 01
Synperonic NP9
Sodium 
deoxycholate
Zwittergent3-14
Sodium dodecyl 
sulphate (SDS)
Cetylammonium 
bromide (CTAB)
Monomer 
molecular 
weight.
628
625
625
415
364
288
336
CMC
(mM).
0.240
0.085
Similar 
to 
Triton 
N101
*4 
**2.4
0.1-0.4
8.2
3.5
Aggregation 
number (N).
140
No data
No data
* 2-3 
**19.9
83
60
169
HLB.
13.5
13.4
12.8
N/A
N/A
N/A
N/A
Micellar 
Mwt 
(kDa).
90 (in 
water)
No data
Poss. 
larger 
than 
Triton 
X100
1.7-4.2
30
18 (in 
water)
62 (in 
0.013M 
KBr)
TABLE 3.1. Properties of the detergents used in the solubilisation study.
The data was taken from Helenius and Simons, 1975; Hjelmland and Chrambach, 
1984 and Neugbauer, 1990. Data for SDS and CTAB are shown for comparison. 
Data from Synperonic NP9 was disclosed by ICI. 
*>pH8 **>pH8in0.15MNaCl.
3.1.6. Mechanism of antigen release from whole virus using a detergent.
The stages of lipid membrane solubilisation are well documented, (Hjelmland, 1990) 
and involve stepwise binding of detergent monomers to the membrane, structural lysis 
and formation of mixed micelles. Such micelles contain a combination of detergent-lipid, 
detergent-lipid-protein, or detergent-protein. Detergents selected for application in this
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Critical concentration
Free detergent Micelles 
monomers
FIGURE 3.4. Micellization of detergent molecules.
Note the arrangement of the micelles. The hydrophilic head groups are in contact 
with the aqueous environment whilst the hydrophobic, hydrocarbon "tails "form 
an inner core. The micelles (illustrated in two-dimension) are actually spherical, 
typical of structural micelles formed by detergents such as Triton X100 used 
herein.
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study included Triton X100, Synperonic NP9 and sodium deoxycholate Triton X100 was 
chosen because it is commonly used as a solubiliser of biological membranes (Helenius 
and Simons, 1975; Meyer et al, 1992; Hjelmland, 1990). Synperonic NP9 was used 
because it shares structural commonality with Triton N101 that is currently used in the 
Medeva Fluvirin™ Process. Sodium deoxycholate was used because it is representative 
of the bile salt class of non-ionic detergents (see Figure 3.3).
3.1.7. Selection of aqueous two-phase systems used in the optimisation study.
The aqueous two-phase system, ATPS (S25) consisting of PEG 300 22.2 % w/w/ 
phosphate 17.9 % w/w pH 7.5, concentrated the virus at the interface, whilst major 
contaminating proteins from allantoic fluid partitioned to the top phase (see Chapter 
Two). It was concluded that a system of relatively long tie-line length (TLL) and low 
PEG molecular weight was required for high recovery of virus within an interface and 
bulk removal of contaminants to the top phase. After the physical removal of the top 
phase, a successful second stage extraction would involve release of surface antigen 
(using a selected detergent) from the virus into the top phase. A system of short TLL and 
high molecular weight of PEG would be expected to promote the partition of viral 
surface antigens into one of the bulk phases (see Figure 3.5). The intermediate systems 
used were based on systems of short TLL previously used (refer to Table 3.2 and 
Appendix II).
100
Chapter Three
PRIMARY ATPS.
Contaminating proteins 
(OA, Apo III-VI). Discard 
this phase.
_ Interphase/bottom phase 
from primary ATPS.
Top phase from 
intermediate system.
Interphase/bottom 
phase from primary 
system.
ADD 
DETERGENT.
SECONDARY (HYBRID) ATPS.
Contaminating proteins. 
Viral particles at interphase. 
Bottom phase.
Blank top phase from intermediate 
ATPS.
Solubilised surface antigen. 
Intact viral cores.
FIGURE 3.5. Schematic proposing the solubilisation of surface antigens (HA and 
NA) front influenza virus particles.
This figure gives a pictorial representation of the scheme outlined in Figure 3.1. The 
primary ATPS (S25) comprises PEG 300 22.2 % w/w/phosphate 17.9% w/w, pH 7.5. 
Identities of the intermediate and the resulting secondary (hybrid) ATPSs used are 
presented in Tables 3.2 and 3.3 respectively. The addition of detergent was expected 
to release HA andNA into a smaller top phase (thus concentrating the antigens).
101
Chapter Three
3.1.7.1 System nomenclature.
As discussed previously (Section 2.1.9) ATPSs in the presence of biomass or detergent 
are not the same as their parent blank system. For convenience the same system number 
was used regardless of whether the system was loaded with biomass or detergent. For 
example, S39 used in this study (see Table 3.3) is also referred to as S39 in the presence 
of biomass or detergent.
3.1.8. Tangential flow ultrafiltration.
Once the antigens had been selectively released from whole partially purified virus, the 
final steps would necessarily involve removal of the phase formants, the detergent and 
contaminating proteins. (British Pharmacopoeia guidelines require the major 
contaminant ovalbumin, should be at a level of less than 1 ug ovalbumin per 15 ug HA 
dose in the final product). Although there are other ways in which this could be achieved 
(for example size exclusion chromatography or dialysis), ultrafiltration was selected 
because the material from the ADTPS could be both dialfiltered and concentrated, 
(Veide et al, 1984). Tangential flow filtration is a frequently used industrial protein 
separation process (van Reis et al, 1991; Millipore Technical Bulletin, 1992). 
Theoretically it could be used for handling the feedstock produced by the ADTPS study 
because of its ability to separate molecules on the basis of size. In contrast to size 
exclusion chromatography, the resulting solution would not be subject to dilution.
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3.2. MATERIALS AND METHODS.
All materials were sourced from Sigma (Dorset, UK) unless otherwise stated.
3.2.1. Preparation of A IPS with detergent.
The primary ATPS S25 (described in Figure 3.1; see also Appendix II) used in this 
study was composed of PEG 300 (22.2 % w/w) and monobasic:dibasic phosphate in the 
ratio 18:7 (17.9 % w/w) pH 7.5 (± 0.5 pH units). System S25 was constructed by adding 
the required amounts of phase-forming chemicals along with 2 g Inactivated Bulk Fluid 
(IBF) material and Milli-Q water into a clean, pre-weighed 15 ml centrifuge tube 
(Sarstedt) to give a system of total mass of 10 g. This amount of added IBF (A/Sydney 
batch 753134) represented a loading of 20 % w/w of the total ATPS. Strains A/Panama 
(Batch 756303) and B/Yamanashi (Batch 756302) were used in subsequent experiments. 
The intermediate ATPSs (in Figure 3.1; see also Table 3.2) were constructed as for the 
loaded system but without the IBF material. The ATPSs were mixed for one hour at 22 
°C (± 3 °C) using a blood rotator (Stuart SB1) and then centrifuged at 2000 xg for 5 
minutes (centrifuge: C422 Jouan). The top phase of S25 was collected for analysis. The 
combined masses of the collected interphase/bottom phase (from S25) and the top phase 
of the intermediate ATPSs were determined. The appropriate mass of a 10 % w/w 
detergent stock solution (in Milli-Q water) was added to give a final detergent 
concentration of 1 % w/w. The various detergents were all used without further 
purification. The resulting hybrid aqueous-detergent two-phase system, (ADTPS), see 
Figure 3.5 was mixed for selective periods between one or four hours and then 
centrifuged as previously described. The top phase and interphase/bottom phases were
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separated and analysed by ELISA and SDS PAGE. Blank hybrids ADTPs were also 
constructed for characterisation and analytical purposes.
PEG
molecular
weight.
PEG 300
PEG 300
PEG 1000
PEG 6000
PEG 8000
Intermediate
ATPS.
PEG (%)/
Phosphate (%).
10.0/30.0(834)
10.0/25.0(835)
10.7/13.9(836)
10.07 9.1 (S37)
8.3/10.0(838)
Root ATPS.
PEG (%)/
Phosphate (%).
20.0/20.0 (S2)
16.1/20.0(83)
12.0/13.0(89)
N/A
11.3/9.2(824)
TLL
(%
w/w).
43.4
28.3
8.3
19.0
13.8
Volume
ratio
(or
Vrd).
0.38
0.36
0.55
0.50
0.52
TABLE 3.2. Intermediate ATPSs used in optimisation study.
Table 3.2 displays the intermediate ATPSs used in the optimisation study (refer to 
Figure 3.1 and the main text, Section 3.1.7). The systems S34 to S38 inclusive (see 
Appendix II) were chosen from systems of same TLL (and hence overall system 
composition) as the root ATPSs except the Vrd's were smaller. For convenience, 
the systems were identified by a number (S34 to S33 shown in brackets) next to the 
system composition to be used herein. See Appendix II for details of these systems. 
The Vrd's were estimated as described in Section 2.1.8.
PEG
molecular
weight of
top phase
used.
PEG 300
PEG 300
PEG 1000
PEG 6000
PEG 8000
Secondary ATPS.
PEG (%)/
Phosphate (%)
16.8/22.9(839)
13.9/24.3 (S40)
7.3/27.6 (841)
7.8/25.3 (842)
7.2/27.1 (843)
TLL (% w/w).
43.5
35.3
29.4
34.7
33.9
Volume
ratio
(Vrd).
0.83
0.93
0.56
0.52
0.44
TABLE 3.3. Secondary (hybrid) ATPSs used in optimisation study.
Table 3.3 displays the secondary ATPSs used in the optimisation study (refer to 
Figure 3.1 and the main text, Section 3.1.7). The system compositions and TLLs 
were estimated from corresponding blank systems (without IBF material or 
detergent), using the relationship between TLL and volume ratio (Huddleston et 
al, 1991b). For convenience, the Systems were designated with a number, (S39 to 
S43 shown in brackets) next to the system composition to be used herein. See 
Appendix IIfor details of these systems. . The Vrd's were estimated as described in 
Section 2.1.8.
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3.2.2. Preparation of the sucrose ultracentrifuge gradient.
A 60 % w/w stock solution of sucrose was prepared in Milli-Q water. Sucrose 
densities and gradient preparation were described in Figure 3.6. Five millilitres of each 
gradient were layered into polycarbonate centrifuge tubes, maximum volume 38 mis, 
(Beckman). Each gradient component concentration contained detergent at a final 
concentration x % w/v selected from one of the following values: 0 % w/v, 0.01 % w/v, 
0.05 % w/v, 0.1 % w/v, 0.5 % w/v, 1.0 % w/v or 5 % w/v. These concentrations were 
chosen to cover three magnitudes of concentration that might be used in solubilisation 
studies and so enable the determination of the optimal concentration(s) for membrane 
solubilisation. The detergents used were Triton XI00, sodium deoxycholate and 
Synperonic NP9 (ICI, Middlesborough, UK). Once the gradients had been prepared and 
the purified zonal concentrate, (PZC, A/Beijing strain, batch 679) had been added, the 
centrifuge tubes were loaded onto a swinging bucket rotor (SW28, Beckman). The 
average radius (rav) from rotor axis to the outer edge was 122.1mm (Beckman operation 
manual). The centrifuge (Beckman L-80) was programmed to run for 4 hours at 25,000 
rpm (90, 000 xg) at 16 °C. After the run time had elapsed, fractions were carefully 
harvested by dipping the tip of a pipette into the top of the tube and withdrawing 3 ml 
aliquots. This procedure was repeated until all the fractions had been collected.
105
Chapter Three
PZC sample.
10 % w/v sucrose (1.038 g ml" 1 ) + x % detergent.
21 % w/v sucrose (1.081 g ml" 1 ) + x % detergent. 
30 % w/v sucrose (1.127 g ml" 1 ) + x % detergent.
42 % w/v sucrose (1.187 g ml" 1 ) + x % detergent. 
53% w/v sucrose (1.247 g ml" 1 ) + x % detergent.
FIGURE 3.6. Schematic illustrating gradient preparation.
The gradient was loaded in order of densest to lightest sucrose solution. The 
sucrose densities (determined at 20 °C) were taken from Bates, (1942). The 
gradient were prepared either in the presence or absence of detergent at a 
final concentration ofx % w/v (x can have a range of values from 0 to 5 % 
w/v (see main text Section 3.2.2).
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3.2.2.1. Preparation of ultracentrifuge sucrose gradient (for assessment of antigen 
release post partition in an ADTPS).
Once the gradient had been prepared 3 to 5 ml of either top phase material or 
interphase/bottom phase material, which had been partitioned in the ADTPS hybrid 
system, was loaded onto the gradient (see Figure 3.6). The tubes were centrifuged as 
described in Section 3.2.2 except the period of centrifugation and temperature were 
altered to 16 hours at 4 °C to allow more time for migration of components in the 
gradient (see Section 3.3.1).
3.2.2.2. Determination of sucrose concentration using refractive indices.
The refractive index was determined for each fraction using a refractometer (Abbe), 
calibrated against distilled water at 20 °C. The sucrose concentration was estimated from 
a standard curve of sucrose or sucrose plus detergent.
3.2.3. Dialysis of samples to remove detergent and sucrose.
A cellulosic dialysis membrane (12 kDa MWCO) was used to dialyse samples 
generated in Section 3.2.2.1.
3.2.3.1. Preparation of the dialysis membrane.
This protocol was supplied by Sigma (Dorset, UK) and involved boiling the 
membrane for 30 minutes in a solution of 10 mM sodium bicarbonate plus 1 mM EDTA. 
This was followed by a five-minute wash in boiling Milli-Q™ water and two further 
washes in the same. After a cooling, the membrane was ready for use.
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3.2.3.2. Sample Dialysis.
Fractions of volume 500 j^l were added to microfuge tubes (with neat holes in their 
lid). The dialysis membrane was placed over the top of tube and the lid was closed 
firmly (Stage 1, Figure 3.7). The tubes were then briskly inverted to ensure their contents 
were in contact with the membrane (Stage 2, Figure 3.7), which was then immersed in 
the dialysis tank (containing 0.01M PBS pH 7.4). The contents of the tank were 
continually stirred for 18 hours ± 3 hours at 4 °C (Stage 3, Figure 3.7). After the dialysis, 
the tubes' exteriors were wiped dry and the samples were centrifuged for 30 seconds at 
11,600 xg. The volume of each tube was noted. The dialysis efficiency was 70 % on the 
basis of total protein recovery BCA assay.
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STAGE 1.
Preparing and loading the dialysis 
tube with sample.
(§> 1.3. Microcentrifuge tube with neat hole in lid.
1.2. Cellulosic membrane.
1.1 Sample to be dialysed.
Closed 
lid.
Swiftly invert.
STAGE 2.
Placing dialysis membrane over the 
tube with sample and inversion.
"J" tube to remove 
air bubbles.
STAGE 3. Dialysis.
FIGURE 3.7. Illustration of the dialysis assembly used.
Details of dialysis are given in Section 3.2.3.
Fixing tape. 
Air bubbles.
Dialysis tank filled with 
0.01MPBS, pH7.4.
Magnetic stirrer.
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3.2.4. SDSPAGE/densitometry.
Homogenous mini gels containing 12 % acrylamide monomer and samples were 
prepared as described in Section 2.2.3 with the modification of using the method 
described by Bensadoun and Weinstein, (1976), which involved addition of 0.16 % w/v 
deoxycholate added to 50 % w/v cold TCA in a ratio of 1: 2. Volumes of 15 to 20 ul 
were loaded into each lane and the samples were electrophoresed at 125 V for 
approximately one hour. Low molecular markers (from AmershamPharmacia Biotech., 
Uppsala, Sweden) consisted of phosphorylase a (97 kDa), bovine serum albumin (67 
kDa), ovalbumin (43 kDa), carbonic anhydrase (31 kDa), trypsin inhibitor, (21 kDa) and 
lysosyme (14 kDa). The gels were stained (Coomassie Brilliant Blue or silver stain), 
destained, dried and scanned (Ultroscan XL densitometer, LKB Pharmacia) as detailed 
in Section 2.2.4.
3.2.4.1. Estimation of total protein from fractions harvested in the Solubilisation Study 
using SDS PA GE gels.
Fractions from the Solubilisation Study (Section 3.1.2 and Figure 3.6) were analysed 
by SDS PAGE and one-dimensional densitometry. The amount of protein in each 
fraction was estimated by correlating the absorbance multiplied by area ratio (obtained 
by densitometry) from IBF relative to sample with the ratio of masses of protein in IBF 
relative to the sample. The amount of IBF loaded onto the gel and the proportion of 
haemagglutinin subunit 1, nucleoprotein and neuraminidase (HAi/NP/NA) and 
haemagglutinin subunit 2 and matrix protein (HA2/M) therein were known thus it was 
possible to deduce the amounts of these proteins in the samples.
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3.2.4.2. Calculation of Purification factors.
Purification factors were used to assess the purity of material produced at each stage 
of the downstream process and to compare the efficiency of purification between 
ultracentrifugation and ATPS (refer to Section 3.3.8). This was undertaken using SDS 
PAGE/one-dimensionaldensitometry.
For example to calculate the purification factor between Inactivated Bulk Fluid (IBF), 
Stage 1 and Purified Zonal Concentrate (PZC), Stage 2:
Stage 1= Mass of surface antigen (HAi and HA2) in IBF/ total proteins in IBF. 
Stage 2 = Mass of surface antigen (HAi and HA2) in PZC/ total proteins in PZC.
Purification Factor = Stage II Stage 1 Equation 3
However the bands of viral proteins on the SDS PAGE gel not only included HAi and 
HA2 surface antigens, but also matrix (M), nucleoprotein (NP) and neuraminidase (NA) 
proteins. The monoblend pool (MBP) material is the final stage product in the Medeva 
Fluvirin™ Process and consists essentially of surface antigen (no core material). To 
ensure accurate comparisons, the proportion of surface antigen in the viral bands on the 
gel in IBF and PZC was estimated to be 30 %. Thus the mass of viral protein on the gel 
was multiplied by 0.3 to estimate the amount of HAi and HA2 in the intact virus.
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3.2.5. HA antigen ELISA.
The HA standard was prepared by CBER, USA and consisted of purified whole virus. 
The total protein content was determined and the proportion of HA established by SDS 
PAGE and densitometry. A single radial immunodiffusion (SRD) test was undertaken to 
assign a potency value. This standard was referred to as the primary standard. A 
secondary standard was sourced at NEBSC and cross-calibrated with the CBER standard 
and assigned a potency value (50 to 100 j^g HA antigen per ml depending on the batch). 
Where indicated, Tris- Buffered Saline (TBS) was used as a diluent instead of TBS/ 
0.1%zwittergent3-14.
3.2.5.1. Preparation of HA antigen standard.
The HA standards and antibodies used in these studies were kindly provided by 
Medeva Pharma, Liverpool, UK. The reference antigens used were: A/Beijing/262/95/X- 
127 and A/Sydney/5/97 Resvir -13 (CBER Ref. # 37). These were reconstituted in 1ml 
Milli-Q water. The anti-HA polyclonal antibodies used were: A/Beijing/262/95 CBER S- 
9606F2 and A/Sydney/97.
3.2.5.2. HA ELISA protocol.
A 96-well microtitre plate (Immunosorb™, Nunc) was coated with O.ljag ml" 1 
concanavalin A (Con A) lectin. The plate was incubated overnight at 4 °C. The plate was 
washed twice in wash buffer (TBS/ 0.1 % v/v Tween 20) and then coated with 2 % w/v 
BSA/TBS to block non-specific binding. The plate was incubated at 25 °C (± 3 °C) for 
90 minutes. The plate was washed again and the samples and HA standard were diluted 
in 0.1 % w/v zwittergent 3-14®, 3-(Tetradecyldimethylammonio) propane-1-sulfonate/ 
TBS and applied to the microtitre plate. After incubating the plate for 90 minutes, the
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plate was washed and the anti-HA antibody was added (1/500 in 1 % w/v BSA/ TBS) 
and incubated for 60 minutes. The plate was washed and the donkey anti-sheep IgG 
peroxidase-labelled conjugate was added (1/1000 in 1% w/v BSA/ TBS) and the plate 
incubated for 90 minutes. After the wash step, the substrate para-nitrophenyl phosphate 
(pNPP) was added. Colour development at 405 nm was allowed to proceed until the top 
HA standard gave an optical density reading of 1. After subtracting the blank value from 
the reading, the HA concentration could be determined from the HA standard curve. The 
minimum level of detection of this assay was 0.1 jug HA antigen per ml.
3.2.5.3. Estimation of mass balances for HA antigen.
The recovery of HA antigen from the ELISA was estimated as shown in Equation 3.1.
Recovery (%) = GHA in samPiP ) x VVsampi^ x 100
C (HA in IBF) x V( IBF) Equation 3.1
Where c = concentration of HA antigen (deduced from absorbance at 405 nm 
measurements) and v = volume of phase.
5.2.6'. Tangential flow ultrafiltration.
A Millipore Labscale™ tangential flow system (see Figure 3.8) was used in 
conjunction with Pellicon Minicassettes containing a polyethersulfone membrane of 
nominal molecular weight cutoff of 100 kDa, (Pellicon XL™). The system was operated 
at an optimised transmembrane pressure (TMP) of 20 pounds per square inch (deduced 
from a flux versus TMP curve, see Figure 3.9).
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Ftetenlato
Diafiftratlon 
Buffer Tank
,v Retoniate Valve
Pump |
Used for DiafiHration Only
Batch UF System Permeate
FIGURE 3.8. Experimental set-up used for diaflltration of ADTPS-partitioned 
IBF material.
This assembly, typical of the set-up described in Section 3.2.6, is reproduced 
from Zydney and Kuriyiel, (2000).
114
Chapter Three
0
•Flux
FIGURE 3.9. Estimation of optimum transmembrane pressure (TMP) from 
flux curve.
The maximum achievable TMP with minimal polarisation effect occurred at a 
TMP of 20 Psi (approximately 1.4 bar).
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3.2.6.1. Membrane pre-conditioning.
The membrane was prepared by washing in Milli-Q water (2 litres), to remove 
membrane preservatives, followed by 0.1M NaOH (recirculation mode for 18 hours) to 
remove bacteria. A further 2 litres of Milli-Q water was flushed through membrane to 
remove the NaOH. Finally 0.1M NaCl primed the membrane to minimise charge- 
dependent binding (Millipore Technical Brief, Literature Number TB032, 1992).
3.2.6.2. Diafiltration in continuous mode.
Top phase material (80 ml) from the optimised hybrid ADTPS and containing 
partitioned influenza strain A/Panama, was diluted 1:4 in 0.01M PBS pH 7.4. This 
material was concentrated four-fold prior to diafiltration in continuous mode using times 
2.5 diafiltration volumes. Permeate fractions (50 ml) were collected for mass balance 
analysis as described in Section 3.3.7.
3.2.7. A28o determination to estimate concentration.
The top phase samples were diluted 30 to 60 times in 0.01M PBS, pH 7.4, 100 ul 
placed in a small volume (100 (J,l) cuvette and read against an appropriate blank 
(accounting for the contribution of PBS and the phase-forming chemicals) at 280 nm 
(Ultrospec II, LKB). Bottom phase samples were analysed in the same manner, but 
without dilution.
3.2.7.1 A280 determination to estimate detergent mass balance in ADTPS.
The mass balances of detergent from absorbance at 280 nm was estimated as shown 
in Equation 3.2.
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) = C(A?.«n in partitinnpH samp^ X V(Sample) X 1 00
C (A280 detergent) X V(<jetergent used) Equation 3.2
Where c = concentration of detergent in sample (deduced from absorbance at 280 nm 
measurements) and v = volume of phase.
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3.3. RESULTS AND DISCUSSION.
3.3.1. Solubilisation Study using PZC.
Purified Zonal Concentrate (PZC) was used in method development to ascertain the 
optimal detergent conditions to use in the ATPS. Ideally, the optimal detergent would be 
the lowest concentration of detergent that produced a profile similar to B (shown in 
Figure 3.2). The PZC was chosen since it contains purified viral proteins and other 
contaminant proteins would not complicate the profiles generated. Fractions from 
sucrose density ultracentrifugation (as described in Section 3.1.2) were analysed using 
SDS PAGE, one-dimensional densitometry and ELISA (specific for HA antigen). The 
amount of haemagglutinin subunit 1, nucleoprotein and neuraminidase (HAi/NP/NA) 
and haemagglutinin subunit 2 and matrix protein (HA2/M) in each fraction was estimated 
using SDS PAGE and one-dimensional densitometry as described in Section 3.2.4.1. 
Figures 3.10 to 3.12 depict typical data obtained when no detergent or relatively high and 
low concentrations of a detergent (for example 1 % w/w and 0.01 % w/w respectively) 
was added to the gradient. Triton XI00 was selected here as an example. The total 
protein and HA antigen profiles track each other fairly well. In the absence of detergent, 
both the total protein and antigen signals were located at intermediate sucrose 
concentration (approximately 30 % to 35 % w/v sucrose). This was much lower than 
expected (in the Medeva Fluvirin™ Process, where intact viral particles were located in 
sucrose concentrations of 50 to 55 % w/v, personal communication with Medeva Pharma 
Development Scientists). Although the profile shown in Figure 3.10 (a) mimicked the 
expected profile for intact virus particles (Profile "C" in Figure 3.2), their precise 
location in the gradient was unexpected. The run time of four hours may have been 
insufficient to permit components to migrate to their true position in the gradient.
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Although, under the conditions used, this profile still provided information as to where 
the intact particles were likely to be located. Subsequent use of ultracentrifugation 
employed longer processing times (see Section 3.2.2.1). The total protein profile 
depicted in Figure 3.10 (a) was broader than the corresponding profile obtained by 
monitoring the HA antigen (using absorbance at 405 nm). This was because the protein 
was estimated using SDS PAGE and densitometry (see Section 3.2.4.1) and thus 
includes NP and M protein as well as the HA proteins. The ELISA on the other hand, 
detects only the surface HA protein. The gradient location of virus in the presence of low 
Triton X100 concentration (0.01 % w/w) was similar to that in the absence of virus 
(compare Figures 3.10 and 3.11). However the total protein mass balance did not close. 
Since the ELISA mass balance data was not affected, it was suggested that this was due 
to the TCA method used (see Section 2.2.3.1). This method worked well in the absence 
of detergent but produced non-quantitative precipitation in the presence of low Triton 
XI00 concentration. To confirm if this was the source of error, a standard protein of 
known concentration could be subjected to the precipitation in the presence and absence 
of Triton XI00. In the presence of relatively high concentration of Triton XI00 1 % 
w/w, a profile similar to Profile "B" (compare Figures 3.2 and 3.12a) resulted. This type 
of profile indicated that the surface antigens had been solubilised (in a sucrose 
concentration of 10 % to 20 % w/v), leaving intact core particles (in a sucrose 
concentration of approximately 45 % w/v). This is similar to the concentration in the 
Medeva Fluvirin™ Process. Possibly fraction pooling could have diluted the virus and 
thus account for the slightly lower concentration.
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FIGURE 3.10 (a). Total protein (estimated using SDS PAGE and densitometry) and 
HA antigen profiles from sucrose density gradient ultracentrifugation in the absence 
of Triton XI00.
Fractions of 3mls were collected and analysed (see main text) for total protein and HA 
antigen content. The resulting profile indicates that the protein is located in Fractions 5 
to 10 (corresponding to sucrose concentrations of approximately 24 % to 47 % w/v).
HA2/M HA./NP/NA
11 12 13
97.0 kDa 
67.0 kDa
43.0 kDa 
31.0 kDa
21.0 kDa 
14.4 kDa
FIGURE 3.10 (b). The corresponding gel from Figure 3.10 (a).
Lane 1: IBF, Lane 2: PZC, Lanes 3 to 6 inclusive: Fractions 1 to 4. Lane 7: Low
molecular weight marker. Lanes 8 to!3 inclusive: Fractions 5 to 10.
Fractions of 3 mis (from ultracentrifugation, Section 3.2.2) were collected and
analysed using SDS PAGE and one-dimensional densitometry. The resulting profile
in the absence of Triton XI00 indicates that the viral proteins (HA]/NP/NA and
HA2/M) were located in Fractions 5 to 10 inclusive confirming the data presented in
Figure 3.10 (a).
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FIGURE 3.11 (a). Total protein (estimated using SDS PAGE and densitometry) and HA 
antigen profiles from sucrose density gradient ultracentrifugation in the presence of0.01 
% w/w Triton XI00.
Fractions of 3mls were collected and analysed (see main text) for total protein and HA 
antigen content. The resulting profile is similar to that presented in Figure 3.10 (a) with 
respect to the location of the protein peak indicating that the protein is located in Fractions 
5 to 10 (corresponding to sucrose concentrations of approximately 24% to 47' % w/v).
1 4 8 10 11 12 13
97.0 kDa 
67.0 kDa
43.0 kDa
31.0 kDa
21.0 kDa 
14.4 kDa
FIGURE 3.1 l(b). The corresponding gel from Figure 3.11 (a).
Lane 1: IBF, Lane 2: PZC, Lanes 3 to 6 inclusive: Fractions 1 to 4. Lane 7: Low
molecular weight marker. Lanes 8 to 13 inclusive: Fractions 5 to 10. 
Fractions of 3 mis (from ultracentrifugation, Section 3.2.2) were collected and analysed 
using SDS PAGE and one-dimensional densitometry. The resulting profile in the presence 
of 0.01 % w/w Triton XI00 indicates that the viral proteins (HAj/NP/NA and HA2/M) were 
located predominantly at Fraction 7. This profile does not track the HA antigen profile 
presented in Figure 3.11 (a) due to poor staining (and hence protein quantitation on the gel) 
see main text.
121
Chapter Three
1000
Sa
123456789 
Fraction number
•Total Protein
• Total Abs. Units at 
405 nm
FIGURE 3.12 (a). Total protein (estimated using SDS PAGE and densitometry) and 
HA antigen profiles from sucrose density gradient ultracentrifugation in the presence 
ofl % w/w Triton XI00.
Fractions of 3mls were collected and analysed (see main text) for total protein and HA 
antigen content. The resulting profile is similar to that depicted by Profile "B ", (Figure 
3.2) with respect to the location of the protein peaks indicating that the protein is 
located at Fractions I to 4 (corresponding to sucrose concentrations of approximately 4 
% to 15 % w/v) and also Fractions 8 and 9 (corresponding to sucrose concentrations oj 
approximately 41 % to 49 % w/v).
1
HA,/NP/
NA
8 10 11 12 13
HA,/M
97.0 kDa 
67.0 kDa
43.0 kDa
31.0 kDa
21.0 kDa 
14.4 kDa
FIGURE 3.12 (b). The corresponding gel from Figure 3.12 (a).
Lane 1: IBF, Lane 2: PZC, Lanes 3 to 6 inclusive: Fractions I to 4. Lane 7: Low
molecular weight marker. Lanes 8 to 11 inclusive: Fractions 5 to 8. Lane 12: Unused. 
Lane 13: Fraction 9.
Fractions of 3 mis (from ultracentrifugation, Section 3.2.2) were collected and analysed 
using SDS PAGE and one-dimensional densitometry. The resulting profile in the presence 
of 1% w/w Triton X100 indicates that the viral proteins (HAi/NP/NA and HA2/M) were 
located in Fractions I to 4 and Fractions 8 to 9. This data generally tracks the HA 
antigen data presented in Figure 3.12 (a).
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3.3.1.2. The Effect of three non-ionic detergents upon solubilisation of surface from 
purified influenza virus particles.
Figures (3.13 to 3.16 respectively) depict a series of profiles that illustrate the effect 
of selection detergent and operating concentration upon purified whole virus loaded onto 
a sucrose density gradient. When no detergent was present, a characteristic broad peak of 
protein (Fractions 5 to 8 inclusive) was produced. The presence and position of this peak 
has been discussed in the previous section. The use of low concentrations (0.01 % to 0.1 
% w/w) of deoxycholate yielded analyses that indicated that the viral particles remained 
intact. However, at concentrations of 0.5 % w/w and above, the deoxycholate profile 
produced a protein peak at approximately 20 % w/v sucrose (corresponding to a density 
of 1.08 g ml" 1 ), suggesting that solubilisation had occurred. These observations could be 
explained by the relatively high critical micellar concentration (CMC) of deoxycholate 
2.4 to 4 mM compared to the other two detergents (see Table 3.1). Solubilisation is 
thought most likely to occur when a detergent is at or near its CMC (Hjelmland and 
Chrambach, 1984). Thus below this concentration range, the detergent monomers can 
only bind to the hydrophobic domain of the surface antigen. At higher concentrations 
(above the CMC), the surface antigens and other proteins are incorporated into micelles 
leading to solubilisation. This is true for all the detergents used herein, except that with 
deoxycholate the CMC is that much higher; therefore higher concentrations would be 
required to achieve solubilisation. In addition, deoxycholate at these higher 
concentrations produced lower levels of solubilised antigen as compared to the other two 
detergents at similar concentrations and tended to give over-exaggerated mass balances 
in both SDS PAGE analyses and the ELISA. This could be due to interactions with the 
antigen exposing additional sites for the Coomassie dye or for the anti-HA antibody to
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FIGURE 3.13. Total protein profile (deduced using SDS PAGE and one-dimensional 
densitometry) of PZC fractionation using sucrose density ultracentrifugation in the 
absence of detergent.
Three millilitres of PZC was layered onto a sucrose gradient (as described in Section 
3.2.2) in the absence of detergent. The total protein profile is plotted as a mean of two 
consecutive ultracentrifuge runs. Total protein was estimated as described in Section 
3.2.4.1. The broad protein peak (see Figure 3.10a) corresponded to intact viral particles 
located in sucrose concentration of 25 % to 40 % w/v.
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FIGURE 3.14. Total protein profiles (estimated using SDS PAGE and one-dimensional 
densitometry) in the presence of 0.01 % to 1 % w/v sodium deoxycholate.
A range of deoxycholate concentrations were employed to ascertain the optimal 
concentration for selective solubilisation of surface antigens (as described in Section 
3.1.2. and Figure 3.2). Five millilitres of PZC of was layered onto a sucrose density 
gradient (as described in Section 3.2.2). Deoxycholate was added to the each gradient 
density layer (see Figure 3.6). Solubilsation of surface antigens occurred with 
deoxycholate concentrations in excess of 0.5 % w/v as indicated by the presence oj 
protein peaks (Fractions 1 to 4) located in relatively low sucrose concentrations 
(approximately 7 % to 17 % w/v respectively). Intact viral particles are located in 
Fractions 5 to 9 (corresponding to approximate sucrose concentrations of 20 % to 50 % 
w/v). The recovery of total protein was over-inflated in the presence of this detergent (see 
main text for details).
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FIGURE 3.15. Total protein profiles (estimated using SDS PAGE and one- 
dimensional densitontetry) in the presence of 0.01% to 1 % w/v Synperonic NP9.
A range of Synperonic NP9 concentrations were employed to ascertain the optimal 
concentration for selective solubilisation of surface antigens (as described in Section 
3.1.2. and Figure 3.2). Five millilitres of PZC of was layered onto a sucrose density 
gradient (as described in Section 3.2.2). Synperonic NP9 was added to the each 
gradient density layer (see Figure 3.6). Solubilsation of surface antigens occurred with 
Synperonic NP9 concentrations in excess of 0.1 % w/v as indicated by the presence oj 
protein peaks (Fractions I to 4) located in relatively low sucrose concentrations 
(approximately 4 % to 16 % w/v respectively). Intact viral particles are located in 
Fractions 7 to 10 (corresponding to approximate sucrose concentrations of 34 % to 51 
% w/v).
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FIGURE 3.16. Total protein profiles (estimated using SDS PAGE and one- 
dimensional densitometry) in the presence of 0.01% to 1 % w/v Triton XIOO.
A range of Triton XIOO concentrations were employed to ascertain the optimal 
concentration for selective solubilisation of surface antigens (as described in Section 
3.1.2. and Figure 3.2). Five millilitres of PZC of was layered onto a sucrose density 
gradient (as described in Section 3.2.2). Triton XIOO was added to the each gradient 
density layer (see Figure 3.6). Solubilsation of surface antigens occurred with Triton 
XIOO concentrations in excess of 0.1 % w/v as indicated by the presence of protein 
peaks (Fractions 1 to 5) located in relatively low sucrose concentrations (approximately 
4 % to 20 % w/v respectively). Intact viral particles are located in Fractions 7 to 10 
(corresponding to approximate sucrose concentrations of 33 % to 49 % w/v). See also 
Figures 3.11 and 3.12.
127
Chapter Three
bind. Thus this detergent was excluded from further use. Synperonic NP9 (Figure 3.15) 
produced almost "perfect" profiles with respect to its resemblance to that indicated by 
Profile "B" (Figure 3.2) except at the lowest concentration used. However, more 
solubilised antigen was produced when either 1 % w/w or 0.5 % w/w Synperonic NP9 
was used. Triton XI00 profiles showed a similar trend at these higher concentrations 
(Figure 3.16). At lower concentrations, Triton XI00 yielded profiles suggesting that 
intact particles were the predominant species. The 100 % closure of mass balances could 
be variable. This was attributed to variable precipitation yields with TCA during sample 
pre-treatment (see Section 2.2.3.1). The 5 % w/w detergent concentration, (for all three 
detergents) was not considered for further use because the desired solubilisation effect 
had been obtained with much lower concentrations of detergent. The data for this was 
variable due to assay interference and therefore impossible to interpret accurately. On 
this basis, it was decided to use both Triton XI00 and Synperonic NP9 in the 
construction of ADTPSs for solubilising the haemagglutinin antigens. It was difficult to 
assess the true benefit of using these detergents at 0.5 % w/w and 1 % w/w 
concentrations, so both of these were used in the next stage.
3.3.2. Effect of PEG molecular weight upon partition of detergents in secondary (hybrid) 
aqueous-detergent two-phase systems.
Prior to use of Synperonic NP9 and Triton X100 in an ATPS, it was essential to know 
where the detergent would partition in the experimental systems. The well-known 
property of these detergents absorbing ultraviolet light at 280 nm was utilised in this 
experiment. The top phase of each hybrid system was composed of PEG of varying 
molecular weight (as described in Section 3.2.1 and Figure 3.5). This was to assess the
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contribution of PEG chain length to detergent partition. It was decided at this stage to re­ 
display the system identifications since they were frequently used. These are presented in 
Table 3.4. The data presented in Figures 3.17 and 3.18 respectively indicated that both 
detergents preferentially partition to the top phase, regardless of the molecular weight of
System 
identification 
number.
S39
S40
S41
S42
S43
Overall composition. 
PEG (%w/w)/ Phosphate (% w/w).
PEG 300 16.8/22.9
PEG 300 13.9/24.3
PEG 1000 7.3/27.6
PEG 6000 7.8/25.3
PEG 8000 7.2/27.1
TLL
(% w/w).
43.5
35.3
29.4
34.7
33.9
TABLE 3.4. List of secondary (hybrid) ADTPSs used in partition studies.
Refer also to Table 3.3 and Appendix II.
PEG employed. This is unsurprising since the detergent structures are similar to PEG 
(refer to Figure 3.3). In particular, Triton X100 can be considered as PEG with a p-t- 
octylphenol head group). The A2go of a 1 % w/w solution of Triton XI00 was determined 
to be 24.6 absorbance units (data not shown). This compared favourably to the published 
value of 22.0, (Furth et al, 1984). Mass balances were calculated as described in Section 
3.2.8.1 and for Systems S39, S40 and S42 in the presence of Triton X100 (Figure 3.17), 
the mass balances were 72 %, 135 % and 49 % respectively; for Systems S39, S40, S41 
and S43 in the presence of Synperonic NP9 (Figure 3.18), the mass balances were 81 %, 
108 %, 10 % and 131 % respectively. The variability in the mass balance was more 
pronounced in PEG 1000 and PEG 6000- based ADTPSs (S41 and S42 respectively) and 
was attributed to precipitation of the detergent in these Systems. The PEG 300-based 
ADTPS of shorter TLL (S40, refer to Table 3.4) recorded a higher recovery of detergent 
compared to the PEG 300-based ADTPS of longer TLL (S39, refer to Table 3.4). This
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FIGURE 3.17. Utilisation ofabsorbance at 280 nm to monitor the distribution of Triton 
XI00 (at a final concentration ofl% w/w) in selected ATPSs.
The distribution of 1 % w/w Triton XI00 was monitored (by absorbance at 280 nm) in a 
selection of ATPSs (see Table 3.4). The appropriate blanks were subtracted from the 
readings (see Section 3.2.7). The mass balances were estimated as described in Section 
3.2.7.1. The data demonstrates that Triton XI00 partitions preferentially to the top phase 
in these systems in a similar manner to that displayed by Synperonic NP9 (Figure 3.18).
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FIGURE 3.18. Utilisation of absorbance at 280 nm to monitor the distribution of 
Synperonic NP9 (at a final concentration of 1 % w/w) in selected ATPSs.
The distribution of 1 % w/w Synperonic NP9 was monitored (by absorbance at 280 nm) 
in a selection of ATPSs (see Table 3.4). The appropriate blanks were subtracted from 
the readings (see Section 3.2.7). The mass balances were estimated as described in 
Section 3.2.7.1. The data demonstrates that Synperonic NP9 partitions preferentially to 
the top phase in these systems in a similar manner to that displayed by Triton XI00 
(Figure 3.17).
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could be explained by differences in the top phase concentration of PEG and resulting 
excluded volume and salting out mechanisms (Kim, PhD Thesis, 1986). System S39 
contains a higher concentration of PEG and therefore a larger number of PEG molecules 
and hence an increased volume exclusion effect. In addition, an increased salting out 
effect causes precipitation (refer to Section 1.5.5) and hence less recovery (of detergent). 
An explanation for this observation is that water forms an ordered hydration layer around 
PEG (Huddleston et al, 1991b) and presumably around Triton XI00 micelles too (due to 
its structural commonality with PEG, refer to Figure 3.3). As the PEG concentration 
increases, the PEG is hydrated in preference to the bulkier Triton XI00 molecules since 
it is an energetically favourable arrangement. Thus the Triton head groups become 
dehydrated and the solution becomes turbid. This is similar to cloud point phenomenena 
described by Helenius and Simons, (1971). In extreme cases (PEG 1000 and 6000), 
precipitation occurs due to increased salting out effects (hence the non-closure of mass 
balances in these systems). The mass balance in the PEG 8000-based ADTPS, (S43) 
closed indicating that the detergent remained unaffected by the presence of PEG 8000 
(although some cloudiness was observed in this System). An explanation for this could 
be that the long chain length of PEG 8000 and the bulky Triton XI00 micelles are 
equally hydrated by the water molecules (that is they have no preference to hydrate), 
therefore the Triton XI00 head groups are not subjected to dehydration to the same 
extent as PEG 300 and thus the turbidity is lower and the absorbance higher. Possibly the 
salting out effects are lower compared to the PEG 1000 and 6000-based ADTPSs 
therefore aggregation was not observed.
The aim of this experiment was to monitor the partition of detergent alone in 
ADTPSs. The detergent would be employed in the proposed purification scheme (see
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Figure 3.1) using the optimised ADTPS to selectively release surface antigen from intact 
influenza virus particles. It was expected that the surface antigens would partition with 
the detergent to the top phase. Thus confirmation of the detergent partition undertaken in 
this study lends support to this proposal.
3.3.3. Effect of PEG molecular weight upon partition of Inactivated Bulk Fluid in 
secondary hybrid ADTPSs.
In the previous section, it was established that the detergent partitioned almost 
exclusively to the top phase in all systems tested. The experiment documented in Section 
3.3.1 used purified zonal concentrate (PZC) and sucrose density ultracentrifugation as a 
means to determine optimal detergent and concentration for surface antigen release from 
the virus particles. This section employs the detergent(s) and concentration(s) considered 
optimal in selected ADTPSs containing Inactivated Bulk Fluid (IBF). The systems were 
constructed as in Section 3.2.1 and the HA ELISA was used as the analytical technique 
to monitor partition in the ADTPS because of its specificity and its capacity for high 
sample throughput. The neuraminidase (NA) was not monitored due to the lack of a 
suitable assay method to analyse samples partitioned in ATPSs. However, monitoring 
the HA antigen was more important because it is the main surface antigen and 
component in the Fluvirin™ vaccine. The following figures present ELISA mass balance 
data of IBF partitioned in a two-stage extraction (refer to Figure 3.1). Triton XI00 and 
Synperonic NP9 were used at two different concentrations. Mass balances were 
estimated as described in Section 3.2.5.1. It should be noted that the starting IBF value 
for HA antigen content was approximately three-four fold lower than in the experiments 
of the previous chapter. It was concluded that this was because the material was taken
133
Chapter Three
600 -.ua
,e 500 -
.0 ? 400 -
| 1 300 - 
I 1 200 -
^5 100 - 
1 o-
F^1
_t!j:
^^
 S^
s$ 
^ 
^ 
^
^ ss
^ 
^ 
^
1- : ; • 1
H S39 S40 S41 S42
ADTPS
W/////////A
S43
• 1st Top phase 
D 2nd Top phase 
H 2nd Int/Bott. phase
FIGURE 3.19. The effect of Triton XIOO (1 % w/w) upon the distribution of HA 
antigen in selected ADTPSs.
The total HA antigen in each phase (see Section 3.2.5.1) is shown for ADTPSs comprising 
PEG of different molecular weights 300 to 8000 (see Table 3.4). Triton XIOO was added 
to the hybrid system at a final concentration of 1 % w/w (see also Figure 3.20).
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FIGURE 3.20. The effect of Triton XIOO (0.5 % w/w) upon the distribution of HA 
antigen in selected ADTPSs.
The total HA antigen in each phase (see Section 3.2.5.1) is shown for ADTPSs comprising 
PEG of different molecular weights 300 to 8000 (see Table 3.4). Triton XIOO was added 
to the hybrid system at a final concentration of 0.5 % w/w (see also Figure 3.19).
134
Chapter Three
• M
g 600 —————
\ 500-
A
1 o 400 -
•2 s •< a
^ *r> 300 -§ ?
•-C « 200 -
B<c^
 100 -ffi 
3 o^
o 
H
J
S39
^JI
S4
]
3
JoJ
S41 S4 
ADTPS
l.-i
2 S43
• 1st Top phase 
D 2nd Top phase 
El 2nd Int./Bott. phase
FIGURE 3.21. The effect of Synperonic NP9 (1 % w/w) upon the distribution of HA 
antigen in selected ADTPSs.
The total HA antigen in each phase (see Section 3.2.5.1) is shown for ADTPSs comprising 
PEG of different molecular weights 300 to 8000 (see Table 3.4). Synperonic NP9 was 
added to the hybrid system at a final concentration of 1 % w/w (see also Figure 3.22).
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FIGURE 3.22. The effect of Synperonic NP9 (0.5 % w/w) upon the distribution of HA 
antigen in selected ADTPSs.
The total HA antigen in each phase (see Section 3.2.5.1) is shown for ADTPSs comprising 
PEG of different molecular weights 300 to 8000 (see Table 3.4). Synperonic NP9 was 
added to the hybrid system at a final concentration of 0.5 % w/w (see also Figure 3.21).
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from a stock stored at -20 °C prone to proteolytic degradation (as opposed to -70 °C 
which had been completely used up in the previous experiments).
3.3 3.1. First extraction, top phase partitioned samples.
Results for HA recovery from the top phases in the first extraction, (see Figure 3.1) 
averaged out at around 40.0 AWS units. Densitometric analysis (data not shown) of an 
SDS PAGE gel of these samples confirmed that the HA antigen partitions to this phase 
was constant (refer to Figure 3.23). Detergent had not been added at this stage, 
suggesting that PEG has a relatively small impact upon surface antigen release or that the 
virus naturally "sheds" a small proportion of its surface antigens which partition to the 
top phase in PEG 300-based ATPSs.
3.3 3.2. Second extraction, top phase partitioned samples.
In the top phase of the second extraction samples, (see Figure 3.1) the greatest 
amount of HA antigen was quantitated in the PEG 300-based secondary hybrid ADTPSs. 
This occurred regardless of the detergent or detergent concentration used. The recovery 
in this same phase drops abruptly in the hybrid systems comprising PEG 1000 to 8000. 
This could be explained in terms of increased excluded volume effects as the PEG 
molecular weight was increased, coupled with the fact that the detergent preferentially 
partitions to the top phase. Detergent aggregation occurs as a result of preferential 
hydration of PEG as (discussed in Section 3.3.2). Thus less detergent is available to 
solubilise the surface antigens in ADTPSs of intermediate to high PEG molecular 
weight. In general, the proteins in such systems have an increasing natural preference for 
the bottom phase (see Section 2.2.3.4). Thus the low availability of detergent coupled
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FIGURE 3.23. SDS PAGE gel depicting first extraction top phase
samples.
Lane 1: IBF; Lane 2: PZC; Lanes 3 to 5 inclusive and 7 to 10 inclusive:
First extraction top phase samples from primary ATPS S25 (PEG 300 22.2 
% w/w/ phosphate 17.9 % w/w, pH 7.5). Lane 6: Low molecular weight 
markers.
The samples in Lanes 3 to 5 and 7 to 10 inclusive were partitioned in a 
series ofS25 ATPSs loaded with 2 g IBF material (as described in Section 
2.2.2). The interphase/bottom phases of these systems were destined to 
form a series of secondary hybrid ADTPS as illustrated in Figure 3.5. 
Replication of the top phase sample demonstrates the consistency in 
preparation ofS25 and that the partition of HA antigen to this phase was 
similar.
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with opposing partition preferences (of proteins and detergent) means that less 
solubilsation can occur (and hence less HA antigen detected in the top phase), hi PEG 
300-based ADTPSs, the proteins and detergent partition to the same phase, thus more 
solubilisation can occur.
3.3 3.3. Second extraction, interphase/bottom phase partitioned samples.
hi the ADTPSs investigated using ELISA, most of the HA antigen was located in the 
interphase/bottom phase. This was attributed to detergent-solubilised antigen remaining 
at the interphase, unable to partition to the top phase due to entrapment with debris, 
combined with possible micelle breakdown upon contact with the phosphate phase (Save 
et al, 1995). This could be verified by transmission electron microscopy (TEM). Such a 
response was exaggerated in the presence of low molecular weight PEG. This could be 
explained as follows. Haemagglutinin exists as a trimer in its native. Low molecular 
weight PEG exposes a surface, which permits increased binding of antibody in the 
ELISA. Alternatively, detergent affects the antigen in such a way that high capacity, low 
affinity binding sites are uncovered (Hjelmland and Chrambach, 1984). Since Triton 
XI00 and Synperonic NP9 share structural commonality with PEG (Figure 3.3) then 
they probably potentiate these effects. Support for the first explanation derives from 
previous analyses using the Haemagglutination Test (Appendix I) whereby decreased 
recoveries in this assay were attributed to conformation changes in the presence of low 
molecular weight PEG. It is widely accepted that PEG stabilises protein and protein 
intermediates (Mitraki and King, 1989). Stabilisation of antibody binding sites could 
result in increased antibody binding (as detected by ELISA). The alternative explanation 
could be verified by Scatchard analysis. These effects are observed in the presence of
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presence of low molecular weight PEG because it has a smaller chain length thus 
permitting it to get closer to the surface antigen and exert the described effects.
3.3.3.4. Multiple phase formation inADTPSs.
Another interesting observation was that ADTPSs containing detergent at a final 
concentration of 1 % w/w actually formed four-phase systems. That is: a clear bottom 
phase, a translucent interphase sometimes obscured by a turbid top phase and a thin pale 
yellow coloured phase on top due to lipoproteins (as described by Burley and Sleigh, 
1975). The intensity of this colour increased as the PEG molecular weight increased. It 
was difficult to isolate this latter phase (on the scale of system used) thus it was 
harvested and analysed together with the top phase proper. In systems of high PEG 
molecular weight a white precipitate (due to salting out and increased excluded volume 
effects) was observed.
3.3.3.5. The optimal secondary ADTPSfor release of HA from influenza virus.
Aqueous-detergent two-phase systems (ADTPSs) comprising PEG 300 (S39 and S40) 
were the most useful systems for recovering HA antigen in the top phase (as discussed in 
Section 3.3.3.2). System S40 was preferred because of its lower TLL (and lower 
tendency to precipitate the detergent as proposed in Section 3.3.2). Synperonic NP9 was 
marginally better than Triton XI00 at releasing antigen to the top phase because it is 
more hydrophobic and can interact better with the lipid bilayer to release HA antigen. 
This is offset in ADTPSs of higher PEG molecular weights as preferential hydration of 
PEG leads to precipitation of Synperonic NP9 and poor recovery of antigen. However, 
Triton XI00 was preferred because it is easier to remove further downstream (in
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ultrafiltration or dialysis for example) because of its higher CMC (Furth et al, 1984). If 
further processing (including detergent removal) were to be carried out using 
ultracentrifugation (as in the Medeva Process), then either detergent would suffice. In 
addition, detergent at a final concentration of 1 % w/w was used since it released more 
HA antigen to the top phase (compare Figure 3.19 with Figure 3.20 and also Figure 3.21 
with Figure 3.22). The increased viscosity of high molecular weight PEG ADTPSs 
(adding to the technical difficulty of harvesting the interphase) provided another reason 
for not using such systems.
3.3.3.6. Comparison of ADTPSs in the absence of detergent.
In light of data presented in Sections 3.3.31 to 3.3.3.3 inclusive, it was important to 
establish that the HA antigen recovered in the second extraction top phase was a true 
effect due to solubilisation. Figure 3.24 compares the partitioning of IBF material in a 
system that contains detergent (at a final concentration of 1 % w/w) with a system that 
does not. The ADTPS S40 (see Table 3.4) was used because it recovered more HA 
antigen in the top phase (refer to the previous section).
Figure 3.24 indicates that there was little difference between the amounts of HA 
antigen recovered in the top phase of the second extraction in the presence and absence 
of detergent. This could support the arguments discussed in Section 3.3.3.1. 
Approximately 60 to 70 % of the response was located in the interphase/bottom phase in 
the presence of detergent) for reasons previously discussed in Section 3.3.3.3. Other 
possibilities for the lack of difference in top phase recoveries could be that the detergent 
contact time had not been optimised, the detergent action was insufficient in solubilising
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FIGURE 3.24. Recovery of HA antigen from IBF partitioned in ADTPS S40 in the 
absence and presence ofl % w/w Triton X100 and I % w/w Synperonic NP9.
This Figure depicts the amount of HA antigen (determined by ELISA, see Section 3.2.5.1) 
in each phase of the two-stage extraction (illustrated in Figure 3.5). Comparison of the 
recovered amounts of HA antigen in the second extraction top phase (2nd Top phase) 
reveals that there was no difference (in recovery) in the presence or absence of detergent. 
ADTPS S40 comprises PEG 300 13.9% w/w/phosphate 24.3 % w/w, see Table 3.4.
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HA antigen or that solubilised antigen fragments had been produced and were 
aggregating at the interphase. The data in Figure 3.24 include significantly lower values 
for HA than data presented in Figures (3.19 to 3.22 inclusive). These systems had been 
constructed with IBF material that had previously been stored at -20 °C then thawed out 
and stored at 4 °C for a few days before use.
3.3.4. The effect of Triton XI00 contact time upon solubilisation of HA antigen from 
influenza virus.
To evaluate the effect of detergent contact time upon solubilisation of HA antigen 
from influenza virus particles contained within IBF material, a series of ADTPSs S40 
(refer to Table 3.4) were constructed. The IBF material was partitioned in the presence of 
1 % w/w Triton X100 (see Section 3.2.1) for a period of time ranging from 0 to 24 hours. 
The top and bottom phases were analysed using the HA antigen ELISA. The total HA 
antigen recovery profile was biphasic suggesting that two species of molecules 
(containing HA antigen) were recognised by the anti-HA antibody and that detection of 
these species depended upon the length of time that the virus had been in contact with 
the detergent. A plot of total HA antigen versus detergent incubation time (Figure 3.25) 
demonstrated that there was a sustained response between 3 to 12 hours in the presence 
of Triton XI00. This response peaked after an incubation period of three to four hours. 
The second peak response occurred at around 12 to 18 hours in the presence of Triton 
XI00. The first peak was attributed to stabilisation of antibody binding sites in the 
presence of PEG leading to an increase in antibody binding (refer to Section 3.3.3.3). 
The fact that there was a concurrent increase in HA antigen to the top phase (in the 
second extraction suggests that there was HA antigen being released (see Figure 3.26).
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FIGURE 3.25. Impact of Triton X100 incubation time upon recovery of total HA 
antigen from IBFpartitioned in ADTPS S40.
This profile of IBF material partitioned in ADTPS S40 (PEG 300 13.9 % w/w/ 
phosphate 24.3 % w/w, pH 7.5) incubated with Triton XI00 (1 % w/w), illustrates the 
diphasic nature of the response (total recovery is defined as the sum of the amounts oj 
HA antigen in the first extraction top phase, second extraction top phase second 
extraction and interphase/bottom phase).
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FIGURE 3.26. Impact of Triton XI00 incubation time upon recovery of total HA antigen 
from each phase.
These profiles indicating IBF material partitioned in ADTPS S40 (PEG 300 13.9 % w/w/ 
phosphate 24.3 % w/w, pH 7.5) in the presence of Triton (1 % w/w), illustrate the HA 
antigen recovery in each phase (first extraction top phase, second extraction top phase and 
second extraction interphase/bottom phase). The sum of these profiles gives the total 
recovery in the system (refer to Figure 3.25). The response in the second extraction top 
phase was thought to be due to solubilised HAi antigen.
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Gel analysis supports this. Lane 1 (Figure 3.27) demonstrated that there was a band at 55 
kDa in the top phase (thought to be haemagglutinin subunit 1, HAi antigen). There was a 
similar band in the corresponding interphase/bottom phase sample (Lane 3) thought to be 
due to HAi and nucleoprotein (NP) because nucleic acid partition preferentially to the 
bottom phase in PEG-salt ATPSs (Cole, 1991). Bands at approximately 25 and 27 kDa 
representing the matrix (M) protein and haemagglutinin subunit 2 (HA2) proteins 
respectively) were also observed. This suggested that there was a proportion of mostly 
HAi, low concentrations of HA2 and even M protein (since the latter were not detected 
clearly on a Coomassie-stained gel) being released in this first peak. As the sites became 
saturated with antibody, the binding decreased (hence a decreased ELISA response). The 
second peak could be due to the uncovering and stabilising of antigenic sites within the 
HA2 domain since there was a band at 25 to 27 kDa also present in the interphase/bottom 
phase sample (Figure 3.27 Lane 3). The overall recovery of HA antigen appeared to be 
governed by recovery in the interphase/bottom phase since both HA antigen-detergent 
incubation time profiles were identical (compare Figures 3.25 and the interphase/bottom 
phase profile presented in Figure 3.26). Recovery in the top phase of the second 
extraction was approximately four times that of the top phase first extraction (Figure 
3.26). The maximum recovery in the top and interphase/bottom phase of the second 
extraction was approximately two-fold higher than the corresponding phases of the 
systems containing no detergent. This suggests that a maximum action upon the virus 
had been reached under the conditions (of detergent concentration and ADTPS) used. 
Thus in conclusion an incubation time of four hours was selected as optimal and used in 
subsequent experimentation.
144
Chapter Three
HA2/M 
HAi/NP/NA \ Ovalbumin
Apovitellinins III-V
55kDa
25kDa
FIGURE 3.27. Silver stain gel depicting IBF material fractionated in 
PEG/phosphate ADTPs consisting of PEG 300 and 8000 respectively.
Lanes I and 2: Second extraction top phase ADTPS (S40).
Lanes 3 and 4: Second extraction interphase/bottom phase ADTPS (S40).
Lane 5: Second extraction top phase ADTPS (S43).
Lanes 6 and 7: Second extraction interphase/bottom phase ADTPS (S43).
Lane 8: Low molecular weight marker (overloaded).
Fifteen microlitres was of sample was loaded in each lane. Samples were
prepared as described in Section 3.2.4. The differences in staining in Lanes
Sand 4 are as a result differences in the amount of protein precipitated.
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3.3.5. Proposed strategy to evaluate HA antigen solubilisation.
In the previous section, it was assumed that HA antigen detected in the top phase was 
as a result of selectively solubilised antigen. This assumption needed to be confirmed 
since it was possible that the response could have been due to disrupted viral fragments. 
A possible method to clarify this was to load the top phase material from an optimised 
ADTPS S40 onto a sucrose density gradient and centrifuge it (Section 3.2.2). If the 
solubilised antigen had partitioned to the top phase, one would expect to locate it in low- 
density sucrose. This would be repeated with the interphase/bottom phase material from 
the same ADTPS. If core material or intact virus were present, one would expect to 
locate it in the high-density sucrose. The harvested fractions were dialysed overnight (as 
described in Section 3.2.3) and analysed using the HA antigen ELISA, SDS PAGE and 
the BCA total protein assay. A control system was constructed (omitting the detergent) 
and treated in the same manner.
3.3.5.1. Evaluation of HA antigen solubilisation in second extraction top phase samples 
in the absence of detergent.
A sample from the second extraction top phase (refer to Figure 3.1) from partition of 
IBF material in ATPS S40 (see Table 3.4) without detergent was subjected to sucrose 
density ultracentrifugation (as described in Section 3.2.2.1). In the absence of detergent 
there is protein located in Fractions 1 to 7 inclusive (Figure 3.28 a). The SDS PAGE gel 
presented in Figure 3.28 (b), which indicates that the protein consisted of mainly 
ovalbumin and apovitellenins III to V as well as a low concentration of HA] antigen, 
(refer to Figure 2.14 and Table 2.4), supports this. The HA ELISA also confirms the 
presence of antigen in Fraction 15 (and the observations documented in Section 3.3.3.1).
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FIGURE 3.28 (a). Profiles illustrating distribution of HA antigen and total protein (as 
detected by ELISA and BCA assay respectively) from second extraction top phase 
fractions harvested from a sucrose density gradient in the absence of detergent.
A 5ml sample from the second extraction top phase of IBF material partitioned (without 
detergent) in ATPS S40 was layered onto a sucrose density gradient (see Section 3.2.2) 
and processed as described in Sections 3.2.3 and 3.2.4. SDS PAGE gels corresponding to 
these fractions are presented in Figures 3.28 (b) and 3.28 (c) respectively.
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1 2 567 8 9 10
Apovitellenins 
III-V
HAi 
Ovalbumin
55.0 kDa 
43.0 kDa
30.0 kDa
FIGURE 3.28 (b). Silver stain gel showing top phase Fractions I to 8 (in the 
absence of detergent) from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction 
top phase (without detergent) analysed by SDS PAGE and silver stain. The 
corresponding protein and HA antigen concentration profiles are presented in 
Figure 3.28 (a).
Lane 1: Pre dialysis second extraction top phase sample. Lanes 2 to 9: Dialysed 
Fractions 1 to 8 inclusive. Lane 10: PZC. Fifteen microlitres of sample was 
loaded into each lane.
HAi/NP
/NA
HA2/M
FIGURE 3.28 (c). Silver stain gel showing interphase/bottom phase Fractions 
9 to 15 (in the absence of detergent) from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction 
top phase (without detergent) analysed by SDS PAGE and silver stain. The 
corresponding protein and HA antigen concentration profiles are presented in 
Figure 3.28 (a).
Lane 1: PZC. Lanes 2 to 7: Dialysed Fractions 9 to 14 inclusive. Lane 8: 
Unused. Lane 9: Fraction 15. Fifteen microlitres of sample was loaded into 
each lane. 148
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The location of the antigen in the sucrose gradient suggests that the HA antigen derived 
from intact virus.
3.3.5.2. Evaluation of HA antigen solubilisation in second extraction interphase/bottom 
phase samples in the absence of detergent.
A sample from the second extraction interphase/bottom phase (refer to Figure 3.1) 
from partition of DBF material in ATPS S40 (see Table 3.4) without detergent was 
subjected to sucrose density ultracentrifugation (as described in Section 3.2.2.1). In the 
absence of detergent Figure 3.29 (a) depicted profiles (of protein and HA antigen 
concentration), which could be superimposed. Fractions 1 to 3 inclusive indicated large 
total protein and HA antigen responses, backed up by the corresponding silver stained 
gel, Figure 3.29 (b), confirming that virtually all of the total protein detected was due to 
the HA antigen. A comparison of profiles (Figures 3.28 a and 3.29 a) demonstrates that 
the interphase contains approximately 8 times more HA antigen compared to the 
corresponding top phase. The low protein concentration and silver staining appeared 
sensitive enough to resolve the two bands at approximately 25 to 27 kDa (due to matrix 
and HA2 proteins respectively). The lack of protein in Fractions 4 to 15 (refer to Figures 
3.29 a to 3.29 c) was mirrored by the absence of HA antigen in these Fractions (Fig 3.29 
a). Thus in the absence of detergent, contaminant proteins (ovalbumin, apovitellenins III- 
V and phosvitin EI) partitioned to the top phase in ATPS S40, whilst the viral proteins 
predominantly partitioned to the interphase/bottom phase in this same ATPS. The 
location of the interphase/bottom phase material (refer to Figures 3.29 a and 3.29 b) in 
the lower concentration sucrose (0 to 20 % w/v) was somewhat surprising and could be
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FIGURE 3.29 (a). Profiles illustrating distribution of HA antigen and total protein (as 
detected by ELISA and BCA assay respectively) from second extraction 
interphase/bottom phase fractions harvested from a sucrose density gradient in the 
absence of detergent.
A 3 ml sample from the second extraction interphase/bottom phase of IBF material 
partitioned (without detergent) in ATPS S40 was layered onto a sucrose density gradient 
(see Section 3.2.2) and processed as described in Sections 3.2.3 and 3.2.4. SDS PAGE 
gels corresponding to these fractions are presented in Figures 3.29 (b) and 3.29 (c) 
respectively. The HA antigen concentration can be compared with the corresponding top 
phase sample presented in Figure 3.28 (a).
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FIGURE 3.29 (b). Silver stain gel showing interphase/bottom phase Fractions 1 
to 8 (in the absence of detergent) from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction 
interphase/bottom phase (without detergent) analysed by SDS PAGE and silver 
stain. The corresponding protein and HA antigen concentration profiles are 
presented in Figure 3.29 (a).
Lane 1: PZC. Lanes 2 to 9: Dialysed Fractions 1 to 8 inclusive. Lane 10: Low 
molecular weight marker. Fifteen microlitres of sample was loaded into each lane.
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FIGURE 3.29 (c). Silver stain gel showing interphase/bottom phase Fractions 9 
to 15 (in the absence of detergent) from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction 
interphase/bottom phase (without detergent) analysed by SDS PAGE and silver 
stain. The corresponding protein and HA antigen concentration profiles are 
presented in Figure 3.29 (a).
Lane 1: Low molecular weight marker. Lane 2: PZC. 
Lanes 3 to 9: Dialysed Fractions 9 to 15 inclusive. Lane 10: Unused.
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attributed to traces of phosphate remaining post-dialysis, promoting aggregation of 
particles, which formed a (visible) carpet-like layer of lower density.
3.3.5.3. Evaluation of HA antigen solubilisation in second extraction top phase samples 
in the presence of detergent.
After a four-hour incubation period (refer to Section 3.3.4) with 1 % w/w Triton 
XI00 and sample processing, the top phase total protein and HA antigen concentration 
profiles were depicted in Figure 3.30 (a). The profile presented in Figure 3.30 (a) 
indicated that protein and HA antigen were present in Fractions 1 to 4 inclusive, 
(corresponding to a sucrose concentration of approximately 0 to 20 % w/v). Another 
peak of protein and HA antigen was located at Fractions 9 and 10, (corresponding to a 
sucrose concentration of approximately 30 to 38 % w/v). These findings were confirmed 
with SDS PAGE/silver stain analysis (Figure 3.30 b and 3.30 c). The SDS PAGE gel 
presented in Figure 3.30 (b) demonstrated an increase in HA] antigen partitioning to the 
top phase in the presence of Triton X100 (as compared to Figure 3.28 b, no detergent). A 
species of HA antigen-containing fragments was also present in Fraction 9 and 10 
(Figure 3.30 c). The location of this species in the gradient suggested that it was 
associated with denser material such as NP protein (although this was not confirmed by 
the gel). A two-fold increase in protein partition (and HA antigen) to the top phase was 
also detected (compare Figures 3.28 a and 3.30 a). This demonstrates that the increase in 
HA antigen release from the virus particles was due to the action of Triton XI00 at 1 % 
w/w.
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FIGURE 3.30 (a). Profiles illustrating distribution of HA antigen and total protein (as 
detected by ELISA and BCA assay respectively) from second extraction top phase 
fractions harvested from a sucrose density gradient in the presence of Triton XI00.
A 5 ml sample from the second extraction top phase oflBF material partitioned (with I % 
w/w Triton XI00) in ATPS S40 was layered onto a sucrose density gradient (see Section 
3.2.2) and processed as described in Sections 3.2.3 and 3.2.4. SDS PAGE gels 
corresponding to these fractions are presented in Figures 3.30 (b) and 3.30 (c) 
respectively. The HA antigen concentration can be compared with the corresponding top 
phase sample without Triton XI00 presented in Figure 3.28 (a).
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FIGURE 3.30 (b). Silver stain gel showing top phase Fractions 1 to 8 (in the 
presence of Triton X100) from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction 
top phase (in the presence of 1 % w/w Triton XI00) analysed by SDS PAGE and 
silver stain. The corresponding protein and HA antigen concentration profiles 
are presented in Figure 3.30 (a).
Lane 1: Pre dialysis second extraction top phase sample. Lanes 2 to 9: Dialysed 
Fractions 1 to 8 inclusive. Lane 10: PZC. Fifteen microlitres of sample was 
loaded into each lane.
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FIGURE 3.30 (c). Silver stain gel showing top phase Fractions 9 to 15 (in the 
presence of Triton XI00) from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction top 
phase (in the presence of I % w/w Triton XI00) analysed by SDS PAGE and silver 
stain. The corresponding protein and HA antigen concentration profiles are 
presented in Figure 3.30 (a).
Lane 1: Low molecular weight marker. Lane 2: PZC. 
Lanes 3 to 9: Dialysed Fractions 9 to 15 inclusive. Lane 10: Unused.
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3.3.5.4. Evaluation of HA antigen solubilisation in second extraction interphase/bottom 
phase samples in the presence of detergent.
The interphase/bottom phase was removed for analysis (see Section 3.3.4) after IBF 
material was partitioned in ADTPS S40 in the presence of 1 % w/w Triton XI00 for a 
period of fours hours. Total protein and HA antigen concentration profiles were depicted 
in Figures 3.31 (a). The profile presented in Figure 3.31 (a) indicated the presence of 
protein and relative absence of HA antigen in Fractions 1 to 4 inclusive. The protein 
concentration in Fractions 5 to 15 inclusive was relatively low. The HA antigen 
concentration profile generally mimics this (except for the peaks at Fractions 7 and 15. 
The former was thought to be an artifact and the latter, intact viral particles). The 
corresponding SDS PAGE gels of this profile (Figures 3.31 b and 3.31 c), back up the 
total protein profile in Figure 3.31 (a) except at Fraction 15 which suggests that it 
contains a low concentration of intact virus particles. The HA antigen data indicates that 
there is a low concentration of HA antigen in Fractions 1 to 14. The gels (Figures 3.31 b 
and 3.31 c) show protein bands at 55 and 30 kDa (corresponding to sucrose 
concentrations of approximately 0 to 30 % w/v). This means that the virus particles were 
disrupted to different extents and that the bands are predominantly due to NP and M 
respectively (because the ELISA detects HA antigen and more specifically, HAi antigen, 
see Figure 2.1). To summarise, most of the protein (including viral proteins) partitions to 
the top phase upon incubation with Triton XI00. This suggests that the exaggerated HA 
ELISA responses observed with the interphase/bottom samples are due to the detergent 
and mask the fact that solubilisation has occurred. In order to confirm this, transmission 
electron microscopy (TEM) and negative staining was used to visualise the virus 
particles.
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FIGURE 3.31 (a). Profiles illustrating distribution of HA antigen and total protein (as 
detected by ELISA and BCA assay respectively) from second extraction 
interphase/bottom phase fractions harvested from a sucrose density gradient in the 
presence of Triton XI00.
A 5 ml sample from the second extraction top phase oflBF material partitioned (with I % 
w/w Triton XI00) in ATPS S40 was layered onto a sucrose density gradient (see Section 
3.2.2) and processed as described in Sections 3.2.3 and 3.2.4. SDS PAGE gels 
corresponding to these fractions are presented in Figures 3.31 (b) and 3.31 (c) 
respectively. The HA antigen concentration can be compared with the corresponding top 
phase sample without Triton XI00presented in Figure 3.29 (a).
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FIGURE 3.31 (b). Silver stain gel showing interphase/bottom phase Fractions 
I to 8 (in the presence of Triton X100)from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction 
interphase/bottom phase (in the presence of 1 % w/w Triton XI00) analysed by 
SDS PAGE and silver stain. The corresponding protein and HA antigen 
concentration profiles are presented in Figure 3.31 (a).
Lane 1: Pre dialysis interphase/bottom phase sample. Lanes 2 to 9: Dialysed 
Fractions 1 to 8 inclusive. Lane 10: Low molecular weight marker. Fifteen 
microlitres of sample was loaded into each lane.
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FIGURE 3.31 (c). Silver stain gel showing interphase/bottom phase Fractions 9 
to 15 (in the presence of Triton XI00) from Solubilisation Assessment Study.
The gel presented in this figure shows the fractions from the second extraction top 
phase (in the presence of I % w/w Triton XI00) analysed by SDS PAGE and silver 
stain. The corresponding protein and HA antigen concentration profiles are 
presented in Figure 3.31 (a).
Lane 1: Low molecular weight marker. Lane 2: PZC. 
Lanes 3 to 9: Dialysed Fractions 9 to 15 inclusive. Lane 10: Unused. 
Fifteen microlitres of sample was loaded into each lane.
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3.3.6. Analysis of second extraction top and interphase/bottom phases using 
transmission electron microscopy.
Samples described in the previous Section 3.3.5. were sent to Medeva Pharma and 
analysed by B. Getty. Negative staining and transmission electron microscopy (TEM) 
using 2 % w/v phosphotungstic acid (PTA), pH 6.8 and a Phillips TEM 300 were used at 
a magnification of 150,000 times. Despite dialysing the samples prior to analysis, it was 
only possible to capture images of the virus in the absence of detergent. Thus it was not 
possible to confirm the presence of different disrupted species (as presented in Figures 
3.31 b and 3.31 c) and discussed in the previous section. Low concentrations of partially 
stripped virions were present in second extraction top phase pooled Fractions 1 to 4 (see 
profile in Figure 3.28 a), in the absence of detergent (Figures 3.32 a). This confirmed 
previous observations regarding antigen release in the absence of detergent (see Section 
3.3.3.1). Pooled second extraction top phase Fractions 14 and 15 pooled (see profile in 
Figure 3.28 a), in the absence of detergent, also produced the same result Figure 3.33. 
This suggests that there were two species present in the top phase with different densities 
possibly due to more HA antigen being released in the former species compared to the 
latter. Second extraction interphase/bottom pooled Fractions 1 and 2 pooled in the 
absence of detergent, showed a fairly high concentration of essentially whole virus as 
shown in Figure 3.34 a. hi addition, some of the virions were stripped and there was a 
high concentration of membranous debris present (Figure 3.34 b). Pooled Fractions 3 and 
4 from this phase showed a low concentration of partially stripped virions amongst 
debris (electron micrograph not shown) This confirms the data presented in the profile 
shown in Figure 3.29 (a). Methods to improve the detection of components in the 
presence of detergent would be to submit the sample to ultracentrifugation (300,000 xg)
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FIGURE 3.32. Electron micrograph showing a typical influenza 
A/Panama virion from pooled top phase. Fractions 1 to 4 in the absence 
of detergent.
The sample was negatively stained with 2 % w/v PTA pH 6.8 and 
deposited on a carbon coated copper grid. The electron micrograph 
taken at a magnification of 150,000. (Refer to also Figure 3.28 a).
FIGURE 3.33. Electron micrograph showing a typical influenza 
A/Panama virion from pooled top phase. Fractions 14 to 15 in the 
absence of detergent.
The sample was negatively stained with 2 % w/v PTA pH 6.8 and 
deposited on a carbon coated copper grid. The electron micrograph was 
taken at a magnification of 150,000. (Refer to also Figure 3.28 a).
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FIGURE 3.33 (a) Electron micrograph showing a typical influenza 
A/Panama virion from interphase/bottom phase Fractions 1 and 2 in the 
absence of detergent.
The sample was negatively stained with 2 % w/v PTA pH 6.8 and deposited 
on a carbon coated copper grid. The electron micrograph was taken at a 
magnification of 150,000. (Refer to also Figure 3.29 a).
Virus particle
Membraneous 
debris
FIGURE 3.33 (b) Electron micrograph showing a typical influenza 
A/Panama virion from interphase/bottom phase Fractions 1 and 2 in the 
absence of detergent.
The sample was negatively stained with 2 % w/v PTA pH 6.8 and 
deposited on a carbon coated copper grid. The electron micrograph was 
taken at a magnification of 150,000. (Refer to also Figure 3.29 a).
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and then resuspend the pellet in water. This would effectively remove salt, PEG and 
concentrate the sample. Also the ADTPS could be scaled up to create more particles for 
analysis.
5.3.7. Tangential flow ultrafiltration (TF UF).
The solubilised HA antigen recovered in the second extraction top phase of ADTPS 
S40 required further processing. Tangential flow ultrafiltration (TF UF) using a 100 kDa 
polyethersulfone membrane was employed to remove detergent in order to promote 
aggregation of solubilised antigen leading to the formation of aggregates approximately 
300 kDa in size (Brady, PhD Thesis, 1974). These aggregates could then be separated 
from contaminants proteins (refer to Table 2.4). The removal of Triton XI00 was to be 
facilitated by diluting below its critical micellar concentration (CMC) of 0.24 mM (or 
0.02 %, see Table 3.1), so that monomers predominated in solution, which can easily 
pass through the membrane pores. The scheme outlined in Figure 3.35 illustrates the 
protein recoveries in an experiment designed to isolate solubilised HA antigen from 
other impurities. With regards to this study, the post UF (ultrafiltration) retentate 
material would be the end product of the purification scheme using ATPS. This would 
permit a comparison with end stage material generated by the Medeva Fluvirin™ 
Process (refer to Figure 3.1). Almost all the protein was recovered post first and second 
extraction stages. Although the recovery of protein could be accounted for post UF, 90 % 
of the protein was recovered in the permeate (see Figure 3.35). This suggests that the 
detergent had not been removed and that formation of the 300 kDa aggregates did not 
occur. Thus the HA antigens remained as (80 kDa) monomers which passed through the 
pores along with the apovitellenins and ovalbumin.
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Primary ATPS: PEG 300 22.2 % w/w 
/phosphate 17.9 %w/w, pH 7.5, (S25)
IBF concentration: 1.5 mg ml" 1 
Phase volume: 100 ml 
Total protein: ISO.Omg
Intermediate blank ATPS: PEG 300 
/phosphate 10.0% w/wphosphate
/25.0%w/w(S35).
First extraction top phase
Total protein concentration: 
360ug ml" 1
Phase volume: 262 ml 
Total protein: 94.0 mg
First extraction interphase/Bottom 
phase
Total protein concentration: 
270ug ml" 1
Phase volume: 222 ml 
Total protein: 60.0mg
Top I/Bott.
Second extraction top phase
Total protein concentration:
335ugmi"'
Phase volume: 80.0 ml
Total protein: 26.8 mg
Secondary ATPS:
1% (w/w) Triton 
XI00, Mix 4 hours.
Second extraction interphase/bottom 
phase
Total protein concentration:
T
Retentate: End Product.
Total protein concentration: 
50ug ml" 1
Phase volume: 50.0 nil 
Total protein: 2.5 mg
Phase volume: 205 ml 
Total protein: 30.8mg
TFUF
lOOkDaMWCO 
polyethersulfone membrane
Permeate.
Total protein concentration: 50ugml" 1
Phase volume: 9 x 50.0 ml
Total protein: 24.8 mg
FIGURE 3.35. Scheme showing process stages using ATPS and TF 
UF along with recoveries of total protein. Quantities were estimated 
using SDS PAGE and densitometry.
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The presence of detergent micelles is likely because the sample was not sufficiently. In 
the proposed scheme (Figure 3.35), assuming that all the detergent was available for 
solubilisation, the sample would need to be diluted at least fifty times (to disperse the 
micelles into monomers) giving a protein concentration of 0.007 g ml- 1 and negligible 
HA antigen content. This unit operation can be improved by further elimination of 
impurities and a means of removing detergent, which does not require such dilution.
3.3.8. Comparison of ATPSperformance against ultracentrifugation in the processing of 
IBFfrom the Medeva Fluvirin™Process.
Aqueous two-phase systems (ATPS) capable of partitioning whole virus contained 
within inactivated bulk fluid (IBF) to fractionate influenza virus particles from process- 
related contaminants were initially investigated in Chapter Two and further studied in 
this chapter. The stages in the Medeva Fluvirin™ manufacturing process (outlined in 
Chapter Two and re-displayed in Figure 3.36), utilises sucrose density gradient 
ultracentrifugation. The initial ultracentrifugation procedure (Stage 5, Figures 3.36 and 
3.37) eliminates debris and contaminant proteins, producing a whole virus- purified 
zonal concentrate (PZC). Addition of detergent, (Stage 6, Figures 3.36 and Figure 3.37) 
promotes the selective release of surface antigens, (haemagglutinin, HA and 
neuraminidase, NA) from the viral lipid envelope. The solubilised antigens and core 
material are then separated on the basis of size and density differences. Added detergent 
is removed by salting out (achieved by the inclusion of 2M phosphate) and finally, low 
molecular weight contaminants including the added salt are removed by diafiltration. 
This section compares the performance of ATPS with that of sucrose density gradient 
ultracentri fugation.
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1. Virus-infected allantoic fluid (2000 litres).
2. Clarification. 
Using low speed Westfalia centrifugation. Concentration.
3. Ultrafiltration. Inactivated Bulk Fluid.
4. Inactivation with /3-Propiolactone (360 litres).
5. Zonal centrifugation (40 litres).
6. Selective release of HA antigen.
7. Ultrafiltration (40 litres).
8. Pooling ofmonovalent antigen.
Sucrose density 
ultracentrifugation
(produces Purified Zonal 
Concentrate).
Sucrose density 
ultracentrifugation.
Addition of detergent 
(releases HA antigen 
leaving intact viral 
cores).
Diafiltration (polishing).
9. Formulation.
FIGURE 3.36. An outline of the downstream processing stages in the 
current Medeva Fluvirin ™Process.
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Process Stage and brief description of
process material.
Stage 4:
Inactivated Bulk
Fluid (IBF).
Whole virus and
contaminating
proteins in allantoic
fluid.
Stage 5: Purified 
zonal concentrate
(PZC).
Purified whole virus
(very little
contaminating
protein-
apovitellenins III- VI
in PBS.
Post stage 7, pre
stage 8:
Mono-blend pool
(MBP).
Purified surface
antigen (no core
material).
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Process Stage and brief description of
process material.
First Key Stage:
Inactivated bulk
fluid (IBF).
Whole virus and
contaminating
proteins in allantoic
fluid.
Second Key Stage: 
Interphase/bottom
phaselst
extraction.
Debris, semi-
purified, mainly
whole virus; some
stripped virions,
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FIGURE 3.37. Brief description of process feedstock and comparison of 
material at key stages of each purification strategy: ultracentrifugation (the 
Medeva Fluvirin™ process) and ADTPS/ATPS (the candidate process).
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3.3.8.1. Using ATPS as a comparative technique.
As discussed previously, certain bottlenecks exist in the current process, which 
severely impact upon the volumetric throughput, the time to batch completion and 
ultimately, the process costs. These "process-limits" exist primarily at Stages 5 and 6 
(Figure 3.36). The aim of this investigation was to use ATPS technology as a potential 
direct replacement for such process stages (refer to the schematic presented in Figure 
3.38). Since the ultracentrifugation process could not be directly mimicked in this study 
(due to non-availability of the rotors used in the Medeva Fluvirin™ procedure), it was 
decided to use end-process material (post-Stage 7, pre-Stage 8, Figure 3.36), the mono- 
blend pool (MBP) to compare the material generated at the end of partition in the 
aqueous-detergent two-phase systems (ADTPS). The ATPS process performance was 
evaluated as follows: (i) a comparison of the material generated by ATPS with the MBP 
(from Medeva Fluvirin™ process) with respect to purity and yield (as deduced by SDS 
PAGE, a method recommended in the European Pharmacoepia) and (ii) the time taken to 
produce a batch from EBF to MBP (or its equivalent as generated by ATPS). It was 
expected that the ATPS process would yield a different profile of contaminants to that 
produced by the Medeva Fluvirin™ Process (refer to Figure 3.37). This was because the 
contaminants were removed sequentially, in the latter (contaminating proteins, core 
material and finally detergent). In contrast, material generated by partition in an ADTPS 
would still possess varying concentrations of these contaminants.
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Sucrose density ultracentrifugation 
(Medeva Fluvirin™ process)
ATPS/ADTPS
(Candidate process)
Stage 4. 
IBF:6.1gHAAg.
First Key Stage. 
IBF:6.1gHAAg. 
ATPS (S25).
Centrifuge: 90,000 
xgl 18 hours.
Mix Ihour. 
Centrifuge: 2000 xg 710
mns.
Stage 5. 
PZC: 6.6g HA Ag.
Centrifuge: 90,000 
xgl 6 hours
REPLACE ?
Stage 6.
Selective antigen release 
using Triton N101.
Stage 7.
Removal of (approx. 1 litre) 
core material and TFF to 
remove phosphate/residual 
detergent and sucrose.
24 hours
End Product: 
MBP: 4.8g HA Ag.
Recycle?
Second Key Stage.
Fresh Top phase 
composition: 26.6 % 
(w/w) PEG/ phosphate 
11.1 %(w/w).
Second Key Stage contd. 
4.4g HA Ag.
+ 1 % w/w Triton XI00 
ixed 4 hours.
Top I/Bott.
I
Discard.
TFUF
Third Key Stage.
End Product: Retentate.
0.9g HA Ag.
FIGURE 3.38. Purification of haemagglutinin (HA) antigen from influenza virus 
particles contained within IBF material. Comparison of down-stream purification steps 
used to (Medeva prepare a 90 litre batch of purified HA antigen using sucrose density 
ultracentrifugation Fluvirin™ process) and ATPS (proposed process).
The bold arrows indicate process stages that could be potentially replaced by ATPS. The 
ATPS process has been scaled up for direct comparison with the Medeva Fluvirin'™ 
process. In the up-scaled process, the use of an intermediate blank ATPS was replaced 
with phase-forming chemicals of identical composition to the intermediate ATPSs' top 
phase.
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3.3.8.2. Characterisation of material from the Medeva Fluvirin™ Process.
Purity as defined by the Food and Drug administration (PDA) is the relative freedom 
of a product from extraneous matter including pyrogens. Since the bulk of impurities 
were protein in nature, the process was monitored for purity using SDS PAGE reduced 
gels. Purity with respect to mycoplasmas and potential adventitious viruses was not 
assessed here. The IBF and PZC from ultracentrifugation sourced from the Medeva 
Fluvirin™ process were representative of materials from the key process Stages 4 and 5 
respectively (Figures 3.36 and 3.37). The IBF, (Lane 1, Figure 3.39) the starting material 
for this study, consists of many proteins (as described in Section 2.3.2.1) the major 
contaminants being the apovitellenins III-VI, ovalbumin and phosvitins. The viral 
proteins: HA (haemagglutinin), M (matrix protein), NA (neuraminidase) and NP 
(nucleoprotein) are also shown on the gel. The PZC (Lane 2, Figure 3.39) represents 
material from the next key process stage (Stage 5, Figures 3.36 and 3.37). Three bands 
are shown, from top to bottom, at approximately 80 kDa, 55 kDa and 25 kDa. The 80 
kDa band represented residual apovitellenins III to VI. The 55 kDa band corresponded to 
HAi/NP/NA and the 25 kDa band, was due to HA2/M. There was a significant reduction 
in protein contaminants, notably ovalbumin, the phosvitins and the apovitellenins III to 
VI. The MBP material (Lane 9, Figure 3.39) is representative of material from the final 
process stage (with respect to this study), post-Stage 7, pre-Stage 8, Figures 3.36 and 
3.37. This material showed three bands with identical molecular weights to those seen in 
PZC (Lane 2, Figure 3.39). From top to bottom, Lane 9, Figure 3.39, the first band (at 
approximately 80 kDa) represented residual apovitellenins III to VI. Since the core 
material had been removed by ultracentrifugation, the second band (at approximately 55
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Apovitellenins III- VI
Retentate:
Apovitellenins III-VI 
HA, and HA2
HA,/NP/NA: 
(Viral proteins)
Ovalbumin
HA2/M: 
(Viral proteins)
25kDa
Phosvitins
FIGURE 3.39. The purification of IBF purified using sucrose density gradient 
ultracentrifugation (Medeva Fluvirin™ process) was compared with 
purification of IBF using ATPS/ADTPS (candidate process) and monitored 
using SDS PAGE and one-dimensional densitometry.
Samples from key stages of both purification processes (Figure 3.37) were run 
on a 12 % homogeneous gel under reducing conditions. The IBF and PZC (Lanes 
1 and 2) originated from Stages 4 and 5 of the Medeva Fluvirin™ process 
respectively (Figures 3.36 and 3.37). The mono-blend pool (MBP) material 
(Lane 9) represented post Stage 7, pre Stage 8 material from this process 
(Figures 3.36 and 3.37).
For comparison, the IBF and the interphase/bottom phase from the first 
extraction samples (Lanes I and 6 respectively) represented the first and second 
key stages of the ATPS process (Figure 3.37). The sample in Lane 6 formed the 
basis of the ADTPS (Figure 3.38). Lanes 4 and 8 represent purification of semi- 
purified IBF in the ADTPS. The top phase second extraction sample (Lane 4) 
was subjected to TFF. The retentate sample is shown in Lane 7. Thus the final 
stage comparison should be between the MBP (Lane 9) from the Medeva 
Fluvirin'™ process and the retentate (Lane 7) from the ATPS/ADTPS process.
Lane 1: IBF 14.1 ug protein. Lane 2: PZC 4.2 ug protein.
Lane 3: Top phase, first extraction (pre UF) 9.6 ug protein.
Lane 4: Top phase, second extraction (pre UF)<1 ug protein.
Lane 5: Unused. Lane 6: Interphase/bottom phase, first extraction (pre UF) 2.0
ug protein. Lane 7: Post UF Retentate 1.0 ug protein Lane 8: Interphase/bottom
phase, second extraction (pre UF) ug protein. Lane 9: MSP 1.7 ug protein.
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kDa) corresponded to HAi/NA and the third band (at approximately 25 kDa) was due to 
HA2 .
3.3.8.3. Characterisation ofmaterial generated by partitioning IBF in an ATPS.
The optimal primary ATPS for processing IBF material (as deduced in Chapter 
Three) was system S25, PEG 300, 22.2 % w/w/ phosphate 17.9 % w/w, pH 7.5, TLL 
43.3 % w/w. The secondary ADTPS (including Triton X100) was system S40 
corresponding to a blank ATPS of PEG 300 13.0 % w/w/ phosphate 24.3 % w/w. The 
composition of the top phase from ATPS S40 was PEG 300 26.6 % w/w/ phosphate 11.1 
% w/w (refer to Figure 3.38). Fractions from the partition were electrophoresed (as 
described in Section 3.2.5). In addition to displaying material generated from the 
Medeva Fluvirin™ process, Figure 3.39, Lanes 3 to 8 (except Lane 5 which was unused) 
showed material from the ATP-partitioned fractions for comparison. The first extraction, 
top phase sample (from the primary ATPS) clearly shows that approximately 60 % of 
total proteins (including ovalbumin and the apovitellenins) have been eliminated (Figure 
3.39, Lane 3). The resulting interphase/bottom phase of the first extraction, representing 
the start of the Second Key Process Stage (Figure 3.37), was similar to Stage 5 in the 
Medeva Fluvirin™ process, inasmuch as it contained a preparation of intact virus 
particles. (Lane 6, Figure 3.39) shows bands of residual apovitellenins III-VI (at 
approximately 80 kDa) and ovalbumin (at 43 kDa) as well as HAi/NP/NA at 
approximately 55 kDa. The staining of the bands was poor and there was evidence of 
lane spreading. This was due to the high salt content remaining despite TCA 
precipitation. Samples from partition in the secondary ADTPS (including Triton XI00) 
are shown in lanes 4 and 8 (the top phase and interphase/bottom phase respectively). The
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presence of high concentrations of detergent in the top phase samples and high salt 
concentration in the interphase/bottom sample interfered with the TCA precipitation of 
protein leading to poor visualisation of the bands in these lanes. The retentate sample 
(Lane 7, Figure 3.39) shows three faint bands corresponding to residual apovitellenins III 
to VI (approximately 80 kDa) and HAi (approximately 55 kDa) and HA2 (approximately 
25 kDa). The recovery of this fraction was poor due to non-optimisation of the 
diafiltration step in which the presence of detergent and lack of HA antigen aggregation, 
meant that the technique could not separate the HA from the other proteins thus they 
passed through into the permeate (Section 3.3.7).
3.3.8.4. Assessing the performance purification processes using SDS PAGE and 
densitometry.
The behaviour of major proteins at all stages of both processes (Medeva Fluvirin™ 
and ATPS) has already been described (Sections 3.8.2 and 3.8.3). The key protein 
contaminants at similar key stages in both processes are illustrated in Figure 3.37. The 
data in Table 3.5 compares the yield and purity of material produced at each Key Stage 
in each process as well as overall. The end product from the Medeva Fluvirin™ Process 
is MBP, which consists essentially of HA surface antigen devoid of viral core material. 
Thus for calculation of yield and purity (and process comparison), the amount of surface 
antigen in the DBF and PZC materials was estimated from the total viral proteins on the 
gel and the proportion of surface antigen that the viral proteins represented (30 %) see 
Section 3.2.4.2. The estimation could only be applied for intact viral particles. It was 
assumed that the HA antigen in the retentate was due only to solubilised HA antigen.
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The quantitative recovery of surface antigen between Stages 4 and 5 of the Medeva 
Fluvirin™ Process
SUCROSE DENSITY GRADIENT 
ULTRACENTRIFUGATION
Process 
stage
IBF (Stage 
4)
PZC (Stage 
5)
MBP (pre- 
Stage 7, post 
Stage 8)
OVERALL 
PROCESS
Yield (%)
N/A
109.0
73.0
80.0
Purification 
Factor
N/A
4.0
1.8
7.3
AQUEOUS TWO-PHASE PARTITION
Process 
stage
IBF (1 st Key 
Stage)
1 st 
extraction 
Ib (2nd Key 
Stage)
Retentate 
(3rd Key 
Stage)
OVERALL 
PROCESS
Yield (%)
N/A
72.1
35.7
14.7
Purification 
factor
N/A
4.2
3.3
8.9
TABLE 3.5. Comparison of purity obtained at each key process stage (Table 4.1), from 
sucrose density ultracentrifugation and ATPS as determined by SDS PAGE and one- 
dimensional densitometry.
The total amount of protein was estimated by one-dimensional densitometry (Section 
2.2.6). By subtracting the amount of contaminating protein from this, the amount of viral 
proteins were deduced. It was estimated that the surface antigens (HA and NA) 
comprised 30 % of the viral protein. Thus the amount of these antigens could be 
estimated in all the samples (except the MBP).
indicates how effective the ultracentrifugation step is since the intact viral particles are 
both purified and concentrated in the sucrose gradient, hi comparison, the recovery of 
surface antigen between the First and Second Key Process Stages, (IBF to 
interphase/bottom phase, 1 st extraction) using ATPS was 72.1 %. An uneven distribution 
of virus resulted when IBF was partitioned in ATPS S25 with most of the intact viral 
particles located in the interphase/bottom phase. Transmission electron microscopy 
(TEM) analysis (Section 3.3.6) confirmed this, hi addition this technique showed that, a 
proportion of surface antigen partitioned to the top phase of this ATPS. This accounts for
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the lower recovery of surface antigen obtained in the interphase/bottom phase. The 
purification factors obtained between Stages 4 and 5 of the Medeva Fluvirin™ Process 
(ffiF to PZC) and between the First and Second Key Stages of the ATPS process (E3F to 
interphase/bottom phase, 1 st extraction) were similar, (indicating that there was a similar 
degree of efficiency in the removal of bulk protein contaminants ovalbumin and 
apovitellenins). Between Stage 5 and post Stage 7 of the Medeva Fluvirin™ Process, 
(PZC to MBP), 73 % of the surface antigen was recovered. The losses were possibly due 
to non-solubilised surface antigen remaining attached to the core material (and thus 
banding out in higher density sucrose). The yield at the equivalent stage (between the 
Second and Third Key Process Stages, 1 st extraction, interphase/bottom phase to 
retentate) using ATPS was substantially lower (35.7 %). This was due to non- 
optimisation of the ultrafiltration step (discussed in Section 3.3.7). The purification 
factor of the PZC to MBP stage (for the Medeva Fluvirin™ Process) was lower, 
indicating that a greater proportion of protein was surface antigen. The purification 
factor of the equivalent stage of the ATPS process (Third Key Process Stage) was 3.3. 
This showed that further removal of contaminating proteins was still occurring at this 
stage. The data demonstrated that the overall protein purity was marginally better using 
ATPS (overall purification factor of 8.9) but the overall yield was reduced, thus the 
Medeva Fluvirin™ process produced end material that was of similar purity to the ATPS 
material but is produced in much higher yield (80 %). This study demonstrated that 
material containing semi-purified intact virus particles (1 st Key Process Stage) could be 
produced in one hour (combined with a lower energy input). The time to produce the 
equivalent Stage 5 material (from the Medeva Fluvirin™ Process) was 18 hours (using 
energy-intensive ultracentrifugation). Thus a scaled-up process could be beneficial
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(particularly if centrifugal separators were used to decrease the time to equilibrium). In 
the light of the data obtained, the procedure proposed (in Figure 3.38) appears to be too 
ambitious in attempting to remove all the contaminants at once rather than sequentially. 
Thus ATPS has demonstrated advantages in the primary processing of viral particles in 
IBF, but further work is required to in order to fully realise these benefits. The scheme 
outlined in Figure 3.38 compares the process stages followed using sucrose density 
ultracentrifugation (as Medeva) and ATPS. Implementation of ATPS to replace Stage 5 
(and eventually Stage 6) may be advantageous. The advantages would be realised 
primarily through the high volumetric throughput of material and the significant decrease 
in time required to obtain this material, thereby significantly minimising the process 
bottlenecks described at the outset of this work.
3.3.9 CONCLUDING DISCUSSIONS.
The aim of this study was to further the investigations undertaken in Chapter Two, 
using the primary ATPS S25 (PEG 300 22.2 % w/w/ phosphate 17.9 % w/w, pH 7.5) as 
a starting point to propose a purification scheme that yielded an end product similar to 
that obtained in the Medeva Fluvirin™ Process. A simple two-stage extraction process 
was undertaken to achieve selective release of HA antigen from intact virus and removal 
of impurities (see Figure 3.38). Nonionic detergents were evaluated to assess their ability 
to mimic selective release of surface antigens (which occurs in the Medeva Fluvirin™ 
Process). The effect of PEG chain length (molecular weight) was also assessed in the 
ATPSs used. The detergent examined were sodium deoyxhcholate, Triton XI00 and 
Synperonic NP9. The former detergent was discounted from further use because of it 
interfered significantly in SDS PAGE gel analysis. Triton XI00 and Synperonic NP9
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partitioned preferentially to the top phase in the PEG-salt ATPSs due to these detergents 
sharing structural commonalities with PEG (see Figure 3.3). The amount of available 
detergent was affected by the molecular weight of PEG in the system. In general, the 
higher the PEG molecular weight, the poorer recovery of detergent. This was explained 
by preferential hydration of PEG leading to dehydration of the detergent head groups and 
aggregation. Excluded volume and salting out effects also contribute to aggregation 
(hence an ADTPS of shorter TLL would be better for use). A detergent concentration of 
1 % w/w was determined to be optimal for recovery of solubilised HA antigen and 
Triton XI00 was preferred to Synperonic NP9 for use in the ATPS. Recovery of EBF 
material in the ADTPSs was greatest in PEG 300-based systems. In addition a greater 
proportion of HA antigen was detected in the second extraction top phase samples as 
compared to secondary systems comprising other PEG molecular weights (see Section 
3.3.3.2). This was explained in terms of protein and detergent partitioning to the same 
phase, less detergent dehydration in the presence of short chain PEG 300 and less 
excluded volume effects (therefore greater availability of detergent for solubilisation 
purposes). The HA recovery was over-estimated in the presence of PEG 300. It is 
thought that PEG 300 (by virtue of its small size) stabilises the antibody binding domains 
leading to an increase in binding. The presence of detergent probably potentiated this 
effect. This over-estimation was not observed with the other PEG molecular weights 
employed in the presence of detergent. The optimal ADTPS for solubilsation was S40 
(PEG 300 13.9% w/w/ phosphate 24.3 % w/w, containing 1 % w/w Triton X100). The 
Solubilisation Assessment Study (Section 3.3.5) confirmed that HA antigen was released 
to the top phase in the presence of 1 % w/w Triton X100 (refer to Figure 3.30 a). It was 
proposed that solubilisation was non-selective leading to the release of different species
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of HA antigen-containing fragment (refer to profile in Figure 3.30 a). This could be 
confirmed by TEM with samples prepared as discussed in Section 3.3.6. It is also 
necessary to confirm the identity of the high-density species (Fraction 15 in Figure 3.31 
c), since a significant response was generated in the HA ELISA (refer to corresponding 
profile, Figure 3.31 a). This could be a species of core particles with some HA still 
attached which is responsible for the over-exaggerated response in the interphase/bottom 
phase. A more hazardous method for detecting solubilsed antigen (as distinct from core 
material) could involve radiolabelling the viral core and membrane with 32P (Bachmayer, 
1975).
3.9.1. Analytical methodology.
A number of analytical challenges had to be surmounted in this study. The method 
of sample preparation using TCA precipitation for SDS PAGE analysis was at times 
problematic giving non-quantitative recovery. Other methods had been tried previously, 
(Wessel and Flugge, 1984 and Sauve et al, 1995) with varying degrees of success. An 
attempt to back up data presented in the Solubilisation Study (Section 3.3.1) which 
exploited TCA precipitation followed by monitoring absorbance at A28o did not work 
well because (despite repeated washing of the precipitate), the detergent could not be 
sufficiently removed to obtain reproducible results. Thus it was concluded that under the 
circumstances, the best method had been used. In the presence of PEG 300, the HA 
antigen ELISA gave exaggerated responses in the interphase/bottom phase (attributed to 
stabilisation by PEG and an increase in antibody binding in the ELISA). The samples 
from which the data in Figure 3.28 to 3.30 is presented have been dialysed thus the 
interference from PEG and detergent was removed. The fact that the magnitude of the
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responses varied due to the instability of IBF upon storage raised concerns about the 
nature of the biomass loaded into the systems.
3.9.2. Effect of storage temperature upon IBF material.
It was possible that the components in the -70 °C batch differed slightly from those in 
the -20 °C batch (there may be more proteases and degradation products which could 
subtly affect the partition characteristics). Under such circumstances it would not be 
pertinent to compare data generated from these batches. The instability problem was not 
encountered at Medeva Pharma because the material is processed immediately onto the 
next stage (the production of the more stable PZC).
3.9.3. Partition and removal of other components in IBF material.
The main focus of this chapter was to address elimination during virus protein 
purification since they were by far the major source of contamination. However it was 
also recognised that a successful purification strategy should involve the removal of 
other contaminants such as lipids, carbohydrates, nucleic acids and metabolic by­ 
products such as uric acid. Although this aspect was not studied in detail (with the 
exception of uric acid), some inferences can be made on the basis of observation, 
knowledge regarding the composition of the starting material and the handling process 
used. In the ideal situation (that is selective solubilisation of surface antigens), viral 
lipids and nucleic acid (RNA) should not increase the complexity of the purification 
problem. This is because the virus particle should remain intact. It is known that nucleic 
acids prefer to partition to the bottom phase in PEG-salt ATPs (Hustedt et al, 1985; 
Albertsson, 1986). A possible method to detect the RNA could involve developing the
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SDS PAGE/densitometry method used in this study, but using agarose gel 
electrophoresis and RNA standards. It was thought that lipids (mainly in the form of 
low-density lipoproteins) partition to the uppermost phase in a four-phase system (as 
discussed in Section 3.3.3.4). Thus removal of this yellow coloured phase could facilitate 
lipid removal. Carbohydrates should not pose a problem since they are associated with 
the viral protein. Uric acid, an excretory product has a purine-based structure. The levels 
of this metabolite in IBF were estimated to be 0.1 % (by monitoring the absorbance at 
293 nm, Wharton and Wharton, 1960). This would be diluted ten-fold in the ATPS that 
would be negligible. Further analyses indicated a bottom phase preference for this 
product (like nucleic acids).
3.9.4. The effectiveness ofultracentrifugation in selective release of HA antigen.
It was possible that during the mixing of the particulate suspension with solid phase 
forming chemicals and detergent, the particles encountered a wide range of dynamic 
changes in PEG and phosphate concentration (described by Walker, PhD Thesis, 1998). 
This proposal has been lent some credence in that researchers have reported differences 
in partition characteristics depending on whether wet or dry phase formants are used. 
This is attributed to the locally high PEG concentration (Hammar et al, 1989b). The 
particles cross the interface (so-called "trans-interfacial transport"), which could have 
imposed stresses on the particles leading to disruption of virus and generation of HA 
antigen-containing fragments (because even PEG on its own had some ability to remove 
antigen even before detergent addition). In the ultracentrifugation method, the virus 
passes downward through a stabilised localised band of detergent at approximately 30 % 
w/v sucrose (personal communication, P. Sinclair, 2000), with a high concentration of
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micelles per square area gives a higher opportunity to strip more antigen creating a 
releasing antigens to the less dense sucrose and core material travels onwards towards 
denser sucrose concentration. Thus the antigen release is more consistent. If this was 
true, then the method used to select the detergent conditions (using purified whole virus 
and sucrose density ultracentrifugation) could not be satisfactorily applied to selecting 
the optimal detergent conditions in an ADTPS. If time had permitted, the pure intact 
virus (PZC) would have been partitioned in hybrid ADTPS containing different 
concentrations (or more importantly, different detergent: protein ratios).
3.9.4.1. Methods to improve A IPS.
Strategies require developing which permit more solubilised antigen to be recovered 
in the top phase. For example, the volume ratio could be varied (to determine the 
optimum top phase volume for antigen recovery). In this study, a small top phase volume 
was selected in order to concentrate antigen in the top phase and additionally to facilitate 
the ease of handling. This however could have placed restraints upon the recovery of 
antigen in the top phase since other proteins and detergent (so-called competing 
contaminants) also had a preference for the top phase. Indirectly manipulating the 
volume ratio could aid re-partition of the interphase.
3.9.5. Characterisation of loaded ADTPSs.
The naming of secondary hybrid systems ADTPSs was undertaken by using the phase 
composition of the corresponding blank hybrid. This is not strictly correct because by the 
time the IBF and detergent had been added, the system would have changed (refer to
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Section 3.17.1). Characterisation could be performed by observing the distribution of 
radiolabelled amino acids, (Lebreton, PhD Thesis, 1998) in the ADTPs.
3.9.6. The potential of ATPS as a fractionation technique for processing of 
nanoparticles.
Aqueous two-phase partition (ATPS) as a commercially viable purification technique 
is pretty much in its infancy in the UK. Although the data showed that overall, the 
current process (using sucrose density ultracentrifugation) performed better than ATPS 
(for reasons already discussed), this candidate technology displays much potential. It 
demonstrated its worth as a purification technique: by rational selection of appropriate 
systems, bulk protein contaminants were significantly removed from the viral particles. 
Aqueous two-phase partition established its potential not only as a protein purification 
tool, but also as a nanoparticulate purification method (affirming the work of other 
researchers: Braas, 2000; Walker and Lyddiatt, 1999). This technique illustrated that it 
has a major role to play in the purification of commercialised therapeutic products with 
respect to processing large volumes of medium, in the fastest time possible, as 
economically as possible.
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CHAPTER FOUR. 
4. FINAL CONCLUSIONS AND FUTURE WORK.
4.1 Restatement of objectives.
In order to conclude whether the objectives of the study were met, it is necessary and 
helpful to remind one what these aims are. The main aim was to investigate the potential 
of a liquid-liquid fractionation technique, utilising aqueous two-phase systems (ATPS) 
towards the primary purification and recovery of inactivated influenza virus particles 
sourced from allantoic fluid within fertile hens' embryos. These nanoparticles were 
destined to formulate a commercial subunit vaccine, Fluvirin™ (produced by Medeva 
Pharma, Liverpool, UK). The requirement for such a study was highlighted by various 
limitations identified in the current process. Performance of this novel fractionation 
technique was then compared to the current method of manufacture, sucrose density 
ultracentrifugation. The final ultracentrifugation stage utilised Triton N101 in the 
gradient to solubilise the immunoprotective surface antigens haemagglutinin (HA) and 
neuraminidase (NA). Separation was brought about by buoyant density differences 
between the detergent micelles, surface antigens and the intact core material. These 
antigens were further purified and formulated into Fluvirin™ subunit vaccine. 
Comparison between ATPS and ultracentrifugation was undertaken with respect to 
purity, yield and time taken to produce a batch. The possibility of integrating ATPS in 
the established purification and recovery protocol was also investigated leading to the 
proposal of where in the current process ATPS could be used for maximal effect. 
Demonstration of the utility of ATPS in the successful handling of influenza virus
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particles could provide further grounds for embracing it as a serious purification 
technique for handling nanoparticles.
4.2. Investigations undertaken.
Investigations were initially undertaken using purified, intact virus particles (as 
supplied by Medeva Pharma). One of the major influences upon partition in ATPS is the 
molecular weight of PEG employed (as previously discussed). Thus the effect of PEG (in 
the average molecular weight range 300 to 8000 kDa) upon partition was evaluated. The 
analytical procedures developed were SDS PAGE and quantitative one-dimensional 
densitometry to determine fractional mass ratios (FMRs) to monitor partition of 
contaminating proteins and viral proteins and a HA ELISA (originating from Medeva 
Pharma) in order to monitor partition of HA from the virus. Thus it was possible to 
assess the impact of the PEG molecular weight, TLL (with volume ratio being fixed at 
unity). The viral particles partitioned to the interphase in all systems used. Although it 
would have been simpler (from the viewpoint of FMR determination) to ignore this 
phase (on the basis of the small volume occupied), the majority of the virus (>80 % of 
the antibody signal as judged by HA ELISA) was located in this phase. An ATPS 
comprising PEG 300 (S2, refer to Appendix n) was useful at directing major 
contaminating proteins (namely apovitellinins HI-VI and ovalbumin) away from the 
virus at the interphase. In addition, manipulation of volume ratio to concentrate the virus 
into a smaller volume was also undertaken providing the candidate ATPS S25 (refer to 
Appendix II). This system demonstrated the value of ATPS for the primary purification
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of influenza viral particles. The next stage was to attempt to design a strategy whereby 
final stage material (monoblend pool, MBP) equivalent to that produced by the Medeva 
Fluvirin™ Process (using sucrose density ultracentrifugation) could be produced using 
ATPS. Equivalence in this context entailed a comparison using SDS PAGE of the 
proteins present. The process design incorporated addition of a fresh top phase (to 
replace the original one now contaminated with undesirable proteins) and addition of 1 
% w/w Triton XI00 (to solubilise the surface antigens) generating an aqueous detergent 
two-phase system (ADTPS), system- S40 (see Appendix II). A comparison of processes 
was undertaken and discussed with ultracentrifugation designated as the benchmark 
process.
4.3 Main conclusions.
The results demonstrated that in the PEG-phosphate ATPS examined, pH 7.5 (with 
varying PEG molecular weight and TLL with volume ratio of unity), the virus 
preferentially partitioned to the interface. This finding was not unexpected since it is well 
known that particles prefer partition to the interface since this lowers the free energy of 
the system (Albertsson, 1986). As the polymer concentration increases (with increased 
TLL and interfacial tension), the number of particles partitioning to the interface 
increases. Particles with diameters in excess of 10 nm adsorb non-specifically (regardless 
of their surface properties) to the interface leading to partition between this phase and a 
bulk phase (Bamberger, et al, 1985). According to Walter et al, (1991), partition is 
dominated by surface properties per unit area in larger particles (with surface areas in 
excess of 0.2 um2). In the case of particles smaller than this, partition is governed by size
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(surface area). Assuming that the influenza particles are spheres with a radius of 0.05 um 
and using the equation: surface area = 4nr2 , then the calculated surface area is 0.03 um2, 
which suggests that it is the size that governs partition of these particles. However, the 
surface area is much greater than that calculated for a sphere because influenza possesses 
surface HA and NA projections. Therefore one concludes that surface properties 
dominate partition (similar to a-glucosidase inclusion bodies used by Walker, PhD 
Thesis, 1998). In the case of influenza the surface properties must be extremely large to 
elicit almost total adsorption of virus to the interface (as judged by HA antigen ELISA) 
because this occurred in systems of low TLL (for example S9, TLL, 8.3 % w/w). Debris 
also partitions to this phase suggesting that it is of similar density, particle size with 
similar surface properties.
Comparison of process performance between ATPS and sucrose density 
ultracentrifugation was undertaken using SDS PAGE and densitometry to monitor purity 
and to quantitate the recovery. The purification was divided into equivalent stages (refer 
to Table 3.5): DBF to PZC- Stages 4 to 5 (corresponding to the First to Second Key 
extraction stages using ATPS); and PZC to monoblend pool (MBP)- Stages 5 to Post 
Stage 7 corresponding to the Second to Third Key Stages using ATPS. The results 
demonstrated that the first purification stage produced a higher quantitative recovery 
when using ultracentrifugation (109 %) as compared with 72 % using ATPS. 
However product purity at this first stage using either process was similar (purification 
factor 4.0, ultracentrifugation, purification factor 4.2, ATPS). The lower recovery using 
ATPS was attributed to a small proportion of solubilised HA antigen partitioning to the 
top phase. The time to produce this material using ATPS was significantly lower (1
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hour) compared to the time taken to produce equivalent material using 
ultracentrifugation (18 hours). ATPS did not perform well in the second stage of 
purification with respect to quantitative recovery of the HA antigen. This was due to the 
attempts at trying to remove remaining impurities simultaneously rather than 
sequentially and by non-optimisation of the ultrafiltration step. Thus it was proposed that 
ATPS could find a use in the early stage of the purification process. It was not confirmed 
in this study whether the particles remained intact during the first purification stage 
although evidence from TEM analysis (Section 3.3.6) suggested this to be the case. Data 
(not presented) showed that HA and NA in PZC partitioned to the same phase, which 
suggests that the particles did remain intact. This study also emphasised the importance 
of having sensitive, specific assays to allow characterisation of the feedstock 
components. Thus the use and potential of ATPS for selectively fractionating influenza 
virus was demonstrated.
4.4. Future work to improve existing process using ATPS to fractionate allantoic fluid 
containing influenza particles.
The processing of influenza virus particles using ATPS (as documented in Chapters 
Two and Three) demonstrated great potential. However, in order to implement such a 
technique for commercial use a number of investigations need to be undertaken. The first 
stage of the purification proved relatively successful (as discussed in Section 4.3), but 
the second stage was subject to various problems. Due to time constraints, these 
problems were unable to be adequately addressed, thus it was decided to integrate the 
current ATPS process into downstream stages of the Medeva Fluvirin™ Process. The
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fullest benefits of ATPS could be realised if ultracentrifugation was not used at all. 
Walker, (1998) demonstrated that repartitioning of the interphase into an identical ATPS 
lead to further removal of impurities as this gave the interphase components another 
opportunity to release contaminating proteins. Such an occurrence would have been 
beneficial for the purification scheme using influenza. Two strategies could be employed 
to process further the particles at the interphase. The first strategy involves direct 
harvesting of the interphase and incubating it directly with detergent (to enhance to the 
solubilising step) followed by re-partition into an ATPS. Thus the antigens could be 
solubilised and partition into a bulk phase whilst the core material and debris remained at 
the interphase. Confirmation of solubilisation could be performed by TEM. The reasons 
this had not been previously confirmed, pointed to the preparation of samples for 
analysis (see Section 3.3.6). If solubilsation did not occur, then the detergent and 
detergent conditions would require re-evaluation. Instead of using ultracentrifugation to 
assess the potential of a detergent (as described in Section 3.2.2), ATPS would be used. 
The second strategy would involve increasing the loading and (perhaps) manipulation of 
system pH to obtain a sediment, thus mimicking the inclusion body partition experiments 
undertaken by (Walker and Lyddiatt, 1998). The former strategy would probably be the 
most useful since the surface antigens could be isolated and it is these components that 
are ultimately required. The latter strategy may be useful for maximising the number of 
intact particles in the system (that is utilising the full capability of the system capacity). 
However, the type of manipulations involved such as changing the pH would affect the 
conformation of the surface antigens or aggregation properties (Henderson et al, 1973)
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and hence the immunoprotective antibodies generated from any potential vaccine formed 
thereof.
Other important investigations include assessing the impact of allantoic fluid 
(contains uric acid) and P-propiolactone upon the binodal curve. The latter hydrolyses 
(into hydracrylic acid) and it would be useful to know if these affect partition of the 
feedstock. This could be done by determining the phase diagram in the presence and 
absence of (0.05 % v/v) P-propiolactone and then to determine the phase diagram at 
different time points P-propiolactone addition. Superimposition of the phase diagrams 
would indicate P-propiolactone has no effect upon the phase diagram. If ATPS was to be 
employed routinely for handling influenza virus, a generic purification strategy must be 
demonstrated for different strains (for example A/Beijng and B/Panama). In addition, it 
is important to characterise the ATPSs used. This could be done using distribution of 
radiolabelled amino acids, a method used to deduce TLL in loaded ATPSs and hence 
redefine co-ordinates on the binodal curve (Lebreton, PhD Thesis, 1998).
It was believed that the influenza virus partitioning (at the biomass load used) was 
directed by its surface properties and independent to that of the proteins. Partitioning of 
the virus alone would confirm this (at the time of undertaking experiments with pure 
virus, the interpretation of the interphase belonging to a bulk phase was used, therefore it 
was not treated as a discrete phase). The proteins may have exerted some influence on 
each other. Partitioning blank bulk fluid (without influenza virus) and using the SDS 
PAGE/quantitative one-dimensional densitometry to ascertain the fractional mass ratios 
(FMRs) of the main proteins could verify this. Studies on the impact of load are required 
because this would impact on partition of the proteins, manifesting in increased salting
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out effects and the prevention of protein access due to the interphase acting as a physical 
barrier.
A means of estimating the total number of particles and the ability to monitor their 
distribution in an ATPS is required. This would assist in comparison of partition 
behaviour with different feedstock in different ATPSs. However it would be insufficient 
to comment solely on the number of particles, a better correlation involves the number of 
particles per unit area to facilitate comparisions with other particulate feedstocks.
4.5. How ATPS could impact further upstream in the processing ofFluvirin™.
Further upstream of the process described in this study, the influenza particle- 
containing allantoic fluid is harvested from the eggs. It is during this stage that 
presumably the impurities (from fragments of cell membrane and within the allantois) 
and protein contaminants (from the yolk and albumin sacs, Figure 2.2) are introduced. A 
gross clarification step using a continuous flow Westfalia centrifuge (and if necessary, 
microfiltration) is used to separate solids (debris from the embryo) from the soluble 
proteins. It is not envisaged that ATPS could be useful at very early stages due to the 
high solids content produced. However prior to inactivation the bulk fluid is dilute and is 
normally ultrafiltrered (using a Pellicon™ ultrafiltration system and 8.0 jim filter) to 
reduce processing volumes. A possible extension of ATPS is identified to replace this 
ultrafiltration step and provide the initial concentration of the feedstock as well as 
fractionation of the proteins. However the analytical problems associated with the pre- 
concentrated feedstock are likely to be exacerbated in the presence of a more dilute 
feedstock (see Section 2.3.2).
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4.6 The potential ofATPS in processing other nanoparticles.
Advances in the field of genomics and recombinant DNA technology have impacted 
upon the field of biochemical engineering (Shanks and Stephanopoulos, 2000) to provide 
molecular therapies that can treat or prevent acquired and inherited diseases (Alton, 
1995; Cooper, 1996). The portfolio of molecules, which in this context have a particle 
diameter of 2.0 x 10 1 to 2.0 x 102 nm are referred to as nanoparticles (as stated in Section 
1.3.1.3) and include gene therapy vectors (viral and non viral) viruses, plasmid DNA, 
virus-like particles and protein aggregates: small inclusion bodies and prion proteins. 
Meeting the demand for the production of these particles is a tough challenge for the 
bioprocess engineer but one that has to be surmounted if they are to be produced at the 
required levels. In a situation analogous that is to that of influenza virus processing, 
ATPS may be the bioseparation technique to handle this diverse class of particles. The 
following discussion introduces these nanoparticles and proposes how ATPS could be 
used to circumvent limitations of the conventional techniques that are currently 
employed.
4.6.1. A brief description of other nanoparticles with potential use as therapeutics.
Viral gene therapy vectors are replication-deficient viruses containing relevant gene(s) 
(coding for defective or missing proteins) that infect target cells and deliver the gene(s) 
to the nucleus. Their description and application are reviewed (see Bonnet et al, 2000; 
Mountain, 2000; Romano et al, 2000 and Wu and Ataai, 2000 for a discussion of the 
advantages and disadvantages). Non-viral gene vectors include plasmid DNA and virus- 
like particles. Plasmids can be used as delivery vehicles (delivering relevant genetic
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information to the nucleus leading to the generation immunoprotective proteins) or as 
"third generation" vaccines which themselves act as the immunostimulant, stimulating 
both humoral and cellular arms of the immune response (see Section 1.2). This 
discussion refers to small plasmids (containing 5-10 kb genetic information, with particle 
diameters of approximately 1.5 x 102 to 2.5 x 102 nm in their extended form). Virus-like 
particles (vlp's) are artificial structures constructed with the subunit(s)- 
immunoprotective protein(s) of the infectious organism, which can be used as vaccines 
or as delivery vehicles (DaSilva et al, 1999; Neumann et al, 2000). Genes encoding the 
subunit(s) and structural components capable of particle formation are spliced together 
and expressed under strongly inducing conditions to form particles (Andrews et al, 
1995). These particles of diameter of 3.0 x 10 1 to 8.0 x 10 1 nm, have some advantages 
over viral vaccines because a range of immunoprotective proteins identified from various 
diseases can be expressed and the genes encoding these proteins can be selected to 
circumvent problems of infectivity or inappropriate immune reactions (Netter et al, 
2001); Protein aggregates include inclusion bodies and prion proteins, hi some cases 
over-expression of recombinant proteins may lead to the production of inclusion bodies 
(Misawa and Kumagai, 1999), which can be solubilised and correctly refolded to give 
active high value therapeutic proteins including antibody fragments (Tomlinson and 
Holliger, 2000). Most of the inclusion bodies formed are too large to be considered as 
nanoparticles 150 to 300 nm, (Walker, PhD Thesis, 1998), however one example of a 
small inclusion body, a-glucosidase (approximately 150 nm) has been used.
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4.6.2. Prerequisites for the production ofnanoparticulates to be used as therapeutics.
The viral vectors and plasmid DNA described in the previous section have been 
produced for Phase II or Phase III clinical trials (whereas the other nanoparticles are still 
undergoing laboratory investigations). Thus there are a number of requirements that must 
be met if the particle is to succeed in these stages as well as for intended commercial 
production. The foremost requirement is that the particles should be safe to use. Unlike 
traditional vaccine manufacture (from organisms such as influenza viruses), there is no 
safety precedent, thus the regulatory requirements are very strict (Braas et al, 1996). A 
high level of purity is desired to minimise potential toxicity, immunogenicity or in the 
case of gene therapy vectors, inappropriate activation/deactivation of regulatory genes 
(Wu and Ataai, 2000). In addition, the safety of the viral vectors has been thrown under 
the spotlight with the recent fatality in an adenovirus trial due to a strong host immune 
response (Stephenson, 2001). Other important issues regarding nanoparticles production 
is the specificity of the targeting mechanisms employed. This is one of the factors that 
currently make plasmid delivery disappointing (Ferreira et al, 2000). Once the delivery 
of genetic material has taken place, expression must occur at therapeutic levels (Romano 
et al, 2000). Thus to achieve these objectives, large quantities of these particles must be 
produced 10 12 to 1020 particles (Braas et al, 1996).
4.6.3. Current DSP of nanoparticles and application ofATPS.
The unit operation utilised in the primary purification of these nanoparticles are much 
the same as those used in the manufacture of traditional viral vaccines and include 
filtration, centrifugation and adsorption chromatography (see Section 1.3.1.2). These unit
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operations can work well but often have some limitation when applied on large scale 
(refer to Table 4.1 and Section 1.3.1.3).
It is proposed that ATPS when used as primary purification technique could 
circumvent many of the problems encountered. To start with, ATPS is mild (thus it 
should not impair the infectivity of viruses or harm shear sensitive molecules such as 
plasmid DNA); it can be highly selective (and could be used in discriminating between 
the different types of plasmid DNA, currently being looked at in Biochemical Recovery 
Group at the University of Birmingham, UK); the volumetric capacity is high (inclusion 
body work demonstrated a potential capacity of 109 to 10 12 pfu ml" 1 , Walker and 
Lyddiatt, 1999) and scale-up is relatively simple; this method is capable of processing 
large volumes in a relatively short time (as demonstrated in this study and thereby 
eliminating the limitations suffered by ultracentrifugation); each conventional unit 
operation has disadvantages when used to process a specific nanoparticle. ATPS can 
overcome these for a range of particles at a range of scales. This technique could prove 
invaluable if generic systems could be developed and applied and is discussed in the 
following section.
4.7. A generic mechanism for partition.
There are many inter-related factors that impact upon the partition of nanoparticles. 
The main ones are identified as: the surface properties of the nanoparticles; the biomass 
load; the presence of debris; the location of the nanoparticles; the feedstock type. 
Partitioning of a variety of nanoparticles within PEG-salt ATPSs was previously 
investigated (Braas and Lyddiatt, 2000). Analogies were drawn between adenoviruses
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and washed (small) a-glucosidase inclusion bodies (Ib's) and also non-washed oc- 
glucosidase Ib's and retro viruses, based on their surface properties and distribution in an 
ATPS. The washed Ib's presented a more hydrophilic surface, whereas the non-washed 
Ib's presented a more hydrophobic surface. On this basis one would expect the influenza 
virus particles to behave in a manner similar to the non-washed Ib's and retro viruses 
ATPS S24, PEG 8000 11.3 % w/w/ phosphate 9.2 % w/w, pH 7.5 was used to partition 
influenza virus. This was similar to the PEG 8000 10.0 % w/w/ phosphate 10.0 % w/w, 
pH 9.4 ATPS used in the studies undertaken by Braas and Lyddiatt (2000). Partition of 
the influenza virus in S24 showed that the majority of the influenza virus partitioned to 
the interface (see Figure C4). This confirmed the similarities with the non-washed 
inclusion bodies and retro virus particles (see Table 4.1). A report also suggested an 
evolutionary link between orthomxyoviruses (such as influenza) and retroviruses (Harris 
et al, 1999).
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UNIT 
OPERATION.
Particle size range 
(nm).
Nanoparticle 
description.
VGTV.
NVGTV.
AGG. 
Inclusion bodies. 
Prion protein fibrils. 
Vlp's.
Filtration.
MF: 5.0 x 102 2.0 x 
104
UF:5.0xlO°-2.0xl03
Centrifugation.
2.0xlO'-2.0xlOJ
Adsorption 
chromatography.
3.0xlO'-4.0xl02
-Scale limited. 
- Expensive.
-Large hydrodynamic 
radius blocks pores. 
Not sufficiently 
discriminating for 
different DNA's.
-CsCl gradients can 
damage enveloped 
viruses. 
- Scale limited (requires 
large number of 
particles, 10n particles 
ml" 1 per ml). 
-Time-consuming 
(could affect viral 
infectivity).
-Plasmid, shear sensitive 
(breakdown of plasmid, 
leads to worse 
purification problem). 
- Separation from other 
DNA's.
-Can get co-purification 
of contaminating 
proteins. 
-Requires long process 
times.
-Low capacity. 
-Can impair infectivity
-Low capacity. 
-Can impair infectivity. 
-Expensive 
-Rigorous sanitation.
TABLE 4.1. A comparison of the advantages and disadvantages of conventional unit 
operations when applied to the processing of nanoparticles to be used as therapeutics, 
Key: VGTV- viral gene therapy vector; NVGTV- non viral gene therapy vector; VLP- virus-like particle; 
AGG.-protein aggregate (refer to text for detailed descriptions). The ranges in brackets below the unit 
operation heading, refer to the particle diameters that the technique can handle.
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The observed differences in distribution of the nanoparticles in the ATPSs (such as the 
absence of a sediment) were accounted for by differences in biomass loading (Braas and 
Lyddiatt, 2000). The presence of biomass increases the TLL and interfacial tension. This 
in turn, increases adsorption of particles to the interphase up to a saturation limit. This 
limit would be exceeded relatively quickly in a sensitive system compared to those of a 
robust system. Increasing biomass load would increase the debris content and also affect 
the partition of the proteins and other components. The presence and quantity of debris 
and possible interactions with the nanoparticles impact upon the type of interphase 
formed (for example whether the interphase is dispersed or compact as observed in 
Chapter Three). The presence of debris is known to increase the precipitation 
concentration by decreasing the volume available to the salt phase (Zhou et al, 1998) and 
presumably the presence of particles, would by analogy, affect this also. Investigations 
are required to observe and to quantitate the impact of debris upon the binodal curve. 
The type of feedstock and the location of the nanoparticles would affect the type of 
debris produced (and hence the interphase formation, TLL, volume ratio and partition of 
components contained therein). Therefore for generic application of ATPSs for 
nanoparticles processing, methods are required to characterise the feedstocks
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4.8. Future Indications in context of regulatory climate, acceptance as technique of 
choice for nanoparticle processing.
The investigations undertaken in this thesis addressed to some extent potential 
successes and problems encountered when using ATPS to fractionate nanoparticulates as 
applied to an industrially relevant particulate model- influenza virus. Thus this thesis has 
attempted to give an insight as to how ATPS may be employed in the fractionation of 
commercially relevant therapeutic nanoparticles.
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APPENDIX I.
AI. Preliminary data regarding the partitioning and characterisation of Purified Zonal
Concentrate (PZC) in selected ATPS. This feedstock was chosen as a representative 
nanoparticulate and originates from the Medeva Fluvirin™ Process. Such a feedstock 
was used since it could provide information helpful when partitioning the crude material.
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Al. INTRODUCTION.
A. 1.1 Partition of Purified Zonal Concentrate (PZC) and selection ofATPS.
Purified Zonal Concentrate (PZC) from Stage 5 in the Medeva Fluvirin™ Process 
(see Figure 2.4) was partitioned using a range of aqueous two-phase systems (ATPS) of 
varying PEG molecular weight, ILL and volume ratio (see Appendix II). Manipulating 
PEG molecular affects the system hydrophobicity, (Huddleston and Lyddiatt, 1991c), 
high PEG molecular weight, possesses longer chains and creates a more hydrophobic 
environment. Manipulating the ILL affects the interfacial tension of the system and 
manipulating the volume ratio can affect the distribution of target molecules. The reason 
for using PZC was to establish partitioning characteristics of the virus using a simpler 
feedstock (minus contaminating proteins) and to develop analytical methodologies to 
characterise the crude feedstock, Inactivated Bulk Fluid (IBF) from Stage 3 of the 
Medeva Fluvirin™ Process (see Figure 2.4). However from the viewpoints of subsequent 
comparison studies using IBF material and a published use of some ATPS, only a 
representative selection were discussed. Ideally, an ATPS showing potential would direct 
the partition of virus to one of the bulk phases.
A2. MATERIALS AND METHODS.
A.2.1. Construction of ATPS containing PZC.
The loaded ATPSs were constructed as in Section 2.2.2 with the addition of biomass.
The biomass used included: Purified Zonal Concentrate (PZC), PZC spiked with egg 
white, egg white alone and IBF material. Medeva Pharma, Liverpool, UK, provided the 
IBF reserve material: A/Sydney batch 753134, and the PZC material: A/Beijing, batch 
679. Eggs of uncertain age were used, originating from non-fertile hens medium eggs
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(Crown Farm, Wychbold, UK, Lot: P59-4-692 best before 8/7/99). The eggs were used 
well within their best before date Separation of the egg white from the yolk was 
undertaken manually.
A.2.2. Haemagglutination Test (slight modification of WHO method, 1953).
The Haemagglutination (HA) Test was used in this study to quantify the amount of
intact influenza virus. Haemagglutinin interacts with receptors (or more specifically, 
sialic acid residues on the receptors) of erythrocytes thereby promoting 
haemagglutination. This phenomenon formed the basis of the HA test. The virus was 
serially diluted in 0.01M PBS, pH 7.4 and challenged with an equivalent volume of a 
suitably low concentration (0.5 % v/v) solution of day-old chick erythrocytes in 
Alsevers, (TCS Microbiological, UK). The presence of virus was indicated by 
haemgglutination as observed by network formation and non-precipitation. Absence of 
the virus was indicated by pellet formation (Figure Al). Samples from phases of the 
blank and loaded ATPSs were serially diluted (50 \i\ per well), in a "U" -bottomed 96- 
well microtitre plate. The virus was challenged with an equivalent volume of the 
erythrocyte suspension and after gentle tapping, to mix the contents, the plate was 
incubated at 4 °C for one hour. A visual check was made to enable the deduction of the 
titre at which 50 % of the cells were agglutinated. After subtraction of the appropriate 
blanks, the haemagglutination units per ml HAU per ml (which is the titre at which 50 % 
of the virus is agglutinated by a 1 % v/v solution of erythrocytes) could be determined, 
(Barrett and Inglis, 1985). The total HAU was calculated by multiplying the HAU per ml 
by the phase volume. There was estimated to a 50 % error in this assay.
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FIGURE AL Microtitre plate illustrating typical results obtained using the HA 
test.
A negative result is indicated by pellet formation (for example, well 6C). A 
positive result is indicated by erythrocyte network formation (for example, well 
3B). The virus was serially diluted across the plate (from I to 12) and challenged 
with a 0.5 % v/v suspension of erythrocytes.
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Appendix I
A.2.3. Neuraminidase enzyme-linked assay in microplates (NELLAM).
This assay is outlined as follows (adapted from Lambre et al, 1991). Fetuin (a natural 
substrate of neuraminidase, NA), is attacked by NA in the influenza samples exposing) 
the carbohydrates N-acetyl neuramininc acid (NANA). The peroxidase-labelled peanut 
lectin (Po-PNA) recognises and binds to the NANA. Ortho-phenylamine diamine (OPD) 
is converted by the peroxidase to form a coloured complex that can be detected at 450 
nm. The activity of NA is thus proportional to the amount of sialic acid removed, which 
is proportional to the amount of lectin bound and ultimately, to the quantified intensity of 
the coloured complex. A flat-bottomed 96-well microtitre plate was coated with fetuin 
(0.1 % w/v in 0.01M carbonate-bicarbonate buffer, pH 9.6). The plate was incubated 
overnight at 4 °C. Fetuin was removed and the binding sites were blocked with 1 % w/v 
BSA in 0.01M PBS pH 7.4 for one hour at 25 °C. The BSA blocking solution was 
removed and the PZC samples and calibration curve standards (neuraminidase Type II 
from v. cholerae) were then added to the plate. The plate was incubated for 5 hours at 37 
°C then washed twice in 0.1 % v/v Tween 207 0.01M PBS pH 7.4 and the excess fluid 
removed by thorough blotting onto tissue. Peanut lectin peroxidase-labelled conjugate 
(3.3 jag ml" 1 ) was added to each well. The plate was incubated at 37 °C for a further two 
hours. After another wash/blot step, the substrate (10 mg O-PD in 25 ml citrate- 
phosphate buffer pH 5.0, plus 25 ul 30 % v/v hydrogen peroxide) was added. Colour 
development proceeded at room temperature for 15 to 20 minutes and the plate was read 
at 450 nm. After subtraction of the appropriate blanks, the neuraminidase content (in 
Units) could be determined from the calibration curve. The contents were corrected for 
dilution and then multiplied by the phase volume to obtain the total amount of NA Units 
in each phase. The minimum detection level of this assay was 1.0 x 10" NA units. The
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definition of a Unit was as follows: 1 Unit releases 1 jimole NANA from NAN lactose 
min" 1 at pH 5.0 at 37 °C. The decision was taken to present the results in Units because 
the NELLAM as described used fetuin (claimed to be better for viral NA's, Lambre et al, 
1991) and the reaction was undertaken at 20 °C.
A.2.4. Bicinchinonic Acid (BCA) Assay.
The determination of total protein was undertaken using the Micro BCA assay kit 
(Catalogue number: 23235, Pierce, UK). This kit consisted of four reagents: MA 
(sodium carbonate, sodium bicarbonate and sodium tartrate in 0.2N sodium hydroxide), 
MB (4 % BCA in water), MC (4 % copper sulphate pentahydrate in water) and finally, 
BSA standard (2mg ml" 1 total protein in 0.9 % saline and 0.05 % sodium azide). The 
principle of this assay involves the quantitative reduction of proteins in the presence of 
alkaline copper ions (Smith et al, 1985). The resulting purple-coloured complex can be 
spectrophotometrically detected between 540 to 590 nm (with the absorbance maximum 
occurring at 562 nm). For the purpose of this study, the assays were conducted in flat- 
bottomed 96-well microtitre plates (to increase throughput). Reagents MA, MB and MC 
were mixed in the ratio 25:24:1 to form a working reagent (stable for 24 hours at room 
temperature in a closed container). Equal volumes (150 ul) of sample (or blanks) and 
working reagent were incubated for 1 hour at 60 °C (with gentle shaking) and read using 
a plate reader at 540 nm. Total protein within the samples was calculated in BSA 
equivalents after subtraction of the appropriate blanks (consisting of the corresponding 
blank ATPS). The minimum detection limit of this assay using this protocol was 1.0 ng 
ml" 1 total protein.
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A.2.5. SDS PAGE and one-dimensional densitometry.
The methods deveoped using SDS PAGE and one-diensional densitometry formed the
basis of Section 2.2.3.
A3. RESULTS AND DISCUSSIONS.
A.3.1. The effect of PEG molecular weight upon partition ofPZC in selected ATPS.
The key proteins in the PZC material were identified using reduced SDS PAGE gels 
(Figure A5). The total protein concentration was also estimated using the BCA assay 
giving a value of approximately 0.5 mg ml" 1 (Section A.2.4). It was not possible to use 
A280 measurements due to the presence of low levels (0.01 % w/v) of thiomerosal (which 
interfered with the analysis) that had been to PZC added as a preservative. The results 
recorded for the partition of purified zonal concentrate (PZC) were dependent upon both 
PEG molecular weight and tie-line length (TLL). The system comprising PEG 300 20..0 
% w/w/ phosphate 20.0 % w/w, pH 7.5 and long TLL, 43.4 % w/w, (S2) partitioned the 
virus exclusively to the interphase (as shown in Figures A2 to A4). System S9 
(comprising PEG 1000 12.0 % w/w/ phosphate 13.0 % w/w, pH 7.5, TLL, 8.3 % w/w) 
partitioned protein to all three phases, although assays detecting the viral components 
indicated that they partitioned preferentially to the bottom phase in this system (Figures 
A3 and A4). This suggested that either virus disruption had occurred (releasing other 
proteins not detected by the HA Test or neuraminidase enzyme-linked assay in 
microplates, (NELLAM) or there was an interfering agent in the top sample. This was 
also apparent in the partitioning of PZC in System S24 (PEG 8000 11.3 % w/w/ 
phosphate 9.2 % w/w, pH 7.5, TLL, 13.8 % w/w). The fact that the mass balances of 
total protein, HA and NA were variable, suggested that there was a source of
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FIGURE A2. Partition of Purified Zonal Concentrate (PZC) in selected ATPSs 
monitored by BCA assay.
Four ATPSs were used to monitor the distribution of soluble protein in PZC. These 
systems were: S2 (PEG 300 20.0 % w/w/phosphate 20.0 % w/w, pH 7.5), S9 (PEG 1000 
12.0% w/w/phosphate 13.0% w/w, pH 7.5), SIO (PEG 3350 20.0 % w/w/phosphate 
20.0 % w/w, pH 7.5) and S24 (PEG 8000 11.3% w/w/phosphate 9.2% w/w, pH 7.5), 
refer to Appendix II for details. The mass balances were defined as the amount oj 
protein in each phase divided by the load of protein to the system (585 ug in ATPSs S2, 
S9 and S24; 432 ug in ATPS SIO). The mass balances were as follows: S2: 19.0 %, S9: 
67.0%, SI0: 50.8 % and S24: 77.0%. Refer also to Figures A3 and A4. 
Key: T: Top phase; I: Interphase; B: Bottom phase.
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FIGURE A3. Partition of Purified Zonal Concentrate (PZC) in selected ATPSs 
monitored by HA Test.
Four ATPSs were used to monitor the distribution of HA antigen in PZC. These systems 
were: S2 (PEG 300 20.0 % w/w/phosphate 20.0 % w/w, pH 7.5), S9 (PEG 1000 12.0 % 
w/w/phosphate 13.0 % w/w, pH 7.5), S10 (PEG 3350 20.0 % w/w/phosphate 20.0 % 
w/w, pH 7.5) and S24 (PEG 8000 11.3 % w/w/phosphate 9.2 % w/w, pH 7.5), refer to 
Appendix II for details. The mass balances were defined as the amount of 
Haemagglutinin units (HAU) in each phase divided by the total added HAU to the 
system (5.5 xlO5 HAU). The mass balances were as follows: S2: 5.0 %, S9: 75.0 %, 
S10: 29.0 % and S24: 59.0 %. Refer also to Figures A2 and A4.
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FIGURE A4. Partition of Purified Zonal Concentrate (PZC) in selected ATPSs 
monitored by neuraminidase enzyme-linked assay in microplates (NELLAM).
Four ATPSs were used to monitor the distribution of neuraminidase in PZC. These 
systems were: S2 (PEG 300 20.0 % w/w/phosphate 20.0 % w/w, pH 7.5), S9 (PEG 1000 
12.0% w/w/phosphate 13.0% w/w, pH 7.5), SIO (PEG 3350 20.0 % w/w/phosphate 
20.0 % w/w, pH 7.5) and S24 (PEG 8000 11.3 % w/w/phosphate 9.2% w/w, pH 7.5), 
refer to Appendix II for details. The mass balances were defined as the amount of NA 
units in each phase divided by the total added NA to the system (46.3 xlO'5 Units NA). 
The mass balances were as follows: S2: 36.0 %, S9: > 100 %, SIO: Not determined 
and S24: > 100%. Refer also to Figures A2 and A4.
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interference. Thiomerosal was again suspected. This chemical is known to interfere in 
the BCA Assay (at the levels present in PZC), Pierce Technical Bulletin. Presumably 
thiomerosal partitions to the top phase producing false positives. The reason that this was 
apparently not observed in Systems S2 and S10 was because the proteins did not 
partition to the top phase in the former system and the effect of thiomerosal was included 
in the observed response in the latter system, hi addition, the non-closure of mass 
balances in the systems was also attributed to aggregation of viral material at the 
interphase and inaccessibility of reagents in reaching virus in this phase. This suggested 
that the manner of harvesting the interphase needed to be re-evaluated. The fact that NA 
was detected in the top phase of whilst no haemagglutination was detected in Systems S9 
and S24, could be explained by the difference in sensitivities of these assays (the former 
being more sensitive). System S10 (PEG 3350, 20.0 % w/w/ phosphate 20.0 % w/w, pH 
7.5, TLL, 45.8 % w/w) produced a more one-sided partition. The formation of a dense 
interphase was responsible for the poor recovery and possibly prevented the partition of 
virus to the bottom phase. The HA result agreed with the protein distribution data in this 
system. From this study it was concluded that none of the systems could be rejected at 
this stage. System S2 demonstrated exclusive partition of virus to the interphase. The 
effect of 0.01 % thiomerosal upon the assays (BCA, HA and NA) could be monitored in 
order to identify it as a source of interference. If the source(s) could be verified and 
eliminated, then ATPSs S9 and S24 could prove useful in partitioning the virus to the 
bottom phase. If the recovery performance of S10 was verified then this may also have 
potential (in directing the virus to the top phase), hi the first instance, the virus-specific 
assays demonstrated the partition preference of the virus. In addition, they provided
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evidence that the virus remained intact (or that disrupted viral components containing 
HA and NA shared the same phase preference as the intact components).
A.3.2. The effect of PEG molecular weight and TLL upon partition of egg white proteins 
in selected ATPS.
Partition of egg white proteins was investigated using the Micro BCA assay and SDS 
PAGE/ one-dimensional densitometry. This would provide information on how the 
soluble proteins behaved in the ATPS and also the phase preference of individual 
proteins. The main contaminating protein in the crude Inactivated Bulk Fluid (IBF) 
feedstock (derived from the Medeva Fluvirin™ Process) was ovalbumin (personal 
communication P. Sinclair, 1999). Therefore with the data obtained from the partition of 
PZC, it was decided to spike the PZC with an ovalbumin source (a major impurity in the 
crude feedstock). The decision to use egg white was taken because it represented a 
readily available and more realistic (with respect to the proteinaceous process 
contaminants) source of ovalbumin. Analysis of the egg white showed it to be composed 
of a few proteins that could be easily identified by using SDS PAGE/densitometry and 
relative mobility (Rf) plots (Figure A5). The Rf values were deduced as follows:
The distance moved by the sample (mm)
The distance moved by the dyefront (mm) Equation Al.
Ovalbumin, ovotransferrin (also known as conalbumin) and lysosyme were found to be 
present in the proportions listed in Table 2.2 (quantitation obtained from a calibration 
curve in ovalbumin equivalents). The other proteins present as shown in Table 2.2 (for 
example ovoglobin) were not observed due to their relatively low abundance and hence
XI
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97.0 kDa
^___ Ovotransferrin 
67.0 kDa
43.0 kDa Ovalbumin
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20.1 kDa
14.4 kDa ___ Lysosyme
FIGURE AS. Proteins observed in egg white.
The egg white was obtained from a non-fertile hens egg. After separation 
from the egg yolk, the egg white fraction was prepared as and analysed 
using 9 % SDS PAGE gels (see Section 2.2.3). Approximately 5 ug total 
protein was applied to lanes 2 and 3.
Lane 1: Low molecular weight markers (15 ul load). 
Lane 2:100 ug ml'1 total egg white protein (10 ul load). 
Lane 3: Duplicate of Lane 2 (10 ul load).
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FIGURE A6.. Partition of egg white proteins in selected ATPSs monitored by BCA 
Assay.
Four ATPSs were used to monitor the distribution of egg white proteins loaded with 5 % 
w/w biomass. These systems were: S2 (PEG 300 20.0 % w/w/'phosphate 20.0 % w/w, 
pH 7.5), S9 (PEG 1000 12.0 % w/w/phosphate 13.0 % w/w, pH 7.5), S10 (PEG 3350 
20.0 % w/w/ phosphate 20.0 % w/w, pH 7.5) and S24 (PEG 8000 11.3 % w/w/ 
phosphate 9.2 % w/w, pH 7.5), refer to Appendix IIfor details. The mass balances were 
defined as the amount of protein in each phase divided by the total added protein to the 
system (78.8 mg). The mass balances were as follows: S2 and S9: 100.0 %, S10: 49.1 % 
and S24: 99.2 %. Refer also to Figures A7 and A8. 
Key: T: Top phase; I: Interphase; B: Bottom phase.
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less-intense staining and quantitation on the gel. The calculation of relative masses of 
each protein in each phase lead to the earliest definition of what eventually was termed a 
Fractional Mass Ratio (FMR), Section 2.3.2. This early work demonstrated the partition 
preference of individual proteins within a relatively simple protein mixture. Data from 
the partition of PZC suggested that the viral components partitioned exclusively to the 
interphase in S2. Data generated using SDS PAGE/ one-dimensional densitometry 
indicated that the majority of egg white proteins partitioned to the top phase (Figure A6). 
Thus such a system looked promising because it demonstrated selectivity for virus (refer 
to Figures A3 and A4). System S9 (Figures A3 and A4) showed that the viral 
components partitioned preferentially to the bottom phase and this trend was supported 
by SDS PAGE/ one-dimensional densitometry (data not shown). However, this ATPS 
would not be useful since a significant proportion of egg proteins in this ATPS also 
prefer the bottom phase. System S10 initially looked promising with respect to 
selectivity between the virus and contaminating proteins, but was hampered by poor 
recovery. Finally, S24 showed a bottom phase preference with respect to protein 
recovery. This was also mirrored in the recovery of the viral components (and supported 
by the SDS/ one-dimensional densitometry) thus it would seem that this ATPS would not 
be useful. Thus in summary, System S2 comprising PEG 300 appears selective in 
partitioning potential contaminating proteins away from the virus.
A. 3.3. The effect of PEG molecular weight upon partition of PZC spiked with egg white 
selected ATPSs.
Thus far the discrete partitioning behaviour of PZC in selected ATPSs was 
investigated along with the partition of egg white proteins. This section investigates
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whether the observed partition behaviour still held when both components were 
partitioned together. The distribution of egg white proteins in the presence of PZC was 
not significantly altered. A comparison of the total protein concentrations obtained using 
the BCA assay and SDS PAGE/ one-dimensional densitometry was presented in Table 
Al. The magnitude of protein concentration and trends were generally in agreement 
between the methods (except PEG 1000, because S9 is sensitive to changes in 
composition by virtue of it short TLL). This trend was also reflected in the SDS PAGE/ 
densitometry using egg white alone (data not shown), quantitation and monitoring of 
individual proteins. Differences in results were due to the differential staining of proteins 
with Coomassie Brilliant Blue partly due to the varied number of positive charges on the 
proteins, (Tal et al, 1985). It was therefore decided to produce separate calibration curves 
for each protein to account for this effect. The data from the HA Test (Figure A7) 
demonstrated that in all systems (including S10 although the value was very low) the HA 
antigen was predominantly located at the interphase except in S24 (where the preferred 
location was the bottom phase). The data could not be analysed quantitatively because 
the HA antigens were not binding adequately to the receptors on the erythrocytes. This 
was thought to be due to a conformation change or a possible antigen stripping 
mechanism exerted by the presence of PEG. The recovery was not affected by the 
presence of contaminating proteins in the egg white since the same total HAU was 
obtained with PZC alone. This suggested that the poor recovery was not due to masking 
of the receptor sites by the contaminating proteins. The magnitude of the values shown 
in Figure A8 was greater when compared to the data for PZC partitioned alone (Figure 
A4). This was attributed to the difference in scale of ATPS used and possibly due to the 
lower loading used (allowing greater accessibility of the enzyme to the substrate). The
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ATPS
(Analytical 
method).
S2 (BCA)
S9 (BCA)
S9 (SDS PAGE)
S10 (BCA)
SIO(SDSPAGE)
S24 (BCA)
S24(SDS PAGE)
Top phase 
Total protein 
(rag).
11.9
5.2
9.1
1.2
1.3
0.2
0.0
Interphase 
Total protein 
(mg).
0.6
1.3
0.0
1.2
1.2
N/A
N/A
Bottom phase 
Total protein 
(mg).
0.4
8.7
3.5
0.6
0.0
14.4
41.3
Recovery (%).
103.0
121.6
101.6
24.0
20.0
116.8
330.0
TABLE Al. The partition of egg white proteins spiked with PZC within selected ATPSs 
comparing results produced by BCA assay and SDS PAGE /one-dimensional 
densitometry method.
Four ATPSs were used to monitor the distribution of egg white proteins spiked with PZC 
loaded with 5 % w/w biomass. These systems were: S2 (PEG 300 20.0 % w/w/phosphate 
20.0 % w/w, pH 7.5), S9 (PEG 1000 12.0 % w/w/phosphate 13.0 % w/w, pH 7.5), S10 
(PEG 3350 20.0 % w/w/phosphate 20.0 % w/w, pH 7.5) and S24 (PEG 8000 11.3% w/w/ 
phosphate 9.2 % w/w, pH 7.5), refer to Appendix II for details. The mass balances were 
defined as the amount of protein in each phase divided by the total added protein to the 
system (12.5 mg). 
Key: ND: Not determined; N/A:Not applicable.
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FIGURE A 7. Partition of Purified Zonal Concentrate (PZC) in the presence of egg 
white proteins within selected ATPSs monitored by HA Test.
Four ATPSs were used to monitor the distribution of HA antigen of PZC in the presence 
of 12.5 mg egg white protein. These systems were: S2 (PEG 300 20.0 % w/w/phosphate 
20.0 % w/w, pH 7.5), S9 (PEG 1000 12.0 % w/w/phosphate 13.0 % w/w, pH 7.5), S10 
(PEG 3350 20.0 % w/w/phosphate 20.0 % w/w, pH 7.5) and S24 (PEG 8000 11.3 % 
w/w/phosphate 9.2% w/w, pH 7.5), refer to Appendix IIfor details. The mass balances 
were defined as the amount of Haemagglutinin units (HAU) in each phase divided by 
the total added HAU to the system (1.5 xlO5 HAU). The mass balances were as follows: 
S2 and S9: 26.7 %, SI0: 0.0% and S24: 50.0 %. Refer also to Figures A6 and A8. 
Key: T: Top phase; I: Interphase; B: Bottom phase.
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FIGURE A8. Partition of Purified Zonal Concentrate (PZC) in the presence of egg 
white proteins within selected ATPSs monitored by neuraminidase enzyme-linked 
assay in microplates (NELLAM).
Four ATPSs were used to monitor the distribution of neuraminidase (NA) antigen oj 
PZC in the presence of 12.5 mg egg white protein. These systems were: S2 (PEG 300 
20.0 % w/w/phosphate 20.0 % w/w, pH 7.5), S9 (PEG 1000 12.0 % w/w/phosphate 
13.0 % w/w, pH 7.5), S10 (PEG 3350 20.0 % w/w/phosphate 20.0 % w/w, pH 7.5) and 
S24 (PEG 8000 11.3 % w/w/phosphate 9.2 % w/w, pH 7.5), refer to Appendix IIfor 
details. The mass balances were defined as the amount ofNA units (NA) in each phase 
divided by the total added NA to the system (28.0 xlO'3 NA Units). The mass balances in 
all four systems were greater than 100 %. Refer also to Figures A6 and A7. 
Key: T: Top phase; I: Interphase; B: Bottom phase.
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presence of contaminating proteins did not affect the assay since PZC also gave the same 
result. In S2, the largest concentration of NA was present at the interphase. However this 
phase contributed the smallest volume. The top and bottom phase volumes were larger 
and contained lower concentrations of NA (hence the high recovery in these phases). The 
NELLAM was probably more sensitive than the HA test at detecting virus. There 
appeared to be no virus in these phases on the basis of haemagglutination. The same 
trend was observed in S9 and S24 and demonstrated that the majority of NA was 
detected in the bottom phase. Greater than 100 % closure of mass balances in the 
NELLAM was seen in majority of the systems used (in the absence or presence of egg 
white). This non-closure of mass balance occurs in the HA Test (less than 100 % 
closure) In both cases, this could be explained by changes in conformation. In the 
presence of phase forming chemicals leading to an increase in binding in the NELLAM 
and a decrease in binding in the HA Test. Methods to verify this would involve the 
analysis of the phases by binding studies. Alternatively, deliberate release the surface 
antigens using a detergent (Helenius and Simons, 1975), which would permit 
comparisons of the ability of haemagglutination and release of carbohydrates (by HA 
and NA respectively), with a non-disrupted preparation. The distribution of egg white 
proteins in the presence of PZC did not alter significantly. Also the magnitude of the 
concentration was as expected (an approximate five-fold decrease from the values shown 
in Figure A6). This study demonstrated that S2 (see Appendix II) would be useful for 
processing influenza since the virus favours the interphase whilst bulk proteins favour 
the top phase. The data obtained from S9 (see Appendix II) was not consistent. This was 
possibly because it was more sensitive (due to its low TLL) with respect to partition. 
System S10 was not useful from point of view of poor recovery and partial co-
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purification of proteins with the virus and S24 was not useful since the viral proteins co- 
purified with the contaminating proteins.
A4. PRELIMINARY OBSERVATIONS.
The Haemagglutinin Test was useful as a qualitative indicator of the HA content, but 
not as a quantitative measure. Various factors affected the assay including the phase- 
forming chemicals (notably the PEG which lead to variable mass balances) and the age 
of the cells. It was best to use the cells for HA Tests within 5 days of receiving them) as 
they become prone to lysis, (leading to false positive results). Attempts to cryopreserve 
the cells using glycerol were unsuccessful. The assay was sensitive to the erythrocyte 
concentration used (although a well-suspended cell concentration of 0.5 or 1 % v/v was 
typically used. Another future (albeit lesser) concern was that if other viruses were 
present in the complex feedstock, they may also haemadsorb to the erythrocytes thus 
distorting the results. This was not thought to represent a huge problem since the 
adaptation techniques should passage out adventitious viruses. Other reasons for not 
using this test were that it only worked using chick, guinea pig or human erythrocytes. 
The reasons for this were unclear but were possibly linked to surface antigens present on 
these cells, which the virus recognises.
The volume of the interphase was estimated as though it were a disc of thin cylinder. 
This was probably a true representation of the volume but it did not provide an accurate 
picture for the estimation of components therein since (for example) aggregation of virus 
may not permit accessibility to assay reagents and so enable accurate quantitation. It was 
decided to suspend the interphase components in a known volume of buffer prior to their 
analysis. The Micro BCA assay was not suitable to analyse the PZC possibly due to
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some interfering moiety (possibly thiomerosal) not seen in the egg white analysis. The 
Micro BCA assay had been selected in acknowledgement that the low concentration of 
PZC, (approximately 500 ug ml" 1 ), would be diluted even more in the ATPS, 
(approximately five-fold) and a further 50 to 100-fold to remove phase formants, might 
lead to problems of detection. The Bradford assay was not as sensitive as the Micro BCA 
assay and would still face the same problems regarding handling the interphase phase 
formants. Thus in conclusion, the HA and NA tracked each other fairly well suggesting 
that the viral particles remained intact or that there was release of antigens but they 
preferred the same phase. This could again be tested using electron microscopy and 
immunogold staining. System S2 (comprising PEG 300) so far looked the most 
promising ATPS. The behaviour of the individual components mimicked that of the 
spiked material. Differences were attributed to the differences in system loading. The 
importance of having supporting analytical techniques was highlighted as well as the 
problems of handling multiple phases. Suggested mechanisms for the observed partition 
behaviour are illustrated in Figure 2.10.
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APPENDIX II.
Bl Aqueous Two phase systems employed for method scouting and optimisation studies.
A complete list of all the ATPS used in the method scouting and optimisation studies 
documented in Chapters Two, Three and Appendix I of this thesis. These systems were 
chosen such that a range of variables could be investigated in the partitioning of 
influenza virus particles contained in allantoic fluid (which served as an experimental 
vehicle for processing particulate feedstocks, see Appendix I). These variables included 
PEG molecular weight, tie-line length (TLL) and volume ratio (Vrd). This permitted the 
development of methods that could be applied to the influenza virus feedstock (Chapter 
Two and Three). Systems, which directed contaminating proteins away from the virus, 
were deemed useful. The partition of virus was monitored using SDS PAGE/ one- 
dimensional densitometry (on 12 % gels) and an ELISA specific for haemagglutinin 
(HA) antigen (one of the key surface projections on the virus, see Figure 2.1). The 
partition of the contaminants was monitored using SDS PAGE/ one-dimensional 
densitometry.
TABLES Bl to B9. Aqueous two-phase systems (ATPSs) employed in method 
scouting and optimisation studies.
The systems were prepared as described in Sections 2.2.1 and 2.2.2 (for blank and 
loaded systems respectively) and the Vrds were estimated as described in Section 2.1.8. 
Systems highlighted in bold typeface were key systems in the process development 
documented in this thesis.
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TABLE Bl. PEG 300/ potassium phosphate ATPS, pH 7.5.
These systems were used in the method scouting studies documented in Chapter Two. 
System S2 was the source ATPS from which System S25 (the primary ATPS, refer to 
Figure 3.1) arose.
System ID 
number.
SI
S2
S3
S25
S26
S27
S28
S29
PEG 300 (%
w/w).
20.0
20.0
16.1
22.2
25.5
32.2
32.5
32.2
Phosphate (%
w/w)
22.0
20.0
20.0
17.9
15.0
10.0
8.4
7.3
TLL (% w/w).
43.4
45.4
28.3
43.4
43.4
43.4
43.4
Monophasic
Vrd= (Vt/Vb).
1.33
1.33
1.00
1.50
1.92
6.00
7.80
N/A
TABLE B2. PEG 600/ potassium phosphate ATPS, pH 7.5.
System ID 
number.
S4
S5
S6
PEG 600 (%
w/w).
22.2
16.1
16.6
Phosphate (%
w/w)
20.3
15.6
13.3
TLL (% w/w).
40.1
23.0
N/A
Vrd= (Vt/Vb).
1.06
1.13
Monophasic
TABLE B3. PEG 1000/ potassium phosphate ATPS, pH 7.5.
System ID 
number.
S7
S8
S9
PEG 1000 (%
w/w).
17.0
14.0
12.0
Phosphate (%
w/w)
16.8
13.0
13.0
TLL (% w/w).
36.6
25.0
8.3
Vrd= (Vt/Vb).
0.93
0.89
0.89
TABLE B4. PEG 3350/ potassium phosphate ATPS, pH 7.5.
System ID 
number.
S10
Sll
S12
PEG 3350 (%
w/w).
20.0
14.4
12.9
Phosphate (%
w/w)
20.0
12.4
11.4
TLL (% w/w).
45.8
26.1
17.5
Vrd= (Vt/Vb).
0.89
0.89
0.95
TABLE B5. PEG 6000/ potassium phosphate ATPS, pH 7.5.
System ID 
number.
PEG 6000 (%
w/w).
Phosphate (%
w/w)
TLL (% w/w). Vrd= (Vt/Vb).
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S13
S14
S15
20.0
15.0
13.9
15.0
10.5
10.8
37.7
23.9
18.8
1.03
1.10
1.00
TABLE B6. PEG 6000/ Dextran 464T (unbuffered) ATPS.
System ID 
number.
S16
S17
S18
PEG 6000 (%
w/w).
11.0
7.5
5.0
Dextran 464T
(% w/w)
20.9
15.4
9.5
TLL (% w/w).
45.0
31.4
16.9
Vrd= (Vt/Vb).
1.06
1.08
0.99
TABLE B7. PEG 6000/ Dextran 464T (buffered) ATPS, pH 7.5.
System ID 
number.
S19
S20
S21
PEG 6000 (%
w/w).
11.0
7.5
5.0
Dextran SOOT
(% w/w)
20.9
15.4
9.5
TLL (% w/w).
45.2
30.5
13.5
Vrd= (Vt/Vb).
1.00
1.08
0.99
TABLE B8. PEG 80007 potassium phosphate ATPS, pH 7.5.
System S23 was key in the volume ratio manipulation study undertaken (see Section
2.3.2.6) Systems S30 to S33 were generated on the back of S23.
System ID 
number.
S22
S23
S24
S30
S31
S32
S33
PEG 8000 (%
w/w).
22.8
15.0
11.3
12.5
10.0
7.2
5.3
Phosphate (%
w/w)
16.8
11.1
9.2
12.2
13.5
15.3
16.3
TLL (% w/w).
42.9
22.4
13.8
22.4
22.4
22.4
22.4
Vrd= (Vt/Vb).
1.07
1.06
1.18
0.69
0.50
0.29
0.20
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TABLE B9. PEG / potassium phosphate ATPS, pH 7.5.
These systems were used as intermediate systems and secondary hybrid systems (refer to 
Figure 3.1). The effect of PEG molecular weight was evaluated to see which was optimal 
for processing Inactivated Bulk Fluid (IBF) material in Aqueous-detergent two-phase 
systems (ADTPSs). System S40 in the presence of Triton X100 was the optimal system 
(see Section 3.3.3.5).
System ID 
number.
S34
S35
S39
S40
System ID 
number.
S36
S41
System ID 
number.
S37
S42
S43
System ID 
number.
S38
PEG 300 (%
w/w).
10.0
10.0
16.8
13.9
PEG 1000 (%
w/w).
10.7
7.3
PEG 6000 (%
w/w).
10.0
7.8
7.2
PEG 8000 (%
w/w).
8.3
Phosphate (%
w/w)
30.0
25.0
22.9
24.3
Phosphate (%
w/w)
13.9
27.6
Phosphate (%
w/w)
9.1
25.3
27.1
Phosphate (%
w/w)
10.0
TLL (% w/w).
43.4
28.3
43.5
35.3
TLL (% w/w).
8.3
29.4
TLL (% w/w).
19.0
34.7
33.9
TLL (% w/w).
13.8
Vrd= (Vt/Vb).
0.38
0.36
0.83
0.93
Vrd= (Vt/Vb).
0.55
0.56
Vrd= (Vt/Vb).
0.50
0.52
0.44
Vrd= (Vt/Vb).
0.50
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